Disease of genetic or genomic mechanism
MONDO:7770009A grouping class for human diseases caused by genetic or genomic alterations, including chromosomal abnormalities and heritable mutations.
18379 clinical trials for this condition and its sub-types, 2 tagged with Disease of genetic or genomic mechanism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disease of genetic or genomic mechanism
-
Hereditary disease 194 trials · 18,235 incl. sub-types
1,925 sub-types
- Hereditary neurological disease 6 trials · 5,791 incl. sub-types Sub-types →
- Inborn errors of metabolism 48 trials · 2,231 incl. sub-types Sub-types →
- Autosomal genetic disease 0 trials · 1,670 incl. sub-types Sub-types →
- Hereditary disorder of connective tissue 0 trials · 1,314 incl. sub-types Sub-types →
- Inflammatory bowel disease 430 trials · 1,081 incl. sub-types Sub-types →
- Hereditary skin disorder 7 trials · 885 incl. sub-types Sub-types →
- Immunodeficiency disease 55 trials · 779 incl. sub-types Sub-types →
- Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types Sub-types →
- Skeletal dysplasia 1 trial · 663 incl. sub-types Sub-types →
- Cardiogenetic disease 3 trials · 618 incl. sub-types Sub-types →
- Inherited hemoglobinopathy 38 trials · 440 incl. sub-types Sub-types →
- COPD, severe early onset 406 trials
- Hereditary skeletal muscle disorder 1 trial · 406 incl. sub-types Sub-types →
- X-linked disease 19 trials · 327 incl. sub-types Sub-types →
- Inherited blood coagulation disorder 8 trials · 323 incl. sub-types Sub-types →
- Hereditary dementia 2 trials · 322 incl. sub-types Sub-types →
- Inherited kidney disorder 1 trial · 317 incl. sub-types Sub-types →
- Cataract 294 trials · 305 incl. sub-types Sub-types →
- Myopia 259 trials · 274 incl. sub-types Sub-types →
- Preeclampsia 232 trials · 236 incl. sub-types Sub-types →
- Burkitt lymphoma 221 trials Sub-types →
- Gastroesophageal reflux disease 217 trials Sub-types →
- Intervertebral disk degenerative disorder 123 trials · 217 incl. sub-types Sub-types →
- Polycystic ovary syndrome 201 trials
- Classic Hodgkin lymphoma 147 trials · 149 incl. sub-types Sub-types →
- Ewing sarcoma 125 trials · 126 incl. sub-types Sub-types →
- Bronchiectasis 119 trials · 120 incl. sub-types Sub-types →
- Inherited auditory system disease 0 trials · 120 incl. sub-types Sub-types →
- Hereditary otorhinolaryngologic disease 0 trials · 102 incl. sub-types Sub-types →
- Osteonecrosis of genetic origin 0 trials · 102 incl. sub-types Sub-types →
- RASopathy 9 trials · 101 incl. sub-types Sub-types →
- Hypogonadotropic hypogonadism 19 trials · 100 incl. sub-types Sub-types →
- Lymphoproliferative syndrome 70 trials · 100 incl. sub-types Sub-types →
- Gastrointestinal stromal tumor 93 trials
- Familial polycythemia 1 trial · 92 incl. sub-types Sub-types →
- Familial colorectal cancer 3 trials · 91 incl. sub-types Sub-types →
- Celiac disease 81 trials Sub-types →
- Cirrhosis, familial 4 trials · 79 incl. sub-types Sub-types →
- Spondylolisthesis 77 trials Sub-types →
- Orofacial cleft 4 trials · 69 incl. sub-types Sub-types →
- Developmental dysplasia of the hip 62 trials Sub-types →
- Keratoconus 61 trials Sub-types →
- Anodontia 59 trials Sub-types →
- Enterocolitis 3 trials · 58 incl. sub-types Sub-types →
- Lymphatic malformation 17 trials · 56 incl. sub-types Sub-types →
- Inherited aplastic anemia 2 trials · 53 incl. sub-types Sub-types →
- Synovial sarcoma 53 trials Sub-types →
- Hereditary glaucoma 0 trials · 50 incl. sub-types Sub-types →
- Ciliopathy 2 trials · 49 incl. sub-types Sub-types →
- Bone marrow failure syndrome 48 trials Sub-types →
- Inherited primary ovarian failure 2 trials · 48 incl. sub-types Sub-types →
- Ehlers-Danlos syndrome 20 trials · 46 incl. sub-types Sub-types →
- Malocclusion due to protuberant upper front teeth 41 trials
- Craniosynostosis 17 trials · 39 incl. sub-types Sub-types →
- Chronic granulomatous disease 37 trials Sub-types →
- Hereditary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Hypospadias 35 trials Sub-types →
- Preterm premature rupture of the membranes 35 trials
- Fragile X syndrome 34 trials Sub-types →
- Fuchs' endothelial dystrophy 33 trials Sub-types →
- Pilonidal sinus 33 trials
- Spondylosis, cervical 33 trials
- Arteriovenous malformations of the brain 32 trials
- MALT lymphoma 30 trials · 31 incl. sub-types Sub-types →
- Deafness, unilateral 30 trials
- Hirschsprung disease 29 trials
- Inherited thrombocytopenia 2 trials · 29 incl. sub-types Sub-types →
- Pathological gambling 28 trials
- Familial hemolytic anemia 4 trials · 27 incl. sub-types Sub-types →
- Hereditary hypoparathyroidism 0 trials · 26 incl. sub-types Sub-types →
- Inherited bleeding disorder, platelet-type 6 trials · 26 incl. sub-types Sub-types →
- Laminopathy 4 trials · 26 incl. sub-types Sub-types →
- Oculocerebral hypopigmentation syndrome of Preus 26 trials
- Syncope, familial vasovagal 26 trials
- Hypogonadism, male 24 trials
- Diastasis recti and weakness of the linea alba 23 trials
- Trigger thumb 23 trials
- Speech-sound disorder 22 trials
- Tooth agenesis 22 trials Sub-types →
- Anterior segment dysgenesis 2 trials · 21 incl. sub-types Sub-types →
- Alveolar soft part sarcoma 20 trials Sub-types →
- Pectus excavatum 20 trials
- Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 16 trials · 19 incl. sub-types Sub-types →
- Familial clubfoot with or without associated lower limb anomalies 0 trials · 18 incl. sub-types Sub-types →
- Hereditary hypophosphatemic rickets 1 trial · 18 incl. sub-types Sub-types →
- Familial osteosclerosis 0 trials · 16 incl. sub-types Sub-types →
- Hereditary hemophagocytic lymphohistiocytosis 8 trials · 16 incl. sub-types Sub-types →
- Familial nonmedullary thyroid carcinoma 3 trials · 15 incl. sub-types Sub-types →
- Arts syndrome 14 trials
- Chiari malformation 13 trials · 14 incl. sub-types Sub-types →
- Klippel-Feil syndrome 14 trials Sub-types →
- Cryptorchidism 14 trials Sub-types →
- Essential hypertension, genetic 14 trials
- Periodontitis, chronic, adult 14 trials
- Pregnancy loss, recurrent, 4 14 trials
- Visceral leishmaniasis 14 trials
- Aorta coarctation 13 trials Sub-types →
- Familial spontaneous pneumothorax 13 trials
- Hereditary anemia 2 trials · 13 incl. sub-types Sub-types →
- SMAD6-related disease 0 trials · 12 incl. sub-types Sub-types →
- Familial thoracic aortic aneurysm and aortic dissection 11 trials · 12 incl. sub-types Sub-types →
- Ovarian hyperstimulation syndrome 12 trials
- Pleomorphic adenoma 12 trials
- Spermatogenic failure 1 trial · 12 incl. sub-types Sub-types →
- CDKL5 disorder 8 trials · 11 incl. sub-types Sub-types →
- CGF1 11 trials
- Ankyloglossia 11 trials
- Familial long QT syndrome 1 trial · 11 incl. sub-types Sub-types →
- Heritable pulmonary arterial hypertension 10 trials · 11 incl. sub-types Sub-types →
- Inherited interstitial lung disease 5 trials · 11 incl. sub-types Sub-types →
- Parasomnia, sleep bruxism type 11 trials
- Progeroid syndrome 3 trials · 11 incl. sub-types Sub-types →
- Syndromic microphthalmia 0 trials · 11 incl. sub-types Sub-types →
- Tardive dyskinesia 11 trials
- Thyroid Hurthle cell carcinoma 11 trials
- Trichotillomania 11 trials
- Phelan-McDermid syndrome 10 trials Sub-types →
- Raynaud disease 10 trials
- Arthritis, sacroiliac 10 trials
- Bile duct cyst 10 trials
- Central precocious puberty 9 trials · 10 incl. sub-types Sub-types →
- Erythromelalgia 3 trials · 10 incl. sub-types Sub-types →
- Fibrodysplasia ossificans progressiva 10 trials
- Hereditary breast carcinoma 10 trials Sub-types →
- Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 10 trials
- Multinodular goiter 10 trials Sub-types →
- Myostatin-related muscle hypertrophy 10 trials
- IgE responsiveness, atopic 9 trials
- Familial pancreatic carcinoma 9 trials
- Immunodeficiency 32B 9 trials
- Impacted teeth, multiple 9 trials
- Inherited obesity 8 trials · 9 incl. sub-types Sub-types →
- Neuropathy, painful 9 trials
- Obesity-hypoventilation syndrome 9 trials
- Peripheral arterial occlusive disease 1 9 trials
- Polydactyly 2 trials · 9 incl. sub-types Sub-types →
- Syndactyly 3 trials · 9 incl. sub-types Sub-types →
- Central centrifugal cicatricial alopecia 8 trials
- Familial ovarian cancer 1 trial · 8 incl. sub-types Sub-types →
- Hyperhidrosis palmaris ET plantaris 8 trials
- Lower urinary tract obstruction, congenital 8 trials
- Masticatory muscles, hypertrophy of 8 trials
- Severe congenital neutropenia 5 trials · 8 incl. sub-types Sub-types →
- Spondylocostal dysostosis 5 trials · 8 incl. sub-types Sub-types →
- Van der Woude syndrome 8 trials Sub-types →
- Silver-Russell syndrome 7 trials Sub-types →
- Amelogenesis imperfecta 3 trials · 7 incl. sub-types Sub-types →
- Arterial calcification of infancy 7 trials Sub-types →
- Extraskeletal myxoid chondrosarcoma 7 trials Sub-types →
- Febrile seizures, familial 4 trials · 7 incl. sub-types Sub-types →
- Inherited sideroblastic anemia 2 trials · 7 incl. sub-types Sub-types →
- Malposition of teeth with or without hypodontia/oligodontia 7 trials
- Protein-losing enteropathy 7 trials
- Spermatic cord torsion 7 trials
- CSF1R-related disorder 0 trials · 6 incl. sub-types Sub-types →
- DICER1-related tumor predisposition 1 trial · 6 incl. sub-types Sub-types →
- Angioosteohypertrophic syndrome 6 trials
- Bundle branch block, familial isolated complete right 6 trials
- Channelopathy-associated congenital insensitivity to pain, autosomal recessive 6 trials
- Familial isolated congenital asplenia 6 trials
- Fibromuscular dysplasia 6 trials Sub-types →
- Hereditary chronic pancreatitis 6 trials Sub-types →
- Hereditary gastric cancer 1 trial · 6 incl. sub-types Sub-types →
- Hereditary pulmonary alveolar proteinosis 3 trials · 6 incl. sub-types Sub-types →
- Hypotrichosis 5 trials · 6 incl. sub-types Sub-types →
- Laryngeal adductor paralysis 6 trials
- Leukoencephalopathy, hereditary diffuse, with spheroids 1 trial · 6 incl. sub-types Sub-types →
- Periodontitis, aggressive 4 trials · 6 incl. sub-types Sub-types →
- Sclerosteosis 6 trials Sub-types →
- Uterine anomalies 6 trials
- COL4A1/A2-related disorder 2 trials · 5 incl. sub-types Sub-types →
- Cornelia de Lange syndrome 4 trials · 5 incl. sub-types Sub-types →
- Central hypoventilation syndrome, congenital 0 trials · 5 incl. sub-types Sub-types →
- Congenital diarrhea 0 trials · 5 incl. sub-types Sub-types →
- Hereditary Wilms tumor 1 trial · 5 incl. sub-types Sub-types →
- Hereditary narcolepsy 0 trials · 5 incl. sub-types Sub-types →
- Hydatidiform mole 3 trials · 5 incl. sub-types Sub-types →
- Oculoauriculovertebral spectrum with radial defects 0 trials · 5 incl. sub-types Sub-types →
- Primary failure of tooth eruption 5 trials
- Progesterone resistance 5 trials
- Pulmonic stenosis 5 trials
- CTNNB1-related neurodevelopmental disorder and/or vitreoretinopathy 3 trials · 4 incl. sub-types Sub-types →
- WHIM syndrome 4 trials Sub-types →
- Alopecia universalis 4 trials
- Asthma, nasal polyps, and aspirin intolerance 4 trials
- Bile acid malabsorption, primary, 1 4 trials
- Diastema, dental medial 4 trials
- Familial juvenile hypertrophy of the breast 4 trials
- Fetal and neonatal alloimmune thrombocytopenia 4 trials Sub-types →
- Global developmental delay with or without impaired intellectual development 4 trials
- Growth delay due to insulin-like growth factor I resistance 4 trials
- Hernia, double inguinal 4 trials
- Hyperreflexia 4 trials
- Low density lipoprotein cholesterol, mild elevation of 4 trials
- Parathyroid gland carcinoma 4 trials
- Prostate cancer, hereditary 1 trial · 4 incl. sub-types Sub-types →
- Pulmonary atresia-intact ventricular septum syndrome 4 trials
- Urinary bladder, atony of 4 trials
- Volvulus of midgut 4 trials Sub-types →
- 7q11.23 microduplication syndrome 3 trials Sub-types →
- AP-4 deficiency syndrome 0 trials · 3 incl. sub-types Sub-types →
- Cushing syndrome due to macronodular adrenal hyperplasia 3 trials Sub-types →
- Pitt-Hopkins or Pitt-Hopkins-like syndrome 0 trials · 3 incl. sub-types Sub-types →
- Protrusio acetabuli 3 trials
- Capillary malformation-arteriovenous malformation syndrome 3 trials Sub-types →
- Delayed puberty, self-limited 3 trials
- Distal arthrogryposis 0 trials · 3 incl. sub-types Sub-types →
- Ear malformation 3 trials Sub-types →
- Epithelial-stromal TGFBI dystrophy 1 trial · 3 incl. sub-types Sub-types →
- Fibrinolytic defect 3 trials
- Genu valgum, st. Helena familial 3 trials
- Hematuria, benign familial 3 trials Sub-types →
- Lethal congenital contracture syndrome 0 trials · 3 incl. sub-types Sub-types →
- Patella, familial recurrent dislocation of 3 trials
- Pigment dispersion syndrome 3 trials
- Popliteal cyst 3 trials
- Portal hypertension, noncirrhotic 3 trials Sub-types →
- Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome 3 trials
- Spatial visualization, aptitude for 3 trials
- Striae distensae, familial 3 trials
- Tooth ankylosis 3 trials
- Achoo syndrome 2 trials
- Kabuki syndrome 2 trials Sub-types →
- Kasabach-Merritt syndrome 2 trials
- POLR3A-related disorder 0 trials · 2 incl. sub-types Sub-types →
- Pseudofolliculitis barbae 2 trials
- Young syndrome 2 trials
- Alcohol sensitivity, acute 2 trials
- Androgen insensitivity syndrome 1 trial · 2 incl. sub-types Sub-types →
- Anisomastia 2 trials
- Arthrogryposis multiplex congenita 1 trial · 2 incl. sub-types Sub-types →
- Arthropathy, erosive 2 trials
- Atrichia with papular lesions 2 trials
- Autoimmune disease, multisystem, infantile-onset 0 trials · 2 incl. sub-types Sub-types →
- Bone Paget disease 2 trials Sub-types →
- Breath-holding Spells 2 trials
- Capillary infantile hemangioma 2 trials
- Cardiac valvular defect 2 trials Sub-types →
- Celiac trunk compression syndrome 2 trials
- Congenital hereditary endothelial dystrophy of cornea 2 trials
- Congenital pseudoarthrosis of the limbs 1 trial · 2 incl. sub-types Sub-types →
- Cornea plana 0 trials · 2 incl. sub-types Sub-types →
- Cystic disease of lung 2 trials
- Dementia/parkinsonism with non-Alzheimer amyloid plaques 2 trials
- Dyskinesia with orofacial involvement 1 trial · 2 incl. sub-types Sub-types →
- Expansile bone lesions 2 trials
- Familial abdominal aortic aneurysm 0 trials · 2 incl. sub-types Sub-types →
- Familial hyperaldosteronism 0 trials · 2 incl. sub-types Sub-types →
- Familial thrombocytosis 2 trials Sub-types →
- Grouped pigmentation of the retina 2 trials
- Hereditary gingival fibromatosis 0 trials · 2 incl. sub-types Sub-types →
- Histiocytoma, Angiomatoid fibrous 2 trials
- Inherited cutis laxa 0 trials · 2 incl. sub-types Sub-types →
- Inosine triphosphatase deficiency 2 trials
- Insect Stings, hypersensitivity to 2 trials
- Insulin-resistance syndrome type A 2 trials
- Intussusception 2 trials
- Islet cell adenomatosis 0 trials · 2 incl. sub-types Sub-types →
- Juvenile arthritis due to defect in LACC1 2 trials
- Kyphoscoliosis 1 2 trials
- Multisystemic smooth muscle dysfunction syndrome 2 trials Sub-types →
- Muscular hypertonia, lethal 2 trials
- Myelodysplastic syndrome associated with isolated del(5q) 2 trials
- Nose, anomalous shape of 2 trials
- Platelet aggregation, spontaneous 2 trials
- Portal vein, cavernous transformation of 2 trials
- Primary pigmented nodular adrenocortical disease 2 trials Sub-types →
- Ragweed sensitivity 2 trials
- Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 2 trials
- Teeth, supernumerary 2 trials
- 17q11.2 microduplication syndrome 1 trial
- A20 haploinsufficiency 1 trial
- ACAN-related short stature spectrum 0 trials · 1 incl. sub-types Sub-types →
- Axenfeld-Rieger syndrome 1 trial Sub-types →
- BENTA disease 1 trial
- CACNA1C-related disorder 0 trials · 1 incl. sub-types Sub-types →
- CFTR-related disorder 1 trial Sub-types →
- Caroli syndrome 1 trial
- Caronte 1 trial
- Charcot-Marie-Tooth disease-hearing loss-intellectual disability syndrome 1 trial
- Chopra-Amiel-Gordon syndrome 1 trial
- Coffin-Siris syndrome 1 trial Sub-types →
- Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency 1 trial
- DHDDS-CDG 1 trial Sub-types →
- ELANE-related neutropenia 0 trials · 1 incl. sub-types Sub-types →
- Koolen-de Vries syndrome 1 trial Sub-types →
- L-ferritin deficiency 1 trial
- Mazabraud syndrome 1 trial
- Mendelian encephalopathy 0 trials · 1 incl. sub-types Sub-types →
- NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types Sub-types →
- PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder 0 trials · 1 incl. sub-types Sub-types →
- Potocki-Lupski syndrome 1 trial
- RNU4ATAC spectrum disorder 1 trial Sub-types →
- Rombo syndrome 1 trial
- Shashi-Pena syndrome 1 trial
- Snijders Blok-Campeau syndrome 1 trial
- TOR1AIP1-related nuclear envelopathy 0 trials · 1 incl. sub-types Sub-types →
- Taqi polymorphism 1 trial
- WFS1-related disorder 0 trials · 1 incl. sub-types Sub-types →
- X-linked dominant chondrodysplasia, Chassaing-Lacombe type 1 trial
- Y-linked disease 0 trials · 1 incl. sub-types Sub-types →
- Yao syndrome 1 trial
- Acrofacial dysostosis 0 trials · 1 incl. sub-types Sub-types →
- Aganglionosis, total intestinal 1 trial
- Anisocoria 1 trial
- Arcus senilis 1 trial
- Autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency 1 trial
- Beta-aminoisobutyric acid, urinary excretion of 1 trial
- Central areolar choroidal dystrophy 1 trial Sub-types →
- Chromosome 15q24 deletion syndrome 1 trial
- Congenital bilateral absence of vas deferens 1 trial Sub-types →
- Congenital insensitivity to pain syndrome, Marsili type 1 trial
- Contractures, pterygia, and variable skeletal fusions syndrome 0 trials · 1 incl. sub-types Sub-types →
- Coracoclavicular joint, anomalous 1 trial
- Coxa vara 1 trial
- Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy 1 trial
- Dysautonomia-like disorder 1 trial
- Early repolarization associated with ventricular fibrillation 1 trial
- Electroencephalographic peculiarity: fronto-precentral beta wave groups 1 trial
- Eosinophilia, familial 1 trial
- Epilepsy, early-onset 0 trials · 1 incl. sub-types Sub-types →
- Esophagitis, eosinophilic, 1 1 trial
- Familial male-limited precocious puberty 1 trial
- Familial melanoma 1 trial Sub-types →
- Familial vesicoureteral reflux 0 trials · 1 incl. sub-types Sub-types →
- Fleck corneal dystrophy 1 trial
- Focal dermal hypoplasia 1 trial
- Foveal hypoplasia 1 trial Sub-types →
- Frontonasal dysplasia 1 trial Sub-types →
- Gastrointestinal defect and immunodeficiency syndrome 0 trials · 1 incl. sub-types Sub-types →
- Graying of hair, precocious 1 trial
- Growth delay due to insulin-like growth factor type 1 deficiency 1 trial
- Growth hormone insensitivity syndrome with immune dysregulation 0 trials · 1 incl. sub-types Sub-types →
- Hereditary arterial and articular multiple calcification syndrome 1 trial
- Hereditary gallbladder disorder 0 trials · 1 incl. sub-types Sub-types →
- Horizontal gaze palsy with progressive scoliosis 1 trial Sub-types →
- Hyperpigmentation of eyelid 1 trial
- Hypoparathyroidism-deafness-renal disease syndrome 1 trial
- Hypothyroidism, congenital, nongoitrous 0 trials · 1 incl. sub-types Sub-types →
- Ichthyosis prematurity syndrome 1 trial
- Immunodysregulation with variable immunodeficiency and autoimmunity 1 trial
- Infantile liver failure 0 trials · 1 incl. sub-types Sub-types →
- Isolated congenital breast hypoplasia/aplasia 0 trials · 1 incl. sub-types Sub-types →
- Isolated microphthalmia 0 trials · 1 incl. sub-types Sub-types →
- Levator-medial rectus synkinesis 1 trial
- Lumbar stenosis, familial 1 trial
- Megalodactyly 1 trial
- Microtia with meatal atresia and conductive deafness 1 trial
- Modifier, X-linked, for Neurofunctional defects 1 trial
- Myeloperoxidase deficiency 1 trial
- Nasal alar collapse, bilateral 1 trial
- Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 0 trials · 1 incl. sub-types Sub-types →
- Neutropenia, chronic familial 1 trial
- Nocturnal enuresis, 2 1 trial
- Nonimmune chronic idiopathic neutropenia of adults 1 trial
- Pancreatic agenesis 0 trials · 1 incl. sub-types Sub-types →
- Papillomatosis, confluent and reticulated 1 trial
- Pernicious anemia 1 trial
- Platelet membrane fluidity 1 trial
- Posterior polymorphous corneal dystrophy 1 trial Sub-types →
- Premature centromere division 1 trial
- Progressive deafness with stapes fixation 1 trial
- Prolactin deficiency, isolated 1 trial
- Pulmonary atresia with ventricular septal defect 1 trial
- Pyropoikilocytosis, hereditary 1 trial
- Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency 1 trial
- Split hand-foot malformation 0 trials · 1 incl. sub-types Sub-types →
- Tarsal coalition 1 trial
- Taurodontism 1 trial
- Trichomegaly 1 trial Sub-types →
- Triphalangeal thumb, Nonopposable 1 trial
- Tune deafness 1 trial
- Urolithiasis, uric acid, autosomal dominant 1 trial
- Visceral heterotaxy 1 trial Sub-types →
- 3MC syndrome 0 trials Sub-types →
- 46,XX sex reversal 1 0 trials
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency 0 trials
- 46,xx sex reversal 5 0 trials
- 5-hydroxytryptamine oxygenase regulator 0 trials
- 6-phosphogluconolactonase deficiency 0 trials
- ACCES syndrome 0 trials
- ACD-related telomere biology disorder 0 trials Sub-types →
- ADNP-related blepharophimosis-intellectual disability syndrome 0 trials
- AKT3-related overgrowth spectrum 0 trials Sub-types →
- Abruzzo-Erickson syndrome 0 trials
- Achard syndrome 0 trials
- Acrodysplasia with ossification abnormalities, short stature, and fibular hypoplasia 0 trials
- Adams-Oliver syndrome 0 trials Sub-types →
- Alazami-Yuan syndrome 0 trials
- Alfadhel syndrome 0 trials
- Alkuraya-Kucinskas syndrome 0 trials
- Amobarbital, deficient N-hydroxylation of 0 trials
- Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome 0 trials
- Armfield syndrome 0 trials
- Atelis syndrome 0 trials Sub-types →
- Athrombia, essential 0 trials
- Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities 0 trials
- Ayme-Gripp syndrome 0 trials
- B-cell immunodeficiency, distal limb anomalies, and urogenital malformations 0 trials
- BAFopathy 0 trials Sub-types →
- BMP4-related ocular growth disorder 0 trials Sub-types →
- Bamforth-Lazarus syndrome 0 trials
- Baralle-Macken syndrome 0 trials
- Basilicata-Akhtar syndrome 0 trials
- Beck-Fahrner syndrome 0 trials
- Birbeck granule deficiency 0 trials
- Boudin-Mortier syndrome 0 trials
- Bowen syndrome of multiple malformations 0 trials
- Brachmann-de Lange-like facial changes with microcephaly, metatarsus adductus, and developmental delay 0 trials
- Brachymetatarsus 4 0 trials
- Brachymorphism-onychodysplasia-dysphalangism syndrome 0 trials
- Braddock-Carey syndrome 0 trials Sub-types →
- Bryant-Li-Bhoj neurodevelopmental syndrome 0 trials Sub-types →
- Buratti-Harel syndrome 0 trials
- CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome 0 trials
- CEBALID syndrome 0 trials
- CHAND syndrome 0 trials
- CLAPO syndrome 0 trials
- CRYAB-related myofibrillar myopathy-cataract-cardiomyopathy spectrum disorder 0 trials Sub-types →
- Camptosynpolydactyly, complex 0 trials
- Car factor deficiency 0 trials
- Carabelli anomaly of maxillary molar teeth 0 trials
- Cardioneuromyopathy with hyaline masses and nemaline rods 0 trials
- Carey-Fineman-Ziter syndrome 0 trials Sub-types →
- Catifa syndrome 0 trials
- Charcot-Marie-Tooth peroneal muscular atrophy, X-linked, with aplasia cutis congenita 0 trials
- Chitayat syndrome 0 trials
- Chondronectin 0 trials
- Christianson syndrome 0 trials
- Chudley-McCullough syndrome 0 trials
- Cohen-Gibson syndrome 0 trials
- Crane-Heise syndrome 0 trials
- Cree intellectual disability syndrome 0 trials
- DEGCAGS syndrome 0 trials
- DNA, low-repetitive sequences of 0 trials
- DNA, satellite, 3 0 trials
- DONSON-related microcephaly-short stature-limb abnormalities spectrum 0 trials
- DOORS syndrome 0 trials
- Darwinian tubercle of pinna 0 trials
- Dauwerse-Peters syndrome 0 trials
- DeSanto-Shinawi syndrome due to WAC point mutation 0 trials
- Devriendt syndrome 0 trials
- Diamond-Blackfan anemia-like 0 trials
- Diets-Jongmans syndrome 0 trials
- Dohle bodies and leukemia 0 trials
- Dursun syndrome 0 trials
- Dyserythropoiesis, congenital, with ultrastructurally normal erythroblast heterochromatin 0 trials
- EDICT syndrome 0 trials
- EN1-related dorsoventral syndrome 0 trials Sub-types →
- EPHB4-associated vascular malformation spectrum 0 trials Sub-types →
- Elsahy-Waters syndrome 0 trials
- Emanuel syndrome 0 trials
- Eosinophilopenia 0 trials
- FDXR-related optic atrophy mitochondrial dysfunction syndrome 0 trials Sub-types →
- FG syndrome 0 trials Sub-types →
- FICUS syndrome 0 trials
- FRAXD syndrome 0 trials
- FRAXF syndrome 0 trials
- Fanconi-like syndrome 0 trials Sub-types →
- Faundes-Banka syndrome 0 trials
- Fliedner-Zweier syndrome 0 trials
- Floating-Harbor syndrome 0 trials
- Fowler syndrome 0 trials
- Fraser-like syndrome 0 trials
- Freesia Flowers, inability to smell 0 trials
- Friedreich ataxia and congenital glaucoma 0 trials
- Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness 0 trials
- GATA1-Related X-Linked Cytopenia 0 trials Sub-types →
- GCGR-related hyperglucagonemia 0 trials
- GOMBO syndrome 0 trials
- GRACILE syndrome 0 trials
- Gabriele de Vries syndrome 0 trials
- Gamstorp-Wohlfart syndrome 0 trials
- Giacheti syndrome 0 trials
- Glucoglycinuria 0 trials
- Goldberg-Shprintzen syndrome 0 trials
- Grant syndrome 0 trials
- Guillouet-Gordon syndrome 0 trials
- Guttmacher syndrome 0 trials
- Halothane hepatitis 0 trials
- Hengel-Maroofian-Schols syndrome 0 trials
- Heyn-Sproul-Jackson syndrome 0 trials
- Hhhh syndrome 0 trials
- Hirschsprung disease with heart defects, laryngeal anomalies, and preaxial polydactyly 0 trials
- Hirschsprung disease with ulnar polydactyly, polysyndactyly of big toes, and ventricular septal defect 0 trials
- Hirschsprung disease, cardiac defects, and autonomic dysfunction 0 trials
- Hooft disease 0 trials
- Houge-Janssens syndrome 0 trials Sub-types →
- Hoxha-Aliu syndrome 0 trials
- Hunter-Macdonald syndrome 0 trials
- Huppke-Brendel syndrome 0 trials
- Hutterite cerebroosteonephrodysplasia syndrome 0 trials
- ICHAD syndrome 0 trials
- IVIC syndrome 0 trials
- Imagawa-Matsumoto syndrome 0 trials
- Jaberi-Elahi syndrome 0 trials
- Jalili syndrome 0 trials
- Jawad syndrome 0 trials
- Juberg-Hayward syndrome 0 trials
- Jumping Frenchmen of Maine 0 trials
- KLHL7-related Bohring-Opitz-like syndrome 0 trials
- Kallmann syndrome with spastic paraplegia 0 trials
- Karsch-Neugebauer syndrome 0 trials
- Kaya-Barakat-Masson syndrome 0 trials
- Keipert syndrome 0 trials
- Khan-Khan-Katsanis syndrome 0 trials
- Kifafa seizure disorder 0 trials
- Kleefstra syndrome 0 trials Sub-types →
- Kniest-like dysplasia with pursed lips and ectopia lentis 0 trials
- Kohlschutter-Tonz syndrome-like 0 trials
- Kury-Isidor syndrome 0 trials
- Kyrle disease 0 trials
- LTBP2-related ocular dysgenesis 0 trials Sub-types →
- Lamb-Shaffer syndrome 0 trials
- Lambotte syndrome 0 trials
- Lessel-Kreienkamp syndrome 0 trials
- Leydig cell hypoplasia, type 1 0 trials Sub-types →
- Li-Campeau syndrome 0 trials
- Li-Ghorbani-Weisz-Hubshman syndrome 0 trials
- Liang-Wang syndrome 0 trials
- Liberfarb syndrome 0 trials
- Lisch epithelial corneal dystrophy 0 trials
- Long-Olsen-Distelmaier syndrome 0 trials
- Lopes-Maciel-Rodan syndrome 0 trials
- Lui-Jee-Baron syndrome 0 trials
- Luo-Schoch-Yamamoto syndrome 0 trials
- Luscan-Lumish syndrome 0 trials
- MECOM-associated syndrome 0 trials Sub-types →
- MIRAGE syndrome 0 trials
- MOMO syndrome 0 trials
- MORM syndrome 0 trials
- MTOR-related overgrowth spectrum 0 trials
- Malan overgrowth syndrome 0 trials
- Mammastatin 0 trials
- Marinesco-Sjogren-like syndrome 0 trials
- Martinez-Frias syndrome 0 trials
- Meacham syndrome 0 trials
- Meckel diverticulum 0 trials
- Meesmann corneal dystrophy 0 trials Sub-types →
- Meester-Loeys syndrome 0 trials
- Megarbane syndrome 0 trials
- Megarbane-Jalkh syndrome 0 trials
- Melhem-Fahl syndrome 0 trials
- Menke-Hennekam syndrome 0 trials Sub-types →
- Monophalangy of great toe 0 trials
- Moynahan syndrome 0 trials
- Muggenthaler-Chowdhury-Chioza syndrome 0 trials
- Mullegama-Klein-Martinez syndrome 0 trials
- Mungan syndrome 0 trials
- N-acetylaspartate deficiency 0 trials
- NDUFB11-related disorders 0 trials Sub-types →
- NR2F2 related multiple congenital anomalies/dysmorphic syndrome 0 trials
- NR5A1-related sex development disorder 0 trials Sub-types →
- Nance-Horan syndrome 0 trials
- Nguyen syndrome 0 trials
- Nizon-Isidor syndrome 0 trials
- O'Donnell-Luria-Rodan syndrome 0 trials
- Okt4 epitope deficiency 0 trials
- Onychotrichodysplasia and neutropenia 0 trials
- Opitz G/BBB syndrome 0 trials Sub-types →
- Opticocochleodentate degeneration 0 trials
- Oroacral syndrome, Verloes-Koulischer type 0 trials
- Osebold skeletal dysplasia/osteolysis syndrome 0 trials
- PI4KA-related disorder 0 trials Sub-types →
- PIK3R1-related immunodeficiency and SHORT syndrome 0 trials Sub-types →
- PMP22-RAI1 contiguous gene duplication syndrome 0 trials
- POLR1C-related disorder 0 trials Sub-types →
- POLR3B-related disorder 0 trials Sub-types →
- PR interval, variation in 0 trials
- Paine syndrome 0 trials
- Pan-Chung-Bellen syndrome 0 trials
- Paramolar tubercle of bolk 0 trials
- Parotidomegaly, hereditary bilateral 0 trials
- Partington-Anderson syndrome 0 trials
- Passovoy factor defect 0 trials
- Pechet factor deficiency 0 trials
- Perlman syndrome 0 trials
- Pierre Robin syndrome-faciodigital anomaly syndrome 0 trials
- Pilotto syndrome 0 trials
- Polyosteolysis-hyperostosis syndrome 0 trials
- Prepapillary vascular loops 0 trials
- Primrose syndrome 0 trials
- Pseudoatrophoderma colli 0 trials
- Pseudopili annulati 0 trials
- Pseudouridinuria and mental defect 0 trials
- Rabin-Pappas syndrome 0 trials
- Rabson-Mendenhall syndrome 0 trials
- Radio-Tartaglia syndrome 0 trials
- Rahman syndrome 0 trials
- Ramon syndrome 0 trials
- Rauch-Steindl syndrome 0 trials
- Reese retinal dysplasia 0 trials
- Reynolds syndrome 0 trials
- Robin sequence-oligodactyly syndrome 0 trials
- Robinow-Sorauf syndrome 0 trials
- Roussy-Levy syndrome 0 trials
- Rowley-Rosenberg syndrome 0 trials
- SEC61A1 deficiency 0 trials Sub-types →
- STAD syndrome 0 trials
- SYCE1-related gametogenic failure 0 trials Sub-types →
- Sabinas brittle hair syndrome 0 trials
- Sakoda complex 0 trials
- Santos syndrome 0 trials
- Schnyder corneal dystrophy 0 trials
- Sener syndrome 0 trials
- Short stature, Dauber-Argente type 0 trials
- Shukla-Vernon syndrome 0 trials
- Siddiqi syndrome 0 trials
- Sifrim-Hitz-Weiss syndrome 0 trials
- Simpson-Golabi-Behmel syndrome type 1 0 trials
- Simpson-Golabi-Behmel syndrome type 2 0 trials
- Sjogren-Larsson-like ichthyosis without CNS or eye involvement 0 trials
- Skraban-Deardorff syndrome 0 trials
- Somatomedin, embryonic 0 trials
- Spondylospinal thoracic dysostosis 0 trials
- Stargardt macular degeneration, absent or hypoplastic corpus callosum, intellectual disability, and dysmorphic features 0 trials
- Stevenson-Carey syndrome 0 trials
- Stuve-Wiedemann syndrome 0 trials Sub-types →
- Suleiman-El-Hattab syndrome 0 trials
- Sweeney-Cox syndrome 0 trials
- T-cell Subgroups, non-HLA-linked 0 trials
- T-cell immunodeficiency with epidermodysplasia verruciformis 0 trials
- T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant 0 trials
- T-substance anomaly 0 trials
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome 0 trials
- TP63-related ectodermal dysplasia spectrum with limb and orofacial malformations 0 trials Sub-types →
- TPM4-related platelet disorder 0 trials
- TRAF3 haploinsufficiency 0 trials
- Tan-Almurshedi syndrome 0 trials
- Tayoun-Maawali syndrome 0 trials
- Teebi hypertelorism syndrome 0 trials Sub-types →
- Tenorio syndrome 0 trials
- Tented eyebrows 0 trials
- Tessadori-Van-Haaften neurodevelopmental syndrome 0 trials Sub-types →
- Thai symphalangism syndrome 0 trials
- Tn polyagglutination syndrome 0 trials
- Tolchin-Le Caignec syndrome 0 trials
- Tonoki syndrome 0 trials
- Tristichiasis 0 trials
- Tryptophanuria with dwarfism 0 trials
- Tuftsin deficiency 0 trials
- Tyrosinosis 0 trials
- Undritz anomaly 0 trials
- Upington disease 0 trials
- Usher syndrome, type 1M 0 trials
- Usmani-Riazuddin syndrome, autosomal dominant 0 trials
- Usmani-Riazuddin syndrome, autosomal recessive 0 trials
- VACTERL association, X-linked, with or without hydrocephalus 0 trials
- VISS syndrome 0 trials
- Valinemia 0 trials
- Ververi-Brady syndrome 0 trials Sub-types →
- Vissers-Bodmer syndrome 0 trials
- Warsaw breakage syndrome 0 trials
- Webb-Dattani syndrome 0 trials
- Weyers ulnar ray/oligodactyly syndrome 0 trials
- White-Kernohan syndrome 0 trials
- Wiedemann-Steiner syndrome 0 trials
- Wolfram syndrome 2 0 trials
- Woronets trait 0 trials
- X inactivation, familial skewed 0 trials Sub-types →
- X-linked complicated corpus callosum dysgenesis 0 trials
- Y chromosome infertility due to DAZ1 deletion 0 trials
- Yuksel-Vogel-Bauer syndrome 0 trials
- ZTTK syndrome 0 trials
- Zaki syndrome 0 trials
- Zimmermann-Laband syndrome 0 trials Sub-types →
- Ablepharon macrostomia syndrome 0 trials
- Absence deformity of leg-cataract syndrome 0 trials
- Absent radius-anogenital anomalies syndrome 0 trials
- Acetyl-CoA acetyltransferase-2 deficiency 0 trials
- Acetyl-coa carboxylase deficiency 0 trials
- Acetylation, slow 0 trials
- Achalasia, familial esophageal 0 trials
- Acinar dysplasia caused by mutation in FGF10 0 trials
- Acinar dysplasia caused by mutation in FGFR2 0 trials
- Acinar dysplasia caused by mutation in TBX4 0 trials
- Acroleukopathy, symmetric 0 trials
- Acromegaloid changes, cutis verticis gyrata, and corneal leukoma 0 trials
- Acromegaloid features, overgrowth, cleft palate, and hernia 0 trials
- Acromial dimples 0 trials
- Acroosteolysis-keloid-like lesions-premature aging syndrome 0 trials
- Acute insulin response 0 trials
- Adenosine triphosphatase deficiency, anemia due to 0 trials
- Advanced sleep phase syndrome 0 trials Sub-types →
- Agenesis of cerebral white matter 0 trials
- Agenesis of corpus callosum, cardiac, ocular, and genital syndrome 0 trials
- Agenesis of the corpus callosum and congenital lymphedema 0 trials
- Agnathia-otocephaly complex 0 trials
- Alar cleft, isolated 0 trials
- Alopecia - intellectual disability syndrome 0 trials Sub-types →
- Alopecia universalis congenita, 10Y gonadal dysgenesis, and laryngomalacia 0 trials
- Alopecia-epilepsy-pyorrhea-intellectual disability syndrome 0 trials
- Alpha-thalassemia-myelodysplastic syndrome 0 trials
- Amastia, bilateral, with ureteral triplication and dysmorphism 0 trials
- Amegakaryocytic thrombocytopenia, congenital, 2 0 trials
- Amelia and terminal transverse hemimelia 0 trials
- Amelia cleft lip palate hydrocephalus iris coloboma 0 trials
- Amenorrhea-galactorrhea syndrome 0 trials
- Amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis, and acidosis 0 trials
- Amyloidosis of gingiva and conjunctiva, with intellectual disability 0 trials
- Amyloidosis, cutaneous bullous 0 trials
- Amyotonia congenita 0 trials
- Amyotrophic dystonic paraplegia 0 trials
- Anal sphincter dysplasia 0 trials
- Anal sphincter myopathy, internal 0 trials
- Anemia, congenital hypoplastic, with multiple congenital anomalies/intellectual disability syndrome 0 trials
- Anemia, hypochromic microcytic with iron overload 0 trials Sub-types →
- Angiokeratoma corporis diffusum with arteriovenous fistulas 0 trials
- Angiomatosis, diffuse Corticomeningeal, of Divry and van Bogaert 0 trials
- Anhaptoglobinemia 0 trials
- Aniridia - intellectual disability syndrome 0 trials
- Aniridia, microcornea, and spontaneously Reabsorbed cataract 0 trials
- Aniridia-absent patella syndrome 0 trials
- Aniridia-renal agenesis-psychomotor retardation syndrome 0 trials
- Annular erythema 0 trials
- Anonychia-ectrodactyly 0 trials
- Anonychia-onychodystrophy with brachydactyly type b and ectrodactyly 0 trials
- Anosmia for isobutyric acid 0 trials
- Anterior chamber cleavage disorder, cerebellar hypoplasia, hypothyroidism, and tracheal stenosis 0 trials
- Antigen defined by monoclonal antibody Aj9 0 trials
- Antigen defined by monoclonal antibody T87 0 trials
- Antithrombin, familial hemorrhagic diathesis due to 0 trials
- Aortic arch interruption, facial palsy, and retinal coloboma 0 trials
- Aplasia of lacrimal and salivary glands 0 trials
- Apraxia of eyelid opening 0 trials
- Ariboflavinosis 0 trials Sub-types →
- Arms, malformation of 0 trials
- Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities 0 trials
- Arteries, anomalies of 0 trials
- Arteriosclerosis, severe juvenile 0 trials
- Arteritis, familial granulomatous, with juvenile polyarthritis 0 trials
- Arthrogryposis multiplex with deafness, inguinal hernias, and early death 0 trials
- Arthrogryposis, Perthes disease, and upward gaze palsy 0 trials
- Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development 0 trials
- Arthrogryposis, congenital, lower limb, X-linked 0 trials
- Arthrogryposis, distal, with intellectual disability and characteristic facies 0 trials
- Aspirin resistance 0 trials
- Asthma, short stature, and elevated IgA 0 trials
- Asymmetric short stature syndrome 0 trials
- Ataxia with myoclonic epilepsy and presenile dementia 0 trials
- Ataxia, deafness, and cardiomyopathy 0 trials
- Ataxia, intention tremor, and hypotonia syndrome, childhood-onset 0 trials
- Ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and intellectual disability 0 trials
- Ataxia-microcephaly-cataract syndrome 0 trials
- Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome 0 trials
- Atonic-astatic syndrome of Foerster 0 trials
- Atrial septal defect, secundum, with various cardiac and Noncardiac defects 0 trials
- Atrophia maculosa varioliformis cutis, familial 0 trials
- Aurocephalosyndactyly 0 trials
- Autoinflammation with arthritis and dyskeratosis 0 trials
- Autoinflammation with arthritis and vasculitis 0 trials
- Autoinflammation with episodic fever and immune dysregulation 0 trials
- Autoinflammation with episodic fever and lymphadenopathy 0 trials
- Autoinflammation with pulmonary and cutaneous vasculitis 0 trials
- Autoinflammation, immune dysregulation, and eosinophilia 0 trials
- Autoinflammation, panniculitis, and dermatosis syndrome 0 trials Sub-types →
- Autosomal dominant deafness - onychodystrophy syndrome 0 trials
- Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome 0 trials
- Autosomal dominant wooly hair 0 trials
- Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome 0 trials
- Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity 0 trials
- Azoospermia, obstructive, with nephrolithiasis 0 trials
- Azotemia, familial 0 trials
- Baculum, congenital absence of 0 trials
- Berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification 0 trials
- Beta-amino acids, renal transport of 0 trials
- Bilateral microtia-deafness-cleft palate syndrome 0 trials
- Bile acid conjugation defect 1 0 trials
- Bile acid malabsorption, primary, 2 0 trials
- Bile and pancreatic ducts, complete absence of 0 trials
- Biliary malformation with renal tubular insufficiency 0 trials
- Biliary, renal, neurologic, and skeletal syndrome 0 trials
- Bipartite talus 0 trials
- Bladder diverticulum 0 trials Sub-types →
- Blepharochalasis, superior 0 trials
- Blepharophimosis - intellectual disability syndrome, SBBYS type 0 trials
- Blepharophimosis-impaired intellectual development syndrome 0 trials
- Blistering, acantholytic, of oral and laryngeal mucosa 0 trials
- Blue nevi, familial multiple 0 trials
- Bone marrow failure and diabetes mellitus syndrome 0 trials
- Bone pain, periodic 0 trials
- Brachial palsy, familial congenital 0 trials
- Brachycephaly, trichomegaly, and developmental delay 0 trials
- Brachydactyly 0 trials Sub-types →
- Brachydactyly, coloboma, and anterior segment dysgenesis 0 trials
- Brachydactyly, intraventricular septal defect, and deafness 0 trials
- Brachydactyly, type A1, with short stature, scoliosis, microcephaly, ptosis, hearing loss, and intellectual disability 0 trials
- Brachydactyly, type A2, with microcephaly 0 trials
- Brachymesomelia-renal syndrome 0 trials
- Brachyphalangy, polydactyly, and tibial aplasia/hypoplasia 0 trials
- Brain malformation renal syndrome 0 trials
- Branchial myoclonus with spastic paraparesis and cerebellar ataxia 0 trials
- Branchiootic syndrome 0 trials Sub-types →
- Broad terminal phalanges, familial 0 trials
- Bronchiectasis and nasal polyposis 0 trials
- Bullous dystrophy, macular type 0 trials
- Butyrylesterase 1 0 trials
- Calcific aortic disease with immunologic abnormalities, familial 0 trials
- Camera-Marugo-Cohen syndrome 0 trials
- Camptodactyly syndrome, Guadalajara 0 trials Sub-types →
- Camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye 0 trials
- Camptodactyly-ichthyosis syndrome 0 trials
- Cancer, familial, with in vitro Radioresistance 0 trials
- Canine teeth, absence of upper permanent 0 trials
- Carboxypeptidase N deficiency 0 trials
- Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies 0 trials
- Cardiac septal defects with coarctation of the aorta 0 trials
- Cardiac, facial, and digital anomalies with developmental delay 0 trials
- Cardiac-urogenital syndrome 0 trials
- Cardioacrofacial dysplasia 0 trials Sub-types →
- Cardioauditory syndrome of Sanchez Cascos 0 trials
- Cardiofacioneurodevelopmental syndrome 0 trials
- Cardiomyopathy associated with myopathy and sudden death 0 trials
- Cardiomyopathy, fatal fetal, due to myocardial calcification 0 trials
- Cardiomyopathy, infantile hypertrophic 0 trials
- Carnitine acetyltransferase deficiency 0 trials
- Carnitine deficiency, myopathic 0 trials
- Carpal displacement 0 trials
- Cataract, alopecia, oral mucosal disorder, and psoriasis-like syndrome 0 trials
- Cataract, ataxia, short stature, and intellectual disability 0 trials
- Cataract, congenital, with mental impairment and dentate gyrus atrophy 0 trials
- Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 0 trials Sub-types →
- Caudal duplication 0 trials
- Cavernous hemangiomas of face-supraumbilical midline raphe syndrome 0 trials
- Celiac disease-epilepsy-cerebral calcification syndrome 0 trials
- Central incisors, absence of 0 trials
- Cephalin lipidosis 0 trials
- Cerebellar ataxia and neurosensory deafness 0 trials
- Cerebellar ataxia, benign, with thermoanalgesia 0 trials
- Cerebellar ataxia, brain abnormalities, and cardiac conduction defects 0 trials
- Cerebellar atrophy with seizures and variable developmental delay 0 trials
- Cerebellar atrophy, developmental delay, and seizures 0 trials
- Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 0 trials
- Cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome 0 trials
- Cerebellar, ocular, craniofacial, and genital syndrome 0 trials
- Cerebelloparenchymal disorder 0 trials Sub-types →
- Cerebral angiopathy, dysphoric 0 trials
- Cerebral malformation, seizures, hypertrichosis, and overlapping fingers 0 trials
- Cerebral sclerosis, diffuse, scholz type 0 trials
- Cerebrocortical degeneration of infancy 0 trials
- Cervical hypertrichosis with underlying kyphoscoliosis 0 trials
- Cervical rib disease 0 trials
- Cervical ribs, Sprengel anomaly, anal atresia, and urethral obstruction 0 trials
- Cervical vertebrae, agenesis of 0 trials
- Cervical vertebral Bridge 0 trials
- Cervical vertebral dysplasia 0 trials
- Chemodectoma, intraabdominal, with cutaneous angiolipomas 0 trials
- Chloramphenicol toxicity 0 trials
- Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome 0 trials
- Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome 0 trials
- Cholestasis with gallstone, ataxia, and visual disturbance 0 trials
- Cholestasis-pigmentary retinopathy-cleft palate syndrome 0 trials
- Cholesteatoma, congenital 0 trials
- Cholesterol pneumonia 0 trials
- Chondrodysplasia-pseudohermaphroditism syndrome 0 trials
- Chondroitin-6-sulfaturia, defective cellular immunity, nephrotic syndrome 0 trials
- Chorea, childhood-onset, with psychomotor retardation 0 trials
- Choroidal osteoma, bilateral 0 trials
- Chromosomal instability with tissue-specific radiosensitivity 0 trials
- Chromosome 16 inversion, 0.45-Mb 0 trials
- Chromosome 18 pericentric inversion 0 trials
- Chromosome 1p32-p31 deletion syndrome 0 trials
- Chromosome 1p35 deletion syndrome 0 trials
- Chromosome 1p36.33 duplication syndrome, atad3 gene cluster, autosomal dominant 0 trials
- Chromosome 4Q32.1-q32.2 triplication syndrome 0 trials
- Chronic atrial and intestinal dysrhythmia 0 trials
- Chronic mast cell leukemia 0 trials
- Circumvallate placenta syndrome 0 trials
- Citrulline transport defect 0 trials
- Clavicular hypoplasia, zygomatic arch hypoplasia, and micrognathia 0 trials
- Cleft palate, midfacial hypoplasia, triangular facies, and sensorineural hearing loss 0 trials
- Cleft palate, proliferative retinopathy, and developmental delay 0 trials
- Cleft palate-large ears-small head syndrome 0 trials
- Cocoon syndrome 0 trials
- Cognitive impairment with or without cerebellar ataxia 0 trials
- Colloid cysts of third ventricle 0 trials
- Coloboma, ocular, autosomal dominant 0 trials Sub-types →
- Coloboma, ocular, autosomal recessive 0 trials
- Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness 0 trials
- Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome 0 trials
- Colonic varices without portal hypertension 0 trials
- Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia 0 trials
- Combined low LDL and fibrinogen 0 trials
- Combined oxidative phosphorylation deficiency 49 0 trials
- Combined oxidative phosphorylation deficiency 50 0 trials
- Comedones, familial Dyskeratotic 0 trials
- Commissural lip pits 0 trials
- Complement factor b deficiency 0 trials
- Conductive deafness-malformed external ear syndrome 0 trials
- Cone-rod dystrophy and hearing loss 0 trials Sub-types →
- Cone-rod synaptic disorder syndrome, congenital nonprogressive 0 trials
- Congenital analbuminemia 0 trials
- Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0 trials
- Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 0 trials
- Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome 0 trials
- Congenital contractures of the limbs and face, hypotonia, and developmental delay 0 trials
- Congenital disorder of glycosylation, type i/IIx 0 trials
- Congenital enteropathy due to enteropeptidase deficiency 0 trials
- Congenital heart defects and ectodermal dysplasia 0 trials
- Congenital heart defects and skeletal malformations syndrome 0 trials
- Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 0 trials
- Congenital heart defects, multiple types, 7 0 trials
- Congenital hypotonia, epilepsy, developmental delay, and digital anomalies 0 trials
- Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome 0 trials
- Congenital pseudoarthrosis of clavicle 0 trials
- Congenital short bowel syndrome, autosomal recessive 0 trials
- Congenital smooth muscle hamartoma, with or without hemihypertrophy 0 trials
- Congenital stromal corneal dystrophy 0 trials
- Congenital vertical talus 0 trials Sub-types →
- Convulsive disorder, familial, with prenatal or early onset 0 trials
- Cornea guttata with anterior polar cataracts 0 trials
- Corneal degeneration, band-shaped spheroid 0 trials
- Corneal degeneration, ribbonlike, with deafness 0 trials
- Corneal dystrophy, punctiform and polychromatic pre-descemet 0 trials
- Corneal dystrophy-perceptive deafness syndrome 0 trials
- Corpus callosum agenesis-abnormal genitalia syndrome 0 trials
- Corticosteroid-binding globulin deficiency 0 trials
- Corticosterone methyloxidase type 2 deficiency 0 trials
- Coumarin resistance 0 trials
- Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay 0 trials
- Cranial nerves, congenital paresis of 0 trials
- Cranial nerves, recurrent paresis of 0 trials
- Cranioacrofacial syndrome 0 trials
- Craniofacial anomalies and anterior segment dysgenesis syndrome 0 trials
- Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 0 trials Sub-types →
- Craniofacial dysplasia - osteopenia syndrome 0 trials
- Craniofacial-deafness-hand syndrome 0 trials
- Craniofaciocardiohepatic syndrome 0 trials
- Craniolenticulosutural dysplasia 0 trials
- Craniometadiaphyseal osteosclerosis with hip dysplasia 0 trials
- Craniorhiny 0 trials
- Craniosynostosis with anomalies of the cranial base and digits 0 trials
- Craniosynostosis-intellectual disability syndrome of 51N and Gettig 0 trials
- Craniosynostosis-intellectual disability-clefting syndrome 0 trials
- Craniosynostosis-scoliosis syndrome 0 trials
- Creases, infra-auricular cutaneous, with tall stature and advanced bone age 0 trials
- Creatine phosphokinase, elevated serum 0 trials
- Crumpled helices and small mouth 0 trials
- Cryofibrinogenemia, familial primary 0 trials
- Cryptotia, familial 0 trials
- Curved nail of fourth toe 0 trials
- Cutis verticis gyrata and intellectual disability 0 trials
- Cutis verticis gyrata, thyroid aplasia, and intellectual disability 0 trials
- Cyanosis and hepatic disease 0 trials
- Cyanosis, transient neonatal 0 trials Sub-types →
- Cysteine Peptiduria 0 trials
- Dandy-walker malformation with occipital cephalocele, autosomal dominant 0 trials
- De Sanctis-Cacchione syndrome 0 trials
- Deafness with anhidrotic ectodermal dysplasia 0 trials
- Deafness with labyrinthine aplasia, microtia, and microdontia 0 trials
- Deafness, cataract, impaired intellectual development, and polyneuropathy 0 trials
- Deafness, cataract, retinitis pigmentosa, and sperm abnormalities 0 trials
- Deafness, congenital heart defects, and posterior embryotoxon 0 trials
- Deafness, congenital, and adult-onset progressive leukoencephalopathy 0 trials
- Deafness, congenital, and familial myoclonic epilepsy 0 trials
- Deafness, mid-tone neural 0 trials
- Deafness, neural, congenital moderate 0 trials
- Deafness, neural, with atypical atopic dermatitis 0 trials
- Deafness, sensorineural, with peripheral neuropathy and arterial disease 0 trials
- Deafness, unilateral, with delayed endolymphatic hydrops 0 trials
- Deafness-ear malformation-facial palsy syndrome 0 trials
- Deafness-epiphyseal dysplasia-short stature syndrome 0 trials
- Deafness-small bowel diverticulosis-neuropathy syndrome 0 trials
- Deafness-vitiligo-achalasia syndrome 0 trials
- Deeah syndrome 0 trials
- Dens evaginatus 0 trials
- Dens in dente and palatal invaginations 0 trials
- Dental radicular dysplasia 0 trials
- Dentin dysplasia type I 0 trials Sub-types →
- Dentin dysplasia type II 0 trials
- Dentin dysplasia-sclerotic bones syndrome 0 trials
- Dentinogenesis imperfecta type 2 0 trials Sub-types →
- Dentinogenesis imperfecta type 3 0 trials
- Deoxyribose-5-phosphate aldolase deficiency 0 trials
- Dermal Ridges, patternless 0 trials
- Developmental delay with dysmorphic facies and dental anomalies 0 trials
- Developmental delay with hypotonia, myopathy, and brain abnormalities 0 trials
- Developmental delay with or without dysmorphic facies and autism 0 trials
- Developmental delay with or without epilepsy 0 trials
- Developmental delay with or without intellectual impairment or behavioral abnormalities 0 trials
- Developmental delay with short stature, dysmorphic facial features, and sparse hair 0 trials Sub-types →
- Developmental delay with sleep apnea 0 trials
- Developmental delay with variable cardiac and renal congenital anomalies and dysmorphic facies 0 trials
- Developmental delay with variable intellectual disability and dysmorphic facies 0 trials
- Developmental delay with variable neurologic and brain abnormalities 0 trials
- Developmental delay, behavioral abnormalities, and neuropsychiatric disorders 0 trials
- Developmental delay, dysmorphic facies, and brain anomalies 0 trials
- Developmental delay, hypotonia, and impaired language 0 trials
- Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities 0 trials
- Developmental delay, impaired speech, and behavioral abnormalities 0 trials
- Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures 0 trials
- Developmental delay, language impairment, and ocular abnormalities 0 trials
- Dextrocardia with unusual facies and microphthalmia 0 trials
- Diabetes mellitus, congenital autoimmune 0 trials
- Diabetes, deafness, developmental delay, and short stature syndrome 0 trials
- Diaminopentanuria 0 trials
- Diarrhea, glucose-stimulated secretory, with common variable immunodeficiency 0 trials
- Diencephalic-mesencephalic junction dysplasia 0 trials Sub-types →
- Diffuse idiopathic skeletal hyperostosis 0 trials
- Dilution, pigmentary 0 trials
- Disabling pansclerotic morphea of childhood 0 trials
- Discrimination, Two-point, reduction 1N 0 trials
- Dislocated elbows, bowed tibias, scoliosis, deafness, cataract, microcephaly, and intellectual disability 0 trials
- Disseminated sclerosis with narcolepsy 0 trials
- Distal monosomy 10p 0 trials Sub-types →
- Distal osteosclerosis 0 trials
- Distal symphalangism 0 trials
- Distichiasis with congenital anomalies of the heart and peripheral vasculature 0 trials
- Double fingernail of fifth finger 0 trials
- Double nail for fifth toe 0 trials
- Duodenal ulcer due to antral G-cell hyperfunction 0 trials
- Duodenal ulcer, hyperpepsinogenemic 1 0 trials
- Duodenojejunal atresia with volvulus, absent dorsal mesentery, and absent superior mesenteric artery 0 trials
- Dwarfism with stiff joints and ocular abnormalities 0 trials
- Dwarfism with tall vertebrae 0 trials
- Dwarfism, Levi type 0 trials
- Dwarfism, familial, with muscle spasms 0 trials
- Dwarfism, intellectual disability, and eye abnormality 0 trials
- Dwarfism, low-birth-weight type, with unresponsiveness to growth hormone 0 trials
- Dwarfism, proportionate, with hip dislocation 0 trials
- Dyschromatosis, ichthyosis, deafness, and atopic disease 0 trials
- Dysmorphism-cleft palate-loose skin syndrome 0 trials
- Dysmyelination with jaundice 0 trials
- Dysostosis multiplex, Ain-Naz type 0 trials
- Dysraphism-cleft lip/palate-limb reduction defects syndrome 0 trials
- Dystelephalangy 0 trials
- Dystonia with Ringbinden 0 trials
- Dystonia with cerebellar atrophy 0 trials
- Dystonia, early-onset, and/or spastic paraplegia 0 trials
- Ear antitragus, tag at base of 0 trials
- Ear exostoses 0 trials
- Ear folding 0 trials
- Ear pits, posterior helical 0 trials
- Early response to neural induction gene 0 trials
- Early-onset familial hypoaldosteronism 0 trials
- Eccrine syringofibroadenomatosis with eyelid abnormalities 0 trials
- Ectodermal dysplasia syndrome with distinctive facial appearance and preaxial polydactyly of feet 0 trials
- Ectodermal dysplasia with adrenal cyst 0 trials
- Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 0 trials
- Ectodermal dysplasia with intellectual disability and syndactyly 0 trials
- Ectodermal dysplasia, sensorineural hearing loss, and distinctive facial features 0 trials
- Ectopia lentis 1, isolated, autosomal dominant 0 trials
- Ectopia lentis 2, isolated, autosomal recessive 0 trials
- Ectopia lentis et pupillae 0 trials
- Ectopia pupillae 0 trials
- Ectrodactyly and ectodermal dysplasia without cleft lip/palate 0 trials
- Ectrodactyly of lower limbs, congenital heart defect, and micrognathia 0 trials
- Ectrodactyly-cleft palate syndrome 0 trials
- Edema, familial idiopathic, prepubertal 0 trials
- Electroencephalographic peculiarity: 14 and 6 per sec. positive spike phenomenon 0 trials
- Emphysema, congenital, with deafness, penoscrotal web, and intellectual disability 0 trials
- Emphysema, hereditary pulmonary 0 trials
- Enamel hypoplasia, cataracts, and aqueductal stenosis 0 trials
- Encephalitis, acute, infection-induced, susceptibility to, 12 0 trials
- Encephalomalacia, multilocular 0 trials
- Encephalomyopathy, mitochondrial, due to voltage-dependent anion channel deficiency 0 trials
- Endocardial fibroelastosis and coarctation of abdominal aorta 0 trials
- Endocrine-cerebro-osteodysplasia syndrome 0 trials
- Endothelial dystrophy, congenital hereditary, with nail hypoplasia 0 trials
- Enteropathy, familial, with villous edema and immunoglobulin G2 deficiency 0 trials
- Enuresis, nocturnal, 1 0 trials
- Epidermoid cysts 0 trials
- Epidermolysis bullosa with congenital localized absence of skin and deformity of nails 0 trials
- Epidermolysis bullosa with deficiency of galactosylhydroxylysyl glucosyltransferase 0 trials
- Epidermolysis bullosa with diaphragmatic hernia 0 trials
- Epilepsy, partial, with pericentral spikes 0 trials
- Epilepsy, photogenic, with spastic diplegia and intellectual disability 0 trials
- Epiphyseal dysplasia of femoral head, myopia, and deafness 0 trials
- Epiphyseal dysplasia, Baumann type 0 trials
- Episodic muscle weakness, X-linked 0 trials
- Epithelial basolateral chloride conductance regulator, rabbit, homolog of 0 trials
- Epithelial recurrent erosion dystrophy 0 trials
- Epithelial squamous dysplasia, keratinizing desquamative, of urinary tract 0 trials
- Erythema nodosum, familial 0 trials
- Erythema of acral regions 0 trials
- Esophageal ring, lower 0 trials
- Esophagitis, eosinophilic, 2 0 trials
- Estrogen resistance syndrome 0 trials
- Ethanolaminosis 0 trials
- Exchondrosis of pinna, posterior 0 trials
- Exercise intolerance, riboflavin-responsive 0 trials
- Exostoses-anetodermia-brachydactyly type E syndrome 0 trials
- Exostosis, Dupuytren subungual 0 trials
- Extraoral halitosis due to methanethiol oxidase deficiency 0 trials
- Facial abnormalities, kyphoscoliosis, and intellectual disability 0 trials
- Facial dysmorphism, cleft palate, hearing loss, and camptodactyly 0 trials
- Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 0 trials
- Facial dysmorphism, selective tooth agenesis, and choroid calcification 0 trials
- Facial dysmorphism-immunodeficiency-livedo-short stature syndrome 0 trials
- Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome 0 trials
- Facial palsy, congenital, with ptosis and velopharyngeal dysfunction 0 trials
- Facial paresis, hereditary congenital, 3 0 trials
- Facial spasm 0 trials
- Faciocardiomelic syndrome 0 trials
- Faciothoracogenital syndrome 0 trials
- Factor 9 and Factor XI, combined deficiency of 0 trials
- Factor VIII and Factor IX, combined deficiency of 0 trials
- Factors VIII, IX and XI, combined deficiency of 0 trials
- Familial caudal dysgenesis 0 trials Sub-types →
- Familial cavitary optic disk anomaly 0 trials
- Familial cervical artery dissection 0 trials
- Familial gestational hyperthyroidism 0 trials
- Familial glucocorticoid deficiency 0 trials Sub-types →
- Familial hyperthyroidism due to mutations in TSH receptor 0 trials
- Familial lipochrome histiocytosis 0 trials
- Familial monosomy 7 syndrome 0 trials Sub-types →
- Familial parathyroid adenoma 0 trials
- Familial partial paralysis 0 trials
- Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome 0 trials
- Familial supernumerary nipples 0 trials
- Familial visceral myopathy 0 trials Sub-types →
- Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies 0 trials
- Fever, familial lifelong persistent 0 trials
- Fibromatosis, gingival, with hypertrichosis and intellectual disability 0 trials
- Fibromuscular dysplasia, multifocal 0 trials
- Fibrosclerosis, multifocal 0 trials
- Fibrosis, neurodegeneration, and cerebral angiomatosis 0 trials
- Fibula, recurrent dislocation of head of 0 trials
- Flushing of ears and somnolence 0 trials
- Focal epithelial hyperplasia 0 trials
- Focal epithelial hyperplasia of the oral mucosa 0 trials
- Focal segmental glomerulosclerosis and neurodevelopmental syndrome 0 trials
- Follicular atrophoderma, perioral pigmented, with milia and epidermoid cysts 0 trials
- Forsythe-wakeling syndrome 0 trials
- Fragile site 10Q23 0 trials
- Frontoocular syndrome 0 trials
- Fructose and galactose intolerance 0 trials
- Fucosidase regulator 0 trials
- Fucosyltransferase 6 deficiency 0 trials
- Fused mandibular incisors 0 trials
- Gamma-A-globulin, defect in assembly of 0 trials
- Gastric mucosal hypertrophy 0 trials
- Gastric volvulus, intrathoracic 0 trials
- Gelatinous drop-like corneal dystrophy 0 trials
- Genitourinary and/or brain malformation syndrome 0 trials
- Giant neutrophil leukocytes 0 trials
- Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome 0 trials
- Global developmental delay with speech and behavioral abnormalities 0 trials
- Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 0 trials
- Global developmental delay, progressive ataxia, and elevated glutamine 0 trials
- Globulin anomaly involving beta (2A)-globulin 0 trials
- Glomuvenous malformation 0 trials
- Glucocorticoid therapy, response to 0 trials
- Glucose-6-phosphate dehydrogenase-like 0 trials
- Glutamic acid decarboxylase, brain, membrane form 0 trials
- Glutamyl ribose-5-phosphate storage disease 0 trials
- Glutathione transferase activity toward trans-stilbene oxide 0 trials
- Gluteal muscles, absence of 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 21 0 trials
- Gonadal agenesis 0 trials
- Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy 0 trials
- Granddad syndrome 0 trials
- Grange syndrome 0 trials
- Granulocytopenia with immunoglobulin abnormality 0 trials
- Granulomas, congenital cerebral 0 trials
- Granulosis rubra nasi 0 trials
- Growth and developintellectual disability, ocular ptosis, cardiac defect, and anal atresia 0 trials
- Growth failure, microcephaly, intellectual disability, cataracts, large joint contractures, osteoporosis, cortical dysplasia, and cerebellar atrophy 0 trials
- Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies 0 trials
- Growth retardation-mild developmental delay-chronic hepatitis syndrome 0 trials
- Guanylate cyclase 2E 0 trials
- Guanylate kinase 3 0 trials
- Hairy ears, Y-linked 0 trials
- Hairy nose tip 0 trials
- Hairy palms and soles 0 trials
- Hamartoma, Precalcaneal congenital fibrolipomatous 0 trials
- Hand clasping pattern 0 trials
- Headache associated with sexual activity 0 trials
- Hearing loss, noise-induced, susceptibility to 0 trials
- Heart and brain malformation syndrome 0 trials
- Heart-hand syndrome 0 trials Sub-types →
- Hemangiomatosis, cutaneous, with associated features 0 trials
- Hemifacial myohyperplasia 0 trials
- Hemoglobin--variants for which the chain carrying the mutation 1S unknown or uncertain 0 trials
- Hemolytic poikilocytic anemia due to reduced ankyrin binding sites 0 trials
- Hemopoietic proliferation 0 trials
- Hepatic adenomas, familial 0 trials
- Hepatic veno-occlusive disease-immunodeficiency syndrome 0 trials
- Hepatorenocardiac degenerative fibrosis 0 trials
- Hereditary fallopian tube carcinoma 0 trials
- Hereditary hyperferritinemia with congenital cataracts 0 trials
- Hereditary hypotrichosis with recurrent skin vesicles 0 trials
- Hereditary neuro-ophthalmological disease 0 trials
- Hereditary neuroendocrine tumor of small intestine 0 trials
- Hereditary neutrophilia 0 trials
- Hereditary sensory and autonomic neuropathy with deafness and global delay 0 trials
- Heterochromia iridis 0 trials
- High myopia-sensorineural deafness syndrome 0 trials
- Histiocytic dermatoarthritis 0 trials
- Holoprosencephaly, recurrent infections, and monocytosis 0 trials
- Humero-radio-ulnar synostosis 0 trials Sub-types →
- Humerofemoral hypoplasia with radiotibial ray deficiency 0 trials
- Humeroradial synostosis 0 trials Sub-types →
- Humerus trochlea aplasia 0 trials
- Hyaluronan metabolism, defect 1N 0 trials
- Hydrocephalus, congenital communicating, 1 0 trials
- Hydrops fetalis, nonimmune, with gracile bones and dysmorphic features 0 trials
- Hydroxyacyl glutathione hydrolase deficiency 0 trials
- Hydroxyprolinemia 0 trials
- Hymen, imperforate 0 trials
- Hyperbiliverdinemia 0 trials
- Hypercalciuria, absorptive, 2 0 trials
- Hyperglycinuria 0 trials
- Hyperheparinemia 0 trials
- Hyperimmunoglobulin G1(A1) syndrome 0 trials
- Hyperleucine-Isoleucinemia 0 trials
- Hyperlipoproteinemia, type II, and deafness 0 trials
- Hyperlysinuria with hyperammonemia 0 trials
- Hypermetabolism due to defect in mitochondria 0 trials
- Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 0 trials
- Hyperopia, high 0 trials
- Hyperostosis cranialis interna 0 trials
- Hyperparathyroidism, neonatal self-limited primary, with hypercalciuria 0 trials
- Hyperphosphatemia, polyuria, and seizures 0 trials
- Hyperpigmentation of Fuldauer and Kuijpers 0 trials
- Hyperproglucagonemia 0 trials
- Hyperproinsulinemia 0 trials
- Hypersecretion of adrenal androgens, familial 0 trials
- Hypersulfaturia 0 trials
- Hypertelorism and other facial dysmorphism, brachydactyly, genital abnormalities, intellectual disability, and recurrent inflammatory episodes 0 trials
- Hypertelorism and tetralogy of fallot 0 trials
- Hypertelorism-preauricular sinus-punctual pits-deafness syndrome 0 trials
- Hyperthermia, cutaneous, with headaches and nausea 0 trials
- Hyperthyroxinemia, dystransthyretinemic 0 trials
- Hyperthyroxinemia, euthyroid, caused by generalized 5-prime-deiodinase deficiency 0 trials
- Hyperthyroxinemia, familial dysalbuminemic 0 trials
- Hypertrophia musculorum vera 0 trials
- Hypertrophic neuropathy and cataract 0 trials
- Hyperuricemia, infantile, with abnormal behavior and normal hypoxanthine guanine phosphoribosyltransferase 0 trials
- Hypoglycemia, leucine-induced 0 trials
- Hypogonadism with low-grade mental deficiency and microcephaly 0 trials
- Hypohidrosis with abnormal palmar dermal Ridges 0 trials
- Hypoinsulinemic hypoglycemia and body hemihypertrophy 0 trials
- Hypokalemic alkalosis, familial, with specific renal tubulopathy 0 trials
- Hypokalemic tubulopathy and deafness 0 trials
- Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial 0 trials
- Hypophosphatemia, renal, with intracerebral calcifications 0 trials
- Hypophosphatemic bone disease 0 trials
- Hypophosphatemic rickets and hyperparathyroidism 0 trials
- Hypopigmentation, organomegaly, and delayed myelination and development 0 trials
- Hypopituitarism, congenital, with central diabetes insipidus 0 trials
- Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome 0 trials
- Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration 0 trials
- Hypotaurinemic retinal degeneration and cardiomyopathy 0 trials
- Hypotonia, ataxia, and delayed development syndrome 0 trials
- Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 0 trials
- Hypotonia, congenital nystagmus, ataxia, and abnormal auditory brainstem responses 0 trials
- Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities 0 trials
- Hypotonia, seizures, and precocious puberty 0 trials
- Hypotrichosis, progressive patterned scalp, with wiry hair, onycholysis, and cleft lip/palate 0 trials
- Hypoxanthine guanine phosphoribosyltransferase suppressor 0 trials
- Ichthyosis and male hypogonadism 0 trials
- Ichthyosis congenita with biliary atresia 0 trials
- Ichthyosis, split hairs, and amino aciduria 0 trials
- Ichthyosis-cheek-eyebrow syndrome 0 trials
- Ichthyosis-intellectual disability syndrome with large keratohyalin granules in the skin 0 trials
- Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome 0 trials
- Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features 0 trials
- Immune dysregulation with immunodeficiency due to AIOLOS haploinsufficiency 0 trials
- Immune dysregulation, autoimmunity, and autoinflammation 0 trials
- Immune dysregulation, neurodevelopmental defects, and colitis 0 trials
- Immunodeficiency 28 0 trials
- Immunodeficiency 37 0 trials Sub-types →
- Immunodeficiency 39 0 trials
- Immunodeficiency 47 0 trials
- Immunodeficiency with defective T-cell response to interleukin 1 0 trials
- Immunodeficiency, X-linked, with deficiency of 115,000 Dalton surface glycoprotein 0 trials
- Immunodeficiency, developmental delay, and hypohomocysteinemia 0 trials
- Immunoglobulin M, level of 0 trials
- Immunoglobulin d level in plasma, low 0 trials
- Imperforate oropharynx-costo vetebral anomalies syndrome 0 trials
- Imprinting gene related to retinoblastoma 0 trials
- Incisors, lower central, absence of 0 trials
- Incisors, rotation of upper central 0 trials
- Incisors, shovel-shaped 0 trials
- Indolylacroyl glycinuria with intellectual disability 0 trials
- Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development 0 trials
- Inflammatory bowel disease, immunodeficiency, and encephalopathy 0 trials
- Inherited hypertrophic pyloric stenosis 0 trials Sub-types →
- Inherited isolated nail anomaly 0 trials Sub-types →
- Inherited oocyte maturation defect 0 trials Sub-types →
- Inosine phosphorylase deficiency, immune defect due to 0 trials
- Insensitivity to pain with hyperplastic Myelinopathy 0 trials
- Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature 0 trials
- Intellectual developmental disorder with autism and dysmorphic facies 0 trials
- Intellectual developmental disorder with autistic features and language delay, with or without seizures 0 trials
- Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0 trials
- Intellectual developmental disorder with cardiac defects and dysmorphic facies 0 trials
- Intellectual developmental disorder with hypertelorism and distinctive facies 0 trials
- Intellectual developmental disorder with hypotonia and behavioral abnormalities 0 trials
- Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 0 trials
- Intellectual developmental disorder with impaired language and dysmorphic facies 0 trials
- Intellectual developmental disorder with macrocephaly, seizures, and speech delay 0 trials
- Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects 0 trials
- Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies 0 trials
- Intellectual developmental disorder with ocular anomalies and distinctive facial features 0 trials
- Intellectual developmental disorder with or without epilepsy or cerebellar ataxia 0 trials
- Intellectual developmental disorder with or without peripheral neuropathy 0 trials
- Intellectual developmental disorder with paroxysmal dyskinesia or seizures 0 trials
- Intellectual developmental disorder with poor growth and with or without seizures or ataxia 0 trials
- Intellectual developmental disorder with seizures and dysmorphic facies 0 trials
- Intellectual developmental disorder with seizures and language delay 0 trials
- Intellectual developmental disorder with short stature and behavioral abnormalities 0 trials
- Intellectual developmental disorder with short stature and variable skeletal anomalies 0 trials
- Intellectual developmental disorder with speech delay and axonal peripheral neuropathy 0 trials
- Intellectual developmental disorder with speech delay, autism, and dysmorphic facies 0 trials
- Intellectual developmental disorder, autosomal dominant 77 0 trials
- Intellectual developmental disorder, autosomal recessive 84 0 trials
- Intellectual disability and myopathy syndrome 0 trials
- Intellectual disability with optic atrophy, facial dysmorphism, microcephaly, and short stature 0 trials
- Intellectual disability, FRA12A type 0 trials
- Intellectual disability, anterior maxillary protrusion, and strabismus 0 trials
- Intellectual disability, keratoconus, febrile seizures, and sinoatrial block 0 trials
- Intellectual disability, microcephaly, growth retardation, joint contractures, and facial dysmorphism 0 trials
- Intellectual disability, severe, with spasticity and pigmentary tapetoretinal degeneration 0 trials
- Intellectual disability, short stature, facial anomalies, and joint dislocations 0 trials
- Intellectual disability-brachydactyly-Pierre Robin syndrome 0 trials
- Intellectual disability-strabismus syndrome 0 trials
- Interferon antiviral depressor 0 trials
- Internal carotid arteries, hypoplasia of 0 trials
- Internal carotid artery, spontaneous dissection of 0 trials
- Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency 0 trials
- Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked 0 trials
- Iridogoniodysgenesis and skeletal anomalies 0 trials
- Iris pattern 0 trials
- Iris pigment epithelium anomalies 0 trials
- Iris pigment layer, cleavage of 0 trials
- Ischio-vertebral syndrome 0 trials
- Isolated aniridia 0 trials Sub-types →
- Isolated cryptophthalmia 0 trials Sub-types →
- Isolated hyperferritinemia 0 trials
- Isolated neonatal sclerosing cholangitis 0 trials
- Isolated right ventricular hypoplasia 0 trials
- Isoproterenol-mediated vasodilatation 0 trials
- Isovaleric acid, inability to smell 0 trials
- Jaundice, familial obstructive, of infancy 0 trials Sub-types →
- Jejunal atresia with renal adysplasia 0 trials
- Joint contractures, osteochondromas, and B-cell lymphoma 0 trials
- Kallikrein, decreased urinary activity of 0 trials
- Keloid formation 0 trials
- Keratitis fugax hereditaria 0 trials
- Keratoconus and congenital hip dysplasia 0 trials
- Keratoconus posticus circumscriptus 0 trials
- Keratoderma hereditarium mutilans 0 trials
- Keratoderma-ichthyosis-deafness syndrome, autosomal recessive 0 trials
- Keratosis, familial actinic 0 trials
- Knuckle pads 0 trials
- Labia minora, incomplete adhesion of 0 trials
- Lactic acidosis, chronic adult form 0 trials
- Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia 0 trials
- Laryngeal abductor paralysis with cerebellar ataxia and motor neuropathy 0 trials
- Laryngeal atresia, encephalocele, and limb deformities 0 trials
- Lateral semicircular canal malformation, familial, with external and middle ear abnormalities 0 trials
- Lattice degeneration of retina leading to retinal detachment 0 trials
- Leg ulcers, familial, of juvenile onset 0 trials
- Lentiginosis, centrofacial neurodysraphic 0 trials
- Lessel-kubisch syndrome 0 trials
- Lethal faciocardiomelic dysplasia 0 trials
- Lethal polymalformative syndrome, Boissel type 0 trials
- Lethal recessive chondrodysplasia 0 trials
- Leukemia, acute myelocytic, with polyposis coli and colon cancer 0 trials
- Leukocyte nuclear appendages, hereditary prevalence of 0 trials
- Leukodystrophy and acquired microcephaly with or without dystonia; 0 trials
- Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate 0 trials
- Leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 0 trials
- Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome 0 trials
- Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome 0 trials
- Leukoencephalopathy, progressive, infantile-onset, with or without deafness 0 trials
- Limb transversal defect-cardiac anomaly syndrome 0 trials
- Lip, hamartomatous 0 trials
- Lipodystrophy, partial, acquired, with low complement component c3, with or without glomerulonephritis 0 trials
- Lipoprotein types--Lt system 0 trials
- Lipoprotein, variant of beta 0 trials
- Lissencephaly, familial, with cleft palate and cerebellar hypoplasia 0 trials
- Lithium transport 0 trials
- Liver disease, severe congenital 0 trials
- Liver fibrocystic disease and polydactyly 0 trials
- Long chain fatty acids, defect in transport of 0 trials
- Low density lipoprotein, variation in molecular weight of 0 trials
- Lung disease, immunodeficiency, and chromosome breakage syndrome; 0 trials
- Lymphedema-posterior choanal atresia syndrome 0 trials
- Lymphoid system deterioration, progressive 0 trials
- Lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis 0 trials
- Lysine malabsorption syndrome 0 trials
- Macrocephaly, acquired, with impaired intellectual development 0 trials
- Macrocephaly, benign familial 0 trials
- Macrocephaly, dysmorphic facies, and psychomotor retardation 0 trials Sub-types →
- Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 0 trials
- Macrocephaly-developmental delay syndrome 0 trials
- Macrocytosis, familial 0 trials
- Macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance 0 trials
- Macrosomia adiposa congenita 0 trials
- Magnesium, elevated red cell 0 trials
- Maleylacetoacetate isomerase deficiency 0 trials
- Malocclusion and short stature 0 trials
- Mammary-digital-nail syndrome 0 trials
- Mandibulofacial dysostosis syndrome, Bauru type 0 trials
- Mandibulofacial dysostosis with alopecia 0 trials
- Mandibulofacial dysostosis with mental deficiency 0 trials
- Mandibulofacial dysostosis with ptosis, autosomal dominant 0 trials
- Mannose 6-phosphate receptor recognition defect, Lebanese type 0 trials
- Marfanoid habitus with situs inversus 0 trials
- Marfanoid hypermobility syndrome 0 trials
- Maxillofacial dysostosis 0 trials
- Mediosternal depigmentation line 0 trials
- Medium chain 3-ketoacyl-Coa thiolase deficiency 0 trials
- Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations 0 trials
- Megabladder, congenital 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 0 trials Sub-types →
- Megaepiphyseal dwarfism 0 trials
- Megalencephaly with dysmyelination 0 trials
- Megalencephaly-polydactyly syndrome 0 trials
- Megalocornea 0 trials Sub-types →
- Melanoma tumor antigen Gp90 0 trials
- Menstrual cycle-dependent periodic fever 0 trials
- Mental and growth retardation with amblyopia 0 trials
- Mesoaxial hexadactyly and cardiac malformation 0 trials
- Mesomelic dwarfism of hypoplastic tibia and radius type 0 trials
- Mesomelic dysplasia, camera type 0 trials
- Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression 0 trials
- Metachondromatosis 0 trials
- Metachromasia of fibroblasts 0 trials
- Metaphyseal chondrodysplasia with cone-shaped epiphyses, normal hair, and normal hands 0 trials
- Metaphyseal chondrodysplasia, Pena type 0 trials
- Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria 0 trials
- Metaphyseal dysplasia, anetoderma, and optic atrophy 0 trials
- Metaphyseal modeling abnormality, skin lesions, and spastic paraplegia 0 trials
- Metaphyseal undermodeling, spondylar dysplasia, and overgrowth 0 trials
- Metatarsus varus, type 1 0 trials
- Methionine malabsorption syndrome 0 trials
- Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum 0 trials
- Microcephaly, corpus callosum dysgenesis, and cleft lip/palate 0 trials
- Microcephaly, developmental delay, and brittle hair syndrome 0 trials
- Microcephaly, epilepsy, and diabetes syndrome 0 trials Sub-types →
- Microcephaly, facial abnormalities, micromelia, and intellectual disability 0 trials
- Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome 0 trials
- Microcephaly, growth deficiency, seizures, and brain malformations 0 trials
- Microcephaly, growth restriction and increased sister chromatid exchange 0 trials Sub-types →
- Microcephaly, growth retardation, cataract, hearing loss, and unusual appearance 0 trials
- Microcephaly, macrotia, and intellectual disability 0 trials
- Microcephaly, retinitis pigmentosa, and sutural cataract 0 trials
- Microcephaly, severe, with skeletal anomalies including posterior rib-Gap defects 0 trials
- Microcephaly, short stature, and impaired glucose metabolism 0 trials Sub-types →
- Microcephaly, short stature, and limb abnormalities 0 trials
- Microcephaly-brachydactyly-kyphoscoliosis syndrome 0 trials
- Microcephaly-capillary malformation syndrome 0 trials
- Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome 0 trials
- Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome 0 trials
- Microcephaly-micromelia syndrome 0 trials
- Microcephaly-thin corpus callosum-intellectual disability syndrome 0 trials
- Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 0 trials
- Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2 0 trials
- Microphthalmia with cyst, bilateral facial clefts, and limb anomalies 0 trials
- Microphthalmia with hyperopia, retinal degeneration, macrophakia, and dental anomalies 0 trials
- Microphthalmia, isolated, with corectopia 0 trials
- Microspherophakia with hernia 0 trials
- Microspherophakia-metaphyseal dysplasia syndrome 0 trials
- Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis 0 trials
- Midface hypoplasia, obesity, developmental delay, and neonatal hypotonia 0 trials
- Midline malformations, multiple, with limb abnormalities and hypopituitarism 0 trials
- Milia, multiple eruptive 0 trials
- Mitochondrial complex 1 deficiency, nuclear type 35 0 trials
- Mitochondrial import-stimulating factor 0 trials
- Mitochondrial intermembrane space protein Tim12, yeast, homolog of 0 trials
- Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0 trials
- Monosodium glutamate sensitivity 0 trials
- Mucocutaneous ulceration, chronic 0 trials
- Mucus inspissation of respiratory tract 0 trials
- Mullerian aplasia and hyperandrogenism 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 0 trials Sub-types →
- Multiple congenital anomalies-neurodevelopmental syndrome, X-linked 0 trials
- Multiple exostoses with spastic tetraparesis 0 trials
- Multiple fibroadenoma of the breast 0 trials
- Multiple synostoses syndrome 0 trials Sub-types →
- Muscle cramps, familial 0 trials
- Muscular atrophy, malignant neurogenic 0 trials
- Muscular dystrophy, adult-onset, with leukoencephalopathy 0 trials
- Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome 0 trials
- Muscular dystrophy, congenital, with cerebellar atrophy 0 trials
- Muscular dystrophy, congenital, with or without seizures 0 trials
- Muscular dystrophy, congenital, with severe central nervous system atrophy and absence of large myelinated fibers 0 trials
- Muscular hypoplasia, congenital universal, of Krabbe 0 trials
- Musk, inability to smell 0 trials
- Myelinated optic nerve fibers 0 trials
- Myelodysplasia, immunodeficiency, facial dysmorphism, short stature, and psychomotor delay 0 trials
- Myelofibrosis, congenital, with anemia, neutropenia, developmental delay, and ocular abnormalities 0 trials
- Myeloid tumor suppressor 0 trials
- Myelolymphatic insufficiency 0 trials
- Myoclonic epilepsy, congenital deafness, macular dystrophy, and psychiatric disorders 0 trials
- Myopathy due to malate-aspartate shuttle defect 0 trials
- Myopathy with giant abnormal mitochondria 0 trials
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1 0 trials
- Myopathy with storage of glycoproteins and Glycosaminoglycans 0 trials
- Myopathy, congenital, with excess of muscle spindles 0 trials
- Myopathy, granulovacuolar lobular, with electrical myotonia 0 trials
- Nanophthalmia 0 trials Sub-types →
- Nasal bones, absence of 0 trials
- Nasal groove, familial transverse 0 trials
- Nasal hyperpigmentation, familial transverse 0 trials
- Nephropathy - deafness - hyperparathyroidism syndrome 0 trials
- Nephropathy, chronic tubulointerstitial 0 trials
- Nephropathy, progressive, with deafness 0 trials
- Neurocardiofaciodigital syndrome 0 trials
- Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities 0 trials
- Neurodevelopmental, jaw, eye, and digital syndrome 0 trials
- Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 0 trials
- Neuroectodermal melanolysosomal disease 0 trials
- Neuroendocrine carcinoma of salivary glands, sensorineural hearing loss, and enamel hypoplasia 0 trials
- Neurofacioskeletal syndrome with or without renal agenesis 0 trials
- Neurofibromatosis-pheochromocytoma-duodenal carcinoid syndrome 0 trials
- Neurologic disease, infantile multisystem, with osseous fragility 0 trials
- Neuromuscular disease and ocular or auditory anomalies with or without seizures 0 trials
- Neurooculocardiogenitourinary syndrome 0 trials
- Neurooculorenal syndrome 0 trials
- Neuropathy, congenital, with arthrogryposis multiplex 0 trials
- Neuropathy, hereditary motor and sensory, with excessive myelin folding complex, autosomal recessive 0 trials
- Neuropathy, hereditary sensory and autonomic, adult-onset, with anosmia 0 trials
- Neuropathy, with paraprotein in serum, cerebrospinal fluid and urine 0 trials
- Nevus anemicus 0 trials
- Nevus flammeus of nape of neck 0 trials
- Nipples inverted 0 trials
- Noduli Cutanei, multiple, with urinary tract abnormalities 0 trials
- Nondisjunction 0 trials
- Nuclear ribonucleic acid 0 trials
- Obesity and hypopigmentation 0 trials
- Obesity, hyperphagia, and developmental delay 0 trials
- Occipital hair, white lock of 0 trials
- Ocular myopathy with curare sensitivity 0 trials
- Ocular pterygium-digital keloid dysplasia syndrome 0 trials
- Oculocerebrofacial syndrome, Kaufman type 0 trials
- Oculogastrointestinal-neurodevelopmental syndrome 0 trials
- Oculomaxillofacial dysostosis 0 trials Sub-types →
- Oculomotor-abducens synkinesis 0 trials
- Oculopharyngeal myopathy with leukoencephalopathy 1 0 trials
- Oculorenocerebellar syndrome 0 trials
- Oculotrichoanal syndrome 0 trials
- Oculovertebral syndrome 0 trials
- Odontoid hypoplasia 0 trials
- Oligodontia-cancer predisposition syndrome 0 trials
- Olivopontocerebellar atrophy II, autosomal recessive 0 trials
- Omphalocele, X-linked 0 trials
- Omphalocele, autosomal 0 trials
- Omphalocele, diaphragmatic hernia, and radial ray defects 0 trials
- Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome 0 trials
- Onychogryposis, pedal, with keratosis plantaris and coarse hair 0 trials
- Ophthalmomandibulomelic dysplasia 0 trials
- Ophthalmoplegia totalis with ptosis and miosis 0 trials
- Ophthalmoplegia, external, and myopia 0 trials
- Ophthalmoplegia, external, with rib and vertebral anomalies 0 trials
- Ophthalmoplegia, familial static 0 trials
- Ophthalmoplegia, familial total, with iris transillumination 0 trials
- Ophthalmoplegic neuromuscular disorder with abnormal mitochondria 0 trials
- Optic atrophy, hearing loss, and peripheral neuropathy, autosomal recessive 0 trials
- Optic atrophy--spastic paraplegia syndrome 0 trials
- Oral sensibility, disturbance of 0 trials
- Orofaciodigital syndrome 0 trials Sub-types →
- Oromandibular-limb hypogenesis syndrome 0 trials Sub-types →
- Orthostatic hypotensive disorder, Streeten type 0 trials
- Ossicular malformations, familial 0 trials
- Ossified ear cartilages 0 trials
- Osteochondrodysplasia, brachydactyly, and overlapping malformed digits 0 trials
- Osteochondrodysplasia, rhizomelic, with callosal agenesis, thrombocytopenia, hydrocephalus, and hypertension 0 trials
- Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome 0 trials
- Osteodysplasty, precocious, of Danks, Mayne, and Kozlowski 0 trials
- Osteoma of cranial vault, familial 0 trials
- Osteoma of middle ear 0 trials
- Osteootohepatoenteric syndrome 0 trials
- Osteoporosis, childhood- or juvenile-onset, with developmental delay 0 trials
- Osteoporosis-oculocutaneous hypopigmentation syndrome 0 trials
- Osteosclerosis with ichthyosis and fractures 0 trials
- Osteosclerotic chondrodysplasia, lethal, with intracellular inclusions 0 trials
- Otofaciocervical syndrome 0 trials Sub-types →
- Otofacioosseous-gonadal syndrome 0 trials
- Otoonychoperoneal syndrome 0 trials
- Ovalocytosis, hereditary hemolytic, with defective erythropoiesis 0 trials
- Ovarian dysgenesis, hypergonadotropic, with short stature and recurrent metabolic acidosis 0 trials
- Pachydermodactyly, familial 0 trials
- Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures 0 trials
- Palant cleft palate syndrome 0 trials
- Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome 0 trials
- Palmaris longus muscle, absence of 0 trials
- Pancreatic beta cell agenesis with neonatal diabetes mellitus 0 trials
- Pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0 trials
- Pancreatic lymphoma, familial 0 trials
- Pancreatitis, sclerosing cholangitis, and sicca complex 0 trials
- Pancytopenia and occlusive vascular disease 0 trials
- Papillomatosis, florid, of nipple 0 trials
- Parotid salivary glands, polycystic dysgenetic disease of 0 trials
- Parotitis, juvenile recurrent 0 trials
- Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome 0 trials
- Patella aplasia/hypoplasia 0 trials Sub-types →
- Patent ductus venosus 0 trials
- Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome 0 trials
- Pellagra-like syndrome 0 trials
- Pelvic lipomatosis with crossed renal ectopia 0 trials
- Periodic fever, immunodeficiency, and thrombocytopenia syndrome 0 trials
- Peripapillary atrophy, beta type 0 trials
- Peripheral cone dystrophy 0 trials
- Peripheral neuropathy, ataxia, focal necrotizing encephalopathy, and spongy degeneration of brain 0 trials
- Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development 0 trials
- Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome 0 trials
- Peroneal nerve, accessory deep 0 trials
- Peroneus tertius muscle, absence of 0 trials
- Peroxidase, salivary 0 trials
- Phagocytosis, plasma-related defect 1N 0 trials
- Phenformin 4-hydroxylation 0 trials
- Pheochromocytoma-islet cell tumor syndrome 0 trials
- Phlebectasia of lips 0 trials
- Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome 0 trials
- Phosphatase, acid, of tissues 0 trials
- Phosphoglucomutase 4 0 trials
- Phosphoglycoprotein 1 0 trials
- Phosphohydroxylysinuria 0 trials
- Phosphoribosylaminoimidazole carboxylase deficiency 0 trials
- Photomyoclonus, diabetes mellitus, deafness, nephropathy, and cerebral dysfunction 0 trials
- Pigmented purpuric eruption 0 trials
- Pituitary dwarfism with large sella turcica 0 trials
- Plasma clot retraction factor, deficiency of 0 trials
- Plasma fibronectin deficiency 0 trials
- Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease 0 trials
- Platelet adenylate cyclase activity 0 trials
- Platelet disorder, undefined 0 trials
- Platelet factor 3 deficiency 0 trials
- Platelet prostacyclin receptor defect 0 trials
- Platelet responsiveness to adrenaline, depressed 0 trials
- Platelet signal processing defect 0 trials
- Platelet-activating factor acetylhydrolase deficiency 0 trials
- Pleoconial myopathy with salt craving 0 trials
- Polycystic bone disease 0 trials
- Polycystic kidney, cataract, and congenital blindness 0 trials
- Polydactyly-macrocephaly syndrome 0 trials
- Polyhydramnios, chronic idiopathic 0 trials
- Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome 0 trials
- Polymyoclonus, infantile 0 trials
- Polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive 0 trials
- Polyposis of gastric fundus without polyposis coli 0 trials
- Polyposis, intestinal, scattered and discrete 0 trials
- Polyposis, intestinal, with multiple exostoses 0 trials
- Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal 0 trials
- Polysaccharide, storage of unusual 0 trials
- Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal 0 trials Sub-types →
- Porencephaly-microcephaly-bilateral congenital cataract syndrome 0 trials
- Postaxial tetramelic oligodactyly 0 trials
- Posterior column ataxia 0 trials
- Preauricular fistulae, congenital 0 trials
- Preauricular tag, isolated, autosomal dominant, 1 0 trials
- Premature chromatid separation trait 0 trials
- Presenile dementia, Kraepelin type 0 trials
- Priapism, familial idiopathic 0 trials
- Primary hypertrophic osteoarthropathy 0 trials Sub-types →
- Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection 0 trials
- Primary intraosseous venous malformation 0 trials
- Primordial dwarfism-immunodeficiency-lipodystrophy syndrome 0 trials
- Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 0 trials
- Progressive non-infectious anterior vertebral fusion 0 trials
- Prolactin deficiency with obesity and enlarged testes 0 trials
- Pronation-supination of the forearm, impairment of 0 trials
- Properdin deficiency, X-linked 0 trials
- Prostate cancer aggressiveness quantitative trait locus on chromosome 19 0 trials
- Protein Z deficiency 0 trials
- Proteinuria, chronic benign 0 trials
- Proteolytic capacity of plasma 0 trials
- Protocadherin 3 0 trials
- Prune belly syndrome with pulmonic stenosis, intellectual disability, and deafness 0 trials
- Pruritus, hereditary localized 0 trials
- Pseudoacromegaly with severe insulin resistance 0 trials
- Pseudoarthrogryposis 0 trials
- Pseudohyperaldosteronism type 2 0 trials
- Pseudomonilethrix 0 trials
- Pseudoxanthoma elasticum, forme fruste 0 trials
- Psychomotor retardation, epilepsy, and craniofacial dysmorphism 0 trials
- Pterygium colli, isolated 0 trials
- Pubic bone dysplasia 0 trials
- Pulmonary alveolar microlithiasis 0 trials
- Pulmonary alveolar proteinosis with hypogammaglobulinemia 0 trials
- Pulmonary bullae causing pneumothorax 0 trials
- Pulmonary venoocclusive disease 0 trials Sub-types →
- Pulmonic stenosis and congenital nephrosis 0 trials
- Pulmonic stenosis and deafness 0 trials
- Pulmonic stenosis, atrial septal defect, and unique electrocardiographic abnormalities 0 trials
- Pupillary membrane, persistence of 0 trials
- Purpura simplex 0 trials
- Pyloric atresia 0 trials
- Radial deficiency-tibial hypoplasia syndrome 0 trials
- Radial heads, posterior dislocation of 0 trials
- Radial ray deficiency, X-linked 0 trials
- Radiation sensitivity of natural killer activity 0 trials
- Radiculoneuropathy, fatal neonatal 0 trials
- Radio-renal syndrome 0 trials
- Radioulnar synostosis, radial ray abnormalities, and severe malformations in the male 0 trials
- Radius, aplasia of, with cleft lip/palate 0 trials
- Raindrop hypopigmentation 0 trials
- Recombinant 8 syndrome 0 trials
- Recurrent infections associated with rare immunoglobulin isotypes deficiency 0 trials
- Red cell permeability defect 0 trials
- Red cell phospholipid defect with hemolysis 0 trials
- Red skin pigment anomaly of new guinea 0 trials
- Renal and mullerian duct hypoplasia 0 trials
- Renal tubular acidosis, distal, with nephrocalcinosis, short stature, intellectual disability, and distinctive facies 0 trials
- Renal-hepatic-pancreatic dysplasia 0 trials Sub-types →
- Respiratory infections, recurrent, and failure to thrive with or without diarrhea 0 trials
- Respiratory papillomatosis, juvenile recurrent, congenital 0 trials
- Respiratory underresponsiveness to hypoxia and hypercapnia 0 trials
- Restrictive dermopathy 0 trials Sub-types →
- Reticuloendotheliosis, X-linked 0 trials
- Retinal degeneration and epilepsy 0 trials
- Retinal dystrophy and microvillus inclusion disease 0 trials
- Retinal dystrophy with leukodystrophy 0 trials
- Retinal dystrophy with or without macular staphyloma 0 trials
- Retinal telangiectasia and hypogammaglobulinemia 0 trials
- Retinal venous beading 0 trials
- Retinitis pigmentosa 89 0 trials
- Retinitis pigmentosa and erythrocytic microcytosis 0 trials
- Retinitis pigmentosa inversa with deafness 0 trials
- Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome 0 trials
- Retinitis pigmentosa-intellectual disability-deafness-hypogenitalism syndrome 0 trials
- Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome 0 trials
- Retinopathy, pigmentary, and intellectual disability 0 trials
- Rhabdomyosarcoma, embryonal, 2 0 trials
- Rhiny 0 trials
- Rhizomelic dysplasia, scoliosis, and retinitis pigmentosa 0 trials
- Rhizomelic limb shortening with dysmorphic features 0 trials
- Ribbing disease 0 trials
- Right pulmonary artery, anomalous origin of, familial 0 trials
- Ring dermoid of cornea 0 trials
- Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction 0 trials
- Salivary duct calculi 0 trials
- Salivary substance, Clostridium botulinum type 0 trials
- Sandestig-stefanova syndrome 0 trials
- Scimitar anomaly, multiple cardiac malformations, and craniofacial and central nervous system abnormalities 0 trials
- Sebaceous gland hyperplasia, familial presenile 0 trials
- Second metatarsal-metacarpal syndrome 0 trials
- Secretory diarrhea, myopathy, and deafness 0 trials
- Seizures, early-onset, with neurodegeneration and brain calcifications 0 trials
- Sella turcica, bridged 0 trials
- Senile plaque formation 0 trials
- Sensorineural hearing loss, retinal pigment epithelium lesions, discolored teeth 0 trials
- Serpinopathy 0 trials
- Setting-Sun phenomenon, familial benign 0 trials
- Severe dermatitis-multiple allergies-metabolic wasting syndrome 0 trials
- Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome 0 trials
- Sex-linked disease 0 trials
- Short stature and Facioauriculothoracic malformations 0 trials
- Short stature and microcephaly with genital anomalies 0 trials
- Short stature due to GHSR deficiency 0 trials
- Short stature due to primary acid-labile subunit deficiency 0 trials
- Short stature with nonspecific skeletal abnormalities 0 trials Sub-types →
- Short stature, Brussels type 0 trials
- Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis 0 trials
- Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 0 trials Sub-types →
- Short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies 0 trials
- Short stature, intellectual disability, callosal agenesis, Heminasal hypoplasia, microphthalmia, and atypical clefting 0 trials
- Short stature, oligodontia, dysmorphic facies, and motor delay 0 trials
- Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay 0 trials
- Short stature-obesity syndrome 0 trials
- Shoulder and thorax deformity-congenital heart disease syndrome 0 trials
- Sister chromatid exchange, frequency of 0 trials
- Skeletal defects, genital hypoplasia, and intellectual disability 0 trials
- Skeletal dysplasia and progressive central nervous system degeneration, lethal 0 trials
- Skeletal dysplasia with delayed epiphyseal and carpal bone ossification 0 trials
- Skeletal dysplasia, mild, with joint laxity and advanced bone age 0 trials
- Skeletal dysplasia, rhizomelic, with retinitis pigmentosa 0 trials
- Snijders blok-fisher syndrome 0 trials
- Sodium-potassium-ATPase activity of red cell 0 trials
- Spastic diplegia and intellectual disability 0 trials
- Spastic paraparesis-cataracts-speech delay syndrome 0 trials
- Spastic paraparesis-deafness syndrome 0 trials
- Spastic paraplegia and Evans syndrome 0 trials
- Spastic paraplegia with associated extrapyramidal signs 0 trials
- Spastic paraplegia with myoclonic epilepsy 0 trials
- Spastic paraplegia, ataxia, and intellectual disability 0 trials
- Spastic paraplegia, mitochondrial 0 trials
- Spastic paraplegia, optic atrophy, and dementia 0 trials
- Spastic paraplegia, optic atrophy, microcephaly, and 10Y sex reversal 0 trials
- Spastic tetraplegia and axial hypotonia, progressive 0 trials
- Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome 0 trials
- Specific granule deficiency 0 trials Sub-types →
- Sperm protamine P4 0 trials
- Sperm-specific antigen 1 0 trials
- Spinal dysplasia, Anhalt type 0 trials
- Spinal muscular atrophy with intellectual disability 0 trials
- Spinal muscular atrophy with microcephaly and mental subnormality 0 trials
- Spinal muscular atrophy, infantile, James type 0 trials
- Spinocerebellar ataxia with rigidity and peripheral neuropathy 0 trials
- Spinocerebellar atrophy with pupillary paralysis 0 trials
- Splenogonadal fusion-limb defects-micrognathia syndrome 0 trials
- Splenomegaly syndrome with splenic Germinal center hypoplasia and reduced circulating T helper cells 0 trials
- Splenoportal vascular anomalies 0 trials
- Split lower lip 0 trials
- Split-foot malformation-mesoaxial polydactyly syndrome 0 trials
- Split-hand and split-foot with hypodontia 0 trials
- Spondylocostal dysostosis-anal and genitourinary malformations syndrome 0 trials
- Spondylocostal dysostosis-hypospadias-intellectual disability syndrome 0 trials
- Spondylomegaepiphyseal dysplasia with upper limb mesomelia, punctate calcifications, and deafness 0 trials
- Spondylometaphyseal dysplasia with corneal dystrophy 0 trials
- Sternum, premature obliteration of sutures of 0 trials
- Storm syndrome 0 trials
- Streptococcus, group A, severity of infection by 0 trials
- Structural brain anomalies with impaired intellectual development and craniosynostosis 0 trials
- Structural heart defects and renal anomalies syndrome 0 trials
- Subaortic stenosis, membranous 0 trials
- Succinic acidemia 0 trials
- Sucrosuria, hiatus hernia and intellectual disability 0 trials
- Sudden cardiac failure, alcohol-induced 0 trials
- Sudden cardiac failure, infantile 0 trials
- Sudden infant death-dysgenesis of the testes syndrome 0 trials
- Superior transverse scapular ligament, calcification of, familial 0 trials
- Supernumerary der(22)t(8;22) syndrome 0 trials
- Suppressor of tumorigenicity 3 0 trials
- Surface antigen, glycoprotein 75 0 trials
- Surface polypeptides, anonymous 0 trials
- Symphalangism of toes 0 trials
- Symphalangism with multiple anomalies of hands and feet 0 trials
- Symphalangism, C. S. Lewis type 0 trials
- Symphalangism, distal, with microdontia, dental pulp stones, and narrowed zygomatic arch 0 trials
- Syndesmodysplasic dwarfism 0 trials
- Syndromic multisystem autoimmune disease due to ITCH deficiency 0 trials
- Syngnathia multiple anomalies 0 trials
- Syngnathia-cleft palate syndrome 0 trials
- Synovial chondromatosis, familial, with dwarfism 0 trials
- Syringomas, multiple 0 trials
- Tall stature-intellectual disability-renal anomalies syndrome 0 trials
- Talonavicular coalition 0 trials
- Taurodontism, microdontia, and dens invaginatus 0 trials
- Tear protein, anodal 0 trials
- Teeth present at birth 0 trials
- Teeth, fused 0 trials
- Teeth, odd shapes of 0 trials
- Telangiectasia, impaired intellectual development, microcephaly, metaphyseal dysplasia, eye abnormalities, and short stature 0 trials
- Temperature-sensitive lethal mutation 0 trials
- Temtamy syndrome 0 trials
- Testes, rudimentary 0 trials
- Testicular anomalies with or without congenital heart disease 0 trials
- Testicular microlithiasis 0 trials
- Tetraamelia with ectodermal dysplasia and lacrimal duct abnormalities 0 trials
- Tetraamelia-multiple malformations syndrome 0 trials Sub-types →
- Tetralogy of fallot and glaucoma 0 trials
- Tetralogy of fallot syndrome, autosomal recessive 0 trials
- Tetramelic monodactyly 0 trials
- Tetrasomy 18p 0 trials
- Thalamic degeneration, symmetric infantile 0 trials
- Thickened earlobes-conductive deafness syndrome 0 trials
- Thoracic dysostosis, isolated 0 trials
- Thrombocytopenia with elevated serum IgA and renal disease 0 trials
- Thrombocytopenia, anemia, and myelofibrosis 0 trials
- Thrombocytopenia-Robin sequence syndrome 0 trials
- Thumb deformity 0 trials
- Thumb, distal hyperextensibility of 0 trials
- Thumbs, congenital Clasped 0 trials
- Thymic aplasia with fetal death 0 trials
- Thymoma, familial 0 trials
- Thyroid hormone metabolism, abnormal 0 trials Sub-types →
- Thyroid hormone plasma membrane transport defect 0 trials
- Tibia, absence of, with congenital deafness 0 trials
- Tibial aplasia-ectrodactyly syndrome 0 trials Sub-types →
- Tibial torsion, bilateral medial 0 trials
- Tiglic acidemia 0 trials
- Toe, fifth, number of phalanges 1N 0 trials
- Toe, misshapen 0 trials
- Toe, rotated fifth 0 trials
- Toes, relative length of first and second 0 trials
- Toes, space between first and second 0 trials
- Tongue, pigmented fungiform papillae of 0 trials
- Torus palatinus and torus mandibularis 0 trials
- Transient infantile hypertriglyceridemia and hepatosteatosis 0 trials
- Tremor of intention, ataxia, and lipofuscinosis 0 trials
- Tremor, hereditary essential, and idiopathic normal pressure hydrocephalus 0 trials
- Trichilemmal cyst 0 trials
- Trichoepitheliomas, multiple desmoplastic 0 trials
- Trichohepatoneurodevelopmental syndrome 0 trials
- Trichoscyphodysplasia 0 trials
- Triokinase and FMN cyclase deficiency syndrome 0 trials
- Triphalangeal thumb with double phalanges 0 trials
- Triphalangeal thumb-polysyndactyly syndrome 0 trials
- Trisomy 18-like syndrome 0 trials
- Trypsinogen deficiency 0 trials
- Tuberculin skin test reactivity, absence of 0 trials
- Tubulin, beta 0 trials
- Tumor suppressor gene on chromosome 11 0 trials
- Turnpenny-fry syndrome 0 trials
- Ubiquitin-activating enzyme, Y-linked 0 trials
- Ulna hypoplasia-intellectual disability syndrome 0 trials
- Ulnar agenesis and endocardial fibroelastosis 0 trials
- Ulnar hypoplasia-split foot syndrome 0 trials
- Ulnar ray dysgenesis with postaxial polydactyly and renal cystic dysplasia 0 trials
- Umbilicus, familial flat 0 trials
- Uncombable hair syndrome 1 0 trials
- Uncombable hair syndrome 2 0 trials
- Uncombable hair syndrome 3 0 trials
- Unique green phenomenon 0 trials
- Ureter, bifid or double 0 trials
- Ureterocele 0 trials
- Urogenital adysplasia 0 trials
- Uveal coloboma-cleft lip and palate-intellectual disability 0 trials
- Vacuolar Neuromyopathy 0 trials
- Van Bogaert-Hozay syndrome 0 trials
- Van Maldergem syndrome 0 trials Sub-types →
- Varicella, severe recurrent 0 trials
- Vascular helix of umbilical cord 0 trials
- Vascular hyalinosis 0 trials
- Vasculitis, lymphocytic, cutaneous small vessel 0 trials
- Veins, pattern of, on anterior thorax 0 trials
- Ventriculomegaly and arthrogryposis 0 trials
- Ventriculomegaly with defects of the radius and kidney 0 trials
- Ventriculomegaly-cystic kidney disease 0 trials
- Venular insufficiency, systemic 0 trials
- Vertebral anomalies and variable endocrine and T-cell dysfunction 0 trials
- Vertebral hypersegmentation and orofacial anomalies 0 trials
- Vertebral hypoplasia with lumbar kyphosis 0 trials
- Vertebral, cardiac, tracheoesophageal, renal, and limb defects 0 trials
- Vestibulocochlear dysfunction, progressive 0 trials
- Visceral neuropathy, familial 0 trials Sub-types →
- Visual impairment and progressive phthisis bulbi 0 trials
- Vitamin D-dependent rickets, type 3 0 trials
- Vitiligo, progressive, with intellectual disability and urethral duplication 0 trials
- Vitreoretinopathy with phalangeal epiphyseal dysplasia 0 trials
- Warburg-cinotti syndrome 0 trials
- Widow's peak syndrome 0 trials
- Woolly hair-skin fragility syndrome 0 trials
- Wooly hair, autosomal recessive 3 0 trials
- Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia 0 trials
- Xerosis and growth failure with immune and pulmonary dysfunction syndrome 0 trials
- Xylosidase deficiency 0 trials
- Yakut short stature syndrome 0 trials
- Zinc deficiency, transient neonatal 0 trials
-
Chromosomal disorder 13 trials · 278 incl. sub-types
18 sub-types
- Autosomal anomaly 0 trials · 195 incl. sub-types Sub-types →
- Syndrome caused by partial chromosomal deletion 0 trials · 57 incl. sub-types Sub-types →
- Aneuploidy 14 trials · 36 incl. sub-types Sub-types →
- Prader-Willi syndrome 32 trials Sub-types →
- Syndrome caused by partial chromosomal duplication 0 trials · 32 incl. sub-types Sub-types →
- Gonosome anomaly 6 trials · 20 incl. sub-types Sub-types →
- Silver-Russell syndrome 7 trials Sub-types →
- Chromosome inversion disorder 1 trial Sub-types →
- Polyploidy 0 trials · 1 incl. sub-types Sub-types →
- Uniparental disomy 0 trials · 1 incl. sub-types Sub-types →
- Bloom syndrome 0 trials
- FRAXD syndrome 0 trials
- Chromosome 16q12 duplication syndrome 0 trials
- Chromosome 1p36 deletion syndrome, proximal 0 trials
- Chromosome Xq13 duplication syndrome 0 trials
- Duplication/inversion 15q11 0 trials
- Mosaic variegated aneuploidy syndrome 0 trials Sub-types →
- Ring chromosome disorder 0 trials Sub-types →
Most studied deeper sub-types
Showing the 400 most recently updated of 533 trials in this tab.
-
Can a One-Time gene therapy fix fabry disease for years?
Cure Stopped earlyThis study follows people with Fabry disease who have already received FLT190, an experimental gene therapy that delivers a working copy of the GLA gene. The goal is to see how safe the treatment is over the long term and whether its effects last. Researchers will track participa…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can a single gene infusion rewrite the story of fabry disease?
Cure Stopped earlyThis trial is testing a gene therapy called FLT190 in adult men with classic Fabry disease, a genetic condition that causes harmful fat buildup in cells. The therapy uses a modified virus to deliver a working copy of the faulty gene, potentially enabling the body to produce the m…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can a single gene shot free hemophilia b patients from regular infusions?
Cure Stopped earlyThis trial tests a gene therapy called FLT180a in adults with hemophilia B, a condition where the body lacks a clotting protein. The therapy delivers a working gene to help the body produce its own clotting factor. A small group of participants will receive a single dose and be f…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Aug 02, 2026 00:00 UTC
-
One-shot gene editor aims to correct a brain disorder at its source
Cure Stopped earlyThis trial tests whether a single injection of a gene-editing tool can safely correct a specific mutation in the CHD3 gene that causes Snijders Blok-Campeau syndrome, a condition marked by developmental delay and intellectual disability. The gene editor is delivered directly into…
Early phase 1 • Sponsor: Yongguo Yu • Aim: Cure
Last updated Aug 01, 2026 00:00 UTC
-
Can a Chemo-Antibody combo beat a tough leukemia?
Cure Stopped earlyThis phase II trial is testing whether adding the targeted antibody-drug inotuzumab ozogamicin to a standard chemotherapy regimen (Hyper-CVAD) improves outcomes for adults with B-cell acute lymphoblastic leukemia. The study enrolls people with newly diagnosed or recently remitted…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Cure
Last updated Aug 01, 2026 00:00 UTC
-
Brain cancer vaccine trial halted: what we know
Vaccine Stopped earlyThis study tested a vaccine called VBI-1901 in 70 people with recurrent glioblastoma, an aggressive brain cancer. The goal was to find a safe dose and see if the vaccine could boost the immune system against the tumor. The trial was terminated early, so results are limited.
Phase 1/2 • Sponsor: VBI Vaccines Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:30 UTC
-
Hope for genetic dementia: AL001 trial ends early
Disease control Stopped earlyThis phase 3 study tested a drug called AL001 in 119 people who carry a mutation in the progranulin gene, putting them at high risk for or already diagnosed with frontotemporal dementia. The goal was to see if AL001 could slow the worsening of memory, behavior, and language probl…
Phase 3 • Sponsor: Alector Inc. • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
Experimental antibody GNR-084 tested against Hard-to-Treat leukemia
Disease control Stopped earlyResearchers are testing an experimental antibody called GNR-084 in adults with B-cell acute lymphoblastic leukemia that has come back or stopped responding to treatment. The trial enrolls 14 people aged 18 to 45 who have already received at least two prior therapies. Participants…
Phase 1/2 • Sponsor: AO GENERIUM • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New combo therapy shows promise for kids with tough cancers
Disease control Stopped earlyThis study tested a combination of an immunotherapy drug (nivolumab) and low-dose chemotherapy in children and teenagers whose solid tumors had not responded to standard treatments. The goal was to see if the combination was safe and could help control the cancer. The trial was s…
Phase 1/2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo aims to outperform keytruda in lung cancer
Disease control Stopped earlyThis phase 3 trial tests whether adding vibostolimab to pembrolizumab (Keytruda) helps people with PD-L1 positive metastatic non-small cell lung cancer live longer than pembrolizumab alone. Over 1,200 participants received either the combination or pembrolizumab every three weeks…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Double-Drug attack on Hard-to-Treat lymphomas
Disease control Stopped earlyResearchers are testing whether combining two chemotherapy drugs, pralatrexate and romidepsin, is safe and effective for people with lymphoid cancers that have returned or stopped responding to treatment. The trial first finds the highest dose people can tolerate, then gives that…
Phase 1/2 • Sponsor: Jennifer Amengual • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Tiny doses of avastin tested against laser for preemie eye disease
Disease control Stopped earlyThis study tested a low dose of the drug bevacizumab (Avastin) against standard laser treatment for retinopathy of prematurity, an eye disease that can blind premature infants. Sixteen babies with severe disease were enrolled. The goal was to see if the drug could control the dis…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo aims to keep advanced breast cancer in check
Disease control Stopped earlyThis study tested whether a combination of olaparib (a targeted therapy) and pembrolizumab (an immunotherapy) works better than standard chemotherapy plus pembrolizumab for people with advanced triple-negative breast cancer that initially responded to chemo-immunotherapy. The tri…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Slower magnesium drip may help sickest patients hold onto the mineral
Disease control Stopped earlyCritically ill patients often have low magnesium, which can lead to heart rhythm problems and other complications. When magnesium is given through an IV, the body keeps only about half of it. Researchers are testing whether giving the same dose over 8 hours instead of 4 hours hel…
Sponsor: CAMC Health System • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for High-Risk melanoma: combo therapy aims to prevent recurrence
Disease control Stopped earlyThis study tested whether adding vibostolimab to the standard immunotherapy pembrolizumab can better prevent melanoma from returning after surgery. About 1,600 people with high-risk stage II to IV melanoma took part. The goal was to see if the combination keeps cancer away longer…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Spinal injection drug targets genetic cause of ALS and dementia
Disease control Stopped earlyResearchers are testing repeated doses of an experimental drug called WVE-004 in adults who have ALS, frontotemporal dementia, or both, linked to a mutation in the C9orf72 gene. Participants receive the drug by spinal injection every 12 weeks for up to 96 weeks. The study tracks …
Phase 1/2 • Sponsor: Wave Life Sciences USA, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Zapping ovaries: could a quick procedure replace daily pills for PCOS infertility?
Disease control Stopped earlyThis study tests a device that uses heat to ablate (destroy) a small part of the ovary in women with polycystic ovary syndrome (PCOS) who have trouble getting pregnant. The goal is to restore ovulation without needing daily medication. About 195 women will be randomly assigned to…
Sponsor: May Health • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Seizure drug safety trial halted early for dravet and LGS patients
Disease control Stopped earlyThis study looked at the long-term safety of soticlestat when added to standard seizure medicines for people with Dravet syndrome or Lennox-Gastaut syndrome. It included 352 children and adults who had already been in earlier studies. The trial was terminated early, so results ar…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new drug tame seizures in two severe epilepsy syndromes?
Disease control Stopped earlyThis phase 3 trial tests whether soticlestat can reduce seizures in people with Dravet syndrome or Lennox-Gastaut syndrome who have already used fenfluramine. Participants take soticlestat as tablets or mini-tablets, and researchers measure changes in seizure frequency over the f…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug shows promise for Tough-to-Treat seizures in kids
Disease control Stopped earlyThis study looked at the long-term safety of soticlestat, an experimental drug, in children and adults with severe forms of epilepsy like Dravet syndrome and Lennox-Gastaut syndrome. Participants took soticlestat twice a day along with their usual seizure medicines. The study was…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Promising combo therapy for incurable liver cancer shows potential in phase 3 trial
Disease control Stopped earlyThis study tested whether adding two drugs (lenvatinib and pembrolizumab) to a standard liver cancer treatment called TACE helps people with liver cancer that cannot be removed by surgery. About 479 participants received either the drug combo plus TACE or TACE alone. The goal was…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Experimental CAR-T therapy takes on Hard-to-Treat lupus nephritis
Disease control Stopped earlyThis early-phase trial is testing a personalized cell therapy called KYV-101 for people with lupus nephritis that hasn't responded to standard treatments. The therapy uses a patient's own immune cells, modified to target and destroy faulty B cells that drive the disease. Only 2 p…
Phase 1/2 • Sponsor: Kyverna Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can an antiviral drug protect hearing in infants with congenital CMV?
Disease control Stopped earlyThis trial tests whether the antiviral drug valganciclovir can improve hearing and language outcomes in infants who have hearing loss due to congenital cytomegalovirus (CMV) infection. Infants aged 1 to 12 months with confirmed sensorineural hearing loss will receive either valga…
Phase 2 • Sponsor: Albert Park • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Halted gene therapy study raises questions for AMN patients
Disease control Stopped earlyThis early-stage trial tested a gene therapy called SBT101 for adrenomyeloneuropathy (AMN), a rare nerve disease that causes walking difficulties. Eight adults received either the therapy or a sham procedure. The study was terminated early, so we have limited data on safety and e…
Phase 1/2 • Sponsor: SwanBio Therapeutics, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Chemo-Targeted drug combo outsmart Treatment-Resistant prostate cancer?
Disease control Stopped earlyThis phase 2 trial is testing whether giving two chemotherapy drugs (docetaxel and carboplatin) followed by a maintenance drug called rucaparib can help men with metastatic castration-resistant prostate cancer that has specific DNA repair defects. The idea is that the chemo shrin…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat cervical cancer
Disease control Stopped earlyThis trial investigates whether specially engineered immune cells (CAR-T cells) can safely treat advanced or recurrent cervical cancer. The cells are designed to recognize and attack cancer cells that carry certain markers like GD2 or Mesothelin. The study involves 20 adults with…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Engineered immune cells take on deadly brain tumors
Disease control Stopped earlyThis early-phase study tests a new treatment for glioblastoma, an aggressive brain cancer. The approach uses a patient's own immune cells, modified in the lab to better recognize and attack the tumor, combined with chemotherapy. The main goal is to check the safety of this therap…
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Immune cells take on nerve tumors: new trial launches
Disease control Stopped earlyThis early-stage trial is testing whether specially engineered immune cells (called CAR-T and CTL cells) and a dendritic cell vaccine can safely treat people with neurofibromatosis or schwannomatosis, conditions that cause nerve tumors. The study will enroll 100 participants aged…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Gene therapy aims to fix bone marrow failure in fanconi anemia
Disease control Stopped earlyThis trial tests a gene therapy for Fanconi anemia, a rare genetic disorder that causes bone marrow failure and increases cancer risk. Participants receive their own stem cells that have been genetically corrected with a lentiviral vector to fix the faulty FANCA gene. The study e…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New combo therapy aims to wipe out leukemia cells for good
Disease control Stopped earlyThis early-stage trial tests a combination therapy for B-cell acute lymphoblastic leukemia (B-ALL). It uses specially engineered immune cells (CAR-T cells and CTLs) followed by a dendritic cell vaccine to target multiple cancer markers. The goal is to achieve a very deep remissio…
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for recurring c. diff: which treatment works best?
Disease control Stopped earlyThis study tested three different antibiotic regimens for people with recurrent Clostridium difficile infection (C. diff), a serious gut infection that keeps coming back. The goal was to see if newer drugs like fidaxomicin or a tapered/pulsed course of vancomycin work better than…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Experimental drug REC-2282 targets NF2 brain tumors in early trial
Disease control Stopped earlyThis study tested a drug called REC-2282 in people aged 12 and older with progressive meningiomas (brain tumors) linked to NF2 gene mutations. Participants took the drug or a placebo three times a week in cycles. The goal was to see if the drug could slow tumor growth. The trial …
Phase 2/3 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New nasal spray aims to curb relentless hunger in rare genetic disorder
Disease control Stopped earlyThis study tests the long-term safety of a nasal spray called carbetocin for people with Prader-Willi syndrome who experience severe, constant hunger (hyperphagia). About 160 participants who completed a previous study will receive the spray three times daily. The goal is to see …
Phase 3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a daily pill stop hereditary angioedema attacks?
Disease control Stopped earlyThis trial tests whether an experimental oral medication, deucrictibant, can reduce the number of swelling attacks in people with hereditary angioedema (HAE) types I and II. Participants take either a low or high dose of the drug or a placebo for 12 weeks, and then may continue o…
Phase 2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can an inhaled protein save lungs in Alpha-1? new trial aims to find out
Disease control Stopped earlyThis study tests whether inhaling alpha-1 antitrypsin (AAT) daily can slow lung function loss in people with Alpha-1 deficiency and moderate-to-severe lung disease. 220 adults will receive either the drug or a placebo for two years, then all will receive the drug for two more yea…
Phase 3 • Sponsor: Kamada, Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Lupus skin drug trial halted early – only 8 volunteers joined
Disease control Stopped earlyThis study tested an experimental drug called PF-06823859 for adults with lupus that affects the skin. The goal was to see if the drug could reduce skin inflammation and improve symptoms. The trial was stopped early and only enrolled 8 people instead of the planned 48, so results…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can stem cell vesicles heal Crohn's fistulas?
Disease control Stopped earlyThis early-phase trial tests whether ExoFlo, a product made from extracellular vesicles derived from donor bone marrow stem cells, can safely treat perianal fistulas in people with Crohn's disease. The study enrolls adults aged 18-75 who have had Crohn's for at least six months a…
Phase 1/2 • Sponsor: Direct Biologics, LLC • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Virtual cues on a treadmill: a new hope for Parkinson's falls?
Disease control Stopped earlyThis trial tests whether adding augmented reality (AR) to treadmill training can help people with Parkinson's disease who have trouble walking and are at risk of falling. Participants will be randomly assigned to one of three groups: treadmill training with AR, treadmill training…
Sponsor: Klinik Valens • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a new biologic tame lupus flares?
Disease control Stopped earlyThis trial is testing whether an experimental biologic called MK-6194 can reduce disease activity in adults with systemic lupus erythematosus (SLE), an autoimmune condition that causes inflammation and organ damage. Participants receive either MK-6194 or a placebo as an injection…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a vitamin B3 pill help kids with colitis?
Disease control Stopped earlyThis study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3) can help children with mild to moderate ulcerative colitis. About 40 kids will take either the supplement or a placebo for 6 to 12 months, alongside their usual treatment. The main goa…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a new hip implant stand the test of time?
Disease control Stopped earlyThis study follows about 300 people who receive a hip replacement using the GTS cementless stem, a type of implant that anchors to bone without cement. The goal is to see how well the implant performs over up to 10 years, measuring pain, function, and joint stability. Participant…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a gel tame psoriasis? new antibody fragment put to the test
Disease control Stopped earlyThis phase 2 trial is testing whether a topical gel containing ZL-1102, an antibody fragment that blocks IL-17A, can safely and effectively reduce the severity of chronic plaque psoriasis. The study enrolls adults with psoriasis for at least six months and compares different dose…
Phase 2 • Sponsor: Zai Lab (Hong Kong), Ltd. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New injection aims to stop dangerous psoriasis flares in their tracks
Disease control Stopped earlyThis phase 2 trial tests an injection called TQH2929, a lab-made antibody that blocks inflammation, in 36 adults having a sudden, severe flare of generalized pustular psoriasis (GPP). Half get the drug, half get a placebo. The main goal is to see if the drug clears pustules withi…
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a clotting boost make surgery safer for hemophilia patients?
Disease control Stopped earlyThis trial tests whether a medication called eptacog beta can safely prevent excessive bleeding in people with hemophilia A or B who have inhibitors and need major surgery. Participants receive the drug during and after their operation, and doctors measure how well bleeding is co…
Phase 3 • Sponsor: Laboratoire français de Fractionnement et de Biotechnologies • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
A common diabetes drug may protect against hormone therapy's metabolic side effects
Disease control Stopped earlyThis phase 3 trial tests whether metformin, a standard diabetes medication, can prevent or reverse metabolic syndrome in men with prostate cancer who are starting androgen deprivation therapy (ADT). Metabolic syndrome—a cluster of conditions like high blood sugar, high blood pres…
Phase 3 • Sponsor: Canadian Urologic Oncology Group • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
A common supplement may shield bones in kidney disease — a trial puts it to the test
Disease control Stopped earlyThis pilot trial investigates whether potassium citrate can improve bone quality and strength in adults and children with chronic kidney disease. Participants take either potassium citrate or a placebo for six months, along with blood and urine tests and advanced bone scans. The …
Phase 2/3 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat lymphomas
Disease control Stopped earlyThis study tested a combination of two drugs, favezelimab and pembrolizumab, in 137 people with certain blood cancers like Hodgkin lymphoma and B-cell lymphoma. The goal was to see if the combination was safe and could shrink tumors. The study also looked at each drug alone in so…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Psoriasis patients switch biologics in new Real-World study
Disease control Stopped earlyThis study watches 200 adults with moderate to severe psoriasis who switch from ustekinumab to guselkumab in everyday medical practice. Researchers track how well the new drug clears skin symptoms and check for side effects over 52 weeks. The goal is to see if guselkumab works sa…
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a new nucleotide analogue boost cancer treatment?
Disease control Stopped earlyThis trial is testing an experimental drug called NUC-3373, a nucleotide analogue, in combination with standard cancer drugs for people with advanced solid tumors. The study has two parts: one combining NUC-3373 with pembrolizumab, and the other combining it with docetaxel. The g…
Phase 1/2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Zapping the esophagus: an implantable device takes on chronic heartburn
Disease control Stopped earlyThis trial tests whether a small implanted device that electrically stimulates the lower esophageal sphincter can reduce acid reflux in people with GERD. Participants receive either active stimulation or a sham (inactive) device for six months, then all receive stimulation. The s…
Sponsor: EndoStim Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a gel cut down on skin cancer surgeries? new trial investigates
Disease control Stopped earlyThis trial tests a gel called patidegib applied to the face twice daily for 9 months in people who develop many basal cell carcinomas (a common skin cancer) but do not have Gorlin syndrome. The goal is to see if the gel reduces the number of new skin cancers that would normally r…
Phase 2 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can special lenses put the brakes on childhood myopia?
Disease control Stopped earlyThis trial tests whether a new type of spectacle lens can slow the progression of myopia (nearsightedness) in children aged 8 to 13. Over 12 months, researchers measure changes in eye length and prescription, comparing results to a historical group that wore standard lenses. The …
Sponsor: Essilor International • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Double-Duty inhaler aims to ease breathing in COPD
Disease control Stopped earlyThis phase 3 trial tests whether a fixed-dose combination inhaler containing tiotropium and salmeterol works better than either drug alone or placebo for people with chronic obstructive pulmonary disease (COPD). The study measures improvements in lung function, shortness of breat…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a common water pill keep blood pressure in check after childbirth?
Disease control Stopped earlyThis study tested whether a 14-day course of hydrochlorothiazide (a water pill) could prevent high blood pressure from returning after delivery in women with preeclampsia or gestational hypertension. Over 450 women were planned, but the trial was stopped early. The main goals wer…
Phase 3 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can CML patients pause treatment? new study explores Drug-Free remission
Disease control Stopped earlyThis study looked at 124 adults with chronic myeloid leukemia (CML) who had been on the drug nilotinib for at least 3 years and had very low levels of cancer. First, researchers tested if lowering the nilotinib dose by half for a year could help patients stop treatment entirely. …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Light-Activated cream could slow growth of NF1 skin tumors
Disease control Stopped earlyThis trial tests whether a light-activated cream (Levulan Kerastick) followed by red light therapy can slow the growth of benign skin tumors called neurofibromas in people with neurofibromatosis type 1 (NF1). About 30 participants aged 14 and older with superficial tumors on the …
Phase 2 • Sponsor: Donald Basel • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Genetic clues could personalize breast cancer treatment
Disease control Stopped earlyThis study looks at genetic changes in postmenopausal women with a common type of advanced breast cancer (HR+ HER2-). Participants first receive ribociclib plus letrozole; those with a specific mutation (PIK3CA) may later switch to alpelisib plus fulvestrant. The goal is to track…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental Friedreich's ataxia drug tested in kids – but trial halted early
Disease control Stopped earlyThis early-stage trial tested a drug called nomlabofusp (CTI-1601) in 18 adolescents and children with Friedreich's ataxia, a rare genetic disease that affects movement and coordination. The goal was to check safety and how the body processes the drug. However, the study was term…
Phase 1 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New cancer pill shows early promise, but trial halted
Disease control Stopped earlyThis early-stage trial tested an oral drug called TNO155, alone or with another drug (nazartinib), in 227 adults with advanced solid tumors like lung cancer, melanoma, and head/neck cancer. The main goal was to check safety and find the right dose. The study was terminated early,…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
AI speech coach boosts Kids' articulation in hybrid therapy trial
Disease control Stopped earlyThis study tests whether adding an AI speech therapist, named Jessica, to traditional speech therapy helps children with speech sound disorders improve their articulation more than standard therapy alone. Over 8 weeks, children aged 5 to 17 receive weekly sessions with a speech-l…
Sponsor: Syracuse University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Iron infusions may boost gut healing in celiac disease
Disease control Stopped earlyThis trial investigates whether adding intravenous iron to standard oral iron supplements can help heal intestinal damage in people with celiac disease who have iron deficiency and gut atrophy. Participants receive either intravenous iron infusions plus oral iron, or oral iron al…
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Real-World study tracks Selumetinib's impact on NF1 tumors in children
Disease control Stopped earlyThis study observes children aged 3 to 18 with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas and are starting treatment with selumetinib. Researchers will track how well the drug shrinks or stabilizes tumors, how long patients stay on tre…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Leg artery study halted: did platelet screening help?
Disease control Stopped earlyThis study looked at whether screening people for high platelet reactivity (a condition where blood clots easily) before leg artery procedures could improve outcomes. It involved 31 adults with peripheral artery disease who were scheduled for angioplasty or stenting. The trial wa…
Phase 3 • Sponsor: Marissa Jarosinski • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New daily pill aims to tame Crohn's Flare-Ups
Disease control Stopped earlyThis trial investigates whether an oral medication called etrasimod can help people with moderate to severe Crohn's disease who have not responded well to other treatments. Participants take either etrasimod or a placebo daily for up to several years. The study measures improveme…
Phase 2/3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a second dose of steroids help premature babies breathe easier?
Disease control Stopped earlyThis study investigates whether giving a repeat course of betamethasone, a steroid, to pregnant women with preterm premature rupture of membranes (PPROM) can improve health outcomes for their premature babies. The main goal is to see if it shortens the baby's stay in the neonatal…
Phase 2/3 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Two-Drug combo aims to outsmart resistant hodgkin lymphoma
Disease control Stopped earlyThis phase 2 study tests whether combining magrolimab and pembrolizumab can shrink or eliminate tumors in people with classic Hodgkin lymphoma that has come back or not responded to at least two prior treatments. Magrolimab targets a 'don't eat me' signal on cancer cells, while p…
Phase 2 • Sponsor: Ranjana Advani • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for rare hunger disorder: drug shows promise in Long-Term trial
Disease control Stopped earlyThis study tests whether ARD-101 can safely reduce extreme hunger and food-related behaviors in people with Prader-Willi syndrome over 12 months. About 90 participants who completed a prior study will take the drug daily and visit the clinic regularly. The goal is to improve qual…
Phase 3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New cell therapy shows promise for tough-to-treat lymphoma
Disease control Stopped earlyThis study tests an experimental treatment called GLPG5101 for people with B-cell non-Hodgkin lymphoma that has come back or not responded to standard therapy. The treatment is a cell therapy made at the hospital. The study has two phases: first, finding the best dose with the fe…
Phase 1/2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New shot during back surgery may boost spine healing in disc disease patients
Disease control Stopped earlyThis study tests a single injection of a drug called AGA111 given directly into the spine during back fusion surgery for people with degenerative disc disease. The goal is to see if it helps the bones heal together more successfully and improves pain and function. About 412 adult…
Phase 3 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Engineered immune cells take aim at deadly brain tumors
Disease control Stopped earlyThis early-phase trial is testing a new treatment called CHM-1101 for people with a type of brain cancer (glioblastoma) that has come back or is getting worse. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack tumor cells. The …
Phase 1 • Sponsor: Chimeric Therapeutics • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Lymphoma drug combo trial for youth halted after just 5 patients
Disease control Stopped earlyThis early-phase trial tested a combination of two immune-boosting drugs, relatlimab and nivolumab, in children and young adults with Hodgkin or non-Hodgkin lymphoma that had come back or not responded to treatment. The goal was to check safety, drug levels, and whether the tumor…
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Laser zaps sweat glands in tiny hyperhidrosis trial
Disease control Stopped earlyThis early study tested a laser treatment for people with excessive sweating (hyperhidrosis). The approach used a dye to mark sweat glands, then a special laser to destroy them. Only 2 people were enrolled, and the study was terminated early, so we have very little data on whethe…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New biologic drug brazikumab tested for Crohn's – trial cut short
Disease control Stopped earlyThis study tested brazikumab, an experimental biologic drug, in 89 adults with moderate-to-severe Crohn's disease. Participants received either brazikumab, a placebo, or an active comparator (Humira) to see if the drug could improve symptoms and heal the gut lining. The trial was…
Phase 2/3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug shows promise for Long-Term control of ulcerative colitis
Disease control Stopped earlyThis study looks at the long-term safety of brazikumab, a drug given as a shot every 4 weeks, for people with moderate to severe ulcerative colitis. Participants had already taken part in an earlier study of brazikumab. The goal is to see if the drug remains safe over a longer pe…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental vaccine aims to shrink colorectal tumors before surgery
Disease control Stopped earlyThis trial tested a vaccine called PD1-Vaxx given before surgery to people with a specific type of colorectal cancer (MSI-high). The goal was to see if the vaccine could shrink tumors, measured by how many cancer cells remained after treatment. Only 3 people took part, and the st…
Phase 2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New injection for ulcerative colitis shows early promise, but trial halted
Disease control Stopped earlyThis early-phase study tested an injectable drug called NP-201 acetate in healthy volunteers and people with mild-to-moderate ulcerative colitis. The goal was to check safety, how the body processes the drug, and early signs of effectiveness. The trial was terminated early, so on…
Phase 1 • Sponsor: NIBEC Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Experimental achondroplasia drug trial halted early
Disease control Stopped earlyThis study tested an experimental drug called SAR442501 in children with achondroplasia, a common form of dwarfism. The goal was to see if the drug was safe and could improve growth. However, the trial was stopped early after enrolling only 16 children, so we have very little inf…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common blood pressure drug shrink kidney tumors?
Disease control Stopped earlyThis pilot study tested whether propranolol, a beta-blocker, could shrink or stabilize kidney angiomyolipomas in people with tuberous sclerosis. Only 2 participants were enrolled before the trial was terminated, so the results are very limited. The goal was to find a less invasiv…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug brazikumab aims to tame ulcerative colitis Flare-Ups
Disease control Stopped earlyThis phase 2 trial tested brazikumab in 242 adults with moderate-to-severe ulcerative colitis. Participants received either brazikumab or a placebo intravenously and then as injections over 54 weeks. The goal was to see if the drug could improve symptoms and heal the colon lining…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common laxative soothe gut inflammation in cystic fibrosis?
Disease control Stopped earlyThis phase 2 trial investigates whether polyethylene glycol (a laxative) can reduce intestinal inflammation in children with cystic fibrosis. The study includes children aged 4 to 17 with cystic fibrosis and pancreatic insufficiency who have elevated fecal calprotectin (a marker …
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can IBD patients safely stretch their infusion schedule? new study tests two strategies
Disease control Stopped earlyThis study looks at people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are in deep remission. It compares two methods for gradually increasing the time between infliximab infusions: one based on symptoms and one based on drug levels in the blood. T…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Laser plus gel: new hope for port wine stains?
Disease control Stopped earlyThis study tested whether adding timolol gel to pulsed dye laser treatment could improve results for port wine stains on children's faces. Twenty-five children aged 6 months to 18 years were enrolled, but the study was stopped early. The goal was to see if the combination led to …
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Antibiotics at home after early water break: study stopped early
Disease control Stopped earlyThis study looked at whether giving pregnant people oral antibiotics at home could delay delivery after their water broke very early (between 18 and 23 weeks). The goal was to see if more people would stay pregnant for at least 28 days after the water broke. The study was stopped…
Phase 4 • Sponsor: University Hospitals Cleveland Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Promising c. diff drug fails to prove benefit in small, halted trial
Disease control Stopped earlyThis study tested whether an extra dose of bezlotoxumab, a drug that blocks the harmful toxin made by C. diff bacteria, could help very sick patients recover after emergency colon surgery. Only 5 people took part before the study was stopped early. The goal was to see if the drug…
Phase 4 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental bone putty for spinal surgery falls short in early trial
Disease control Stopped earlyThis study tested a special bone graft material (MatriBONE mixed with the patient's own bone marrow) for spinal fusion surgery in people with painful degenerative back problems. The goal was to see how well the bones fused together after 12 months. However, the trial was stopped …
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill for ulcerative colitis shows promise, but trial halted early
Disease control Stopped earlyThis study tested an oral medication, NX-13, in 81 adults with moderate to severe ulcerative colitis. Participants received either NX-13 or a placebo for 12 weeks, with a long-term follow-up option. The trial was terminated early, so the full results are not available, but the da…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gene therapy takes on deadly brain tumor
Disease control Stopped earlyThis study tests a new treatment called Temferon for people with glioblastoma, a fast-growing brain cancer. The therapy uses a patient's own blood stem cells, modified to deliver interferon directly to the tumor. Up to 27 patients with a specific genetic marker (unmethylated MGMT…
Phase 1/2 • Sponsor: Genenta Science • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Experimental drug targets stubborn cholesterol in rare disease
Disease control Stopped earlyThis study tested an experimental drug called ARO-ANG3 in 18 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. Participants received injections of the drug and were monitored for safety and cholesterol change…
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can an extra shot boost COVID protection in autoimmune patients?
Disease control Stopped earlyThis study tests whether an additional dose of a COVID-19 vaccine can improve immune protection in adults and children with autoimmune diseases like rheumatoid arthritis, lupus, multiple sclerosis, and others who are taking immunosuppressive medications. Participants who had a we…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Sickle cell transplant study halted after just one patient
Disease control Stopped earlyThis study tested a drug called siplizumab alongside a stem cell transplant for people with severe sickle cell disease. The goal was to see if it could prevent the body from rejecting the new cells and reduce a serious side effect called graft-versus-host disease. Only one person…
Phase 1/2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
PBC drug combo safety check ends early
Disease control Stopped earlyThis study looked at the long-term safety of a fixed-dose combination of two drugs (obeticholic acid and bezafibrate) for people with primary biliary cholangitis (PBC), a chronic liver disease. It enrolled 62 adults who had already been taking the combination in earlier studies. …
Phase 3 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Experimental cancer drug trial halted early
Disease control Stopped earlyThis early-stage study tested a new drug called PF-07265807 in people with advanced or metastatic solid tumors that had spread. The main goals were to find a safe dose and check for side effects. The trial was terminated early, so results are limited.
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Experimental cancer drug study halted early
Disease control Stopped earlyThis early-stage study tested a new drug called PF-07284892, alone or with other medicines, in people with advanced solid tumors that had specific genetic changes. The goal was to find the safest dose and check for side effects. The study was stopped early, so results are limited…
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Heart drug may tame baby blood vessel growth
Disease control Stopped earlyThis study tested if the beta-blocker propranolol could control the growth of infantile hemangiomas (non-dangerous blood vessel growths) in babies under 4 months old. The trial was terminated early and only enrolled 14 infants. The goal was to measure changes in hemangioma thickn…
Phase 2/3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
CML drug combo aims for Treatment-Free remission, but trial stalls
Disease control Stopped earlyThis phase 3 trial tested whether adding asciminib to the standard drug imatinib could help people with chronic myeloid leukemia (CML) achieve a deep remission and safely stop all medication. Only 8 patients were enrolled before the study was terminated early, making it too small…
Phase 3 • Sponsor: Sarit Assouline • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
HIV drug switch may boost heart health and trim body fat
Disease control Stopped earlyThis study looked at whether switching from a standard HIV drug combination to a different one (Delstrigo) could improve cholesterol, body fat, and blood sugar in people with HIV. The study planned to enroll 60 adults whose HIV was already well-controlled. Participants were rando…
Phase 4 • Sponsor: Chelsea and Westminster NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Heart drug study halted early: what we know
Disease control Stopped earlyThis study tested an experimental drug called CRD-4730 in people with a rare inherited heart rhythm disorder (CPVT) that can cause dangerous fast heartbeats. Seven adults received two different doses of the drug and a placebo to check safety and how the body processes it. The stu…
Phase 2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New eye lens aims to sharpen Mid-Range sight after cataracts
Disease control Stopped earlyThis study tested a new type of artificial lens (enVista Aspire) for people having cataract surgery. The goal was to see if it improves intermediate vision, like seeing a computer screen, better than standard lenses. The trial was stopped early and included 27 adults aged 22 and …
Sponsor: Bausch & Lomb Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Promising seizure drug study halted early
Disease control Stopped earlyThis study looked at the long-term safety of the drug NBI-921352 for people with a rare genetic seizure disorder called SCN8A-DEE. It was an extension of an earlier study, and participants took the drug alongside their usual seizure medications. The study was stopped early and on…
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Promising preeclampsia drug trial halted early – what happened?
Disease control Stopped earlyThis study tested an experimental drug called AMAG-423 (Digoxin Immune Fab) in pregnant women with severe preeclampsia, a dangerous condition of high blood pressure during pregnancy. The goal was to see if the drug could reduce serious health problems in babies, such as bleeding …
Phase 2/3 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a daily injection reshape bodies of HIV patients?
Disease control Stopped earlyThis study looked at whether tesamorelin (Egrifta), a daily injection that boosts growth hormone, can improve body composition in people with HIV who have excess belly fat (lipodystrophy). Six participants received the drug for up to 12 months, with researchers measuring liver fa…
Phase 4 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Warming blankets and fluids tested to prevent hypothermia in C-Section births
Disease control Stopped earlyThis study tested different warming methods—like forced air blankets and warmed IV fluids—to prevent hypothermia in women having planned C-sections. Only 16 women participated before the trial was stopped early. The goal was to see which method best keeps mother and baby warm and…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for tough leukemias? trial of vodobatinib begins, then stops
Disease control Stopped earlyThis study tested a new drug called Vodobatinib (K0706) in people with chronic myeloid leukemia or a related leukemia who had not responded to at least three other treatments. The trial was split into parts: first in healthy volunteers to check safety, then in patients to find th…
Phase 1/2 • Sponsor: Sun Pharma Advanced Research Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Blood cancer transplant study tests safer GVHD prevention
Disease control Stopped earlyThis phase 2 trial tested two different drug combinations to prevent graft-versus-host disease (GVHD) in 150 people with blood cancers receiving a stem cell transplant from an unrelated donor. Both combinations used cyclosporine and sirolimus, plus either mycophenolate mofetil or…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New cataract device tested, but study halted early
Disease control Stopped earlyThis study compared a new device called miCOR, which uses low energy to break up cataracts, to standard cataract surgery. About 402 adults with cataracts were planned to take part. The study was terminated early, so we don't have full results on whether the new device is better o…
Sponsor: Carl Zeiss Meditec, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Cancer drug niraparib tested before prostate surgery – early trial stopped
Disease control Stopped earlyThis phase II trial tested the drug niraparib (Zejula) in 11 men with high-risk prostate cancer that had not spread. All men had specific DNA repair gene mutations. They took niraparib before having their prostate removed surgically. The goal was to see if the drug could eliminat…
Phase 2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Experimental drug for rare skin disease fails to reach goal
Disease control Stopped earlyThis early-stage trial tested a drug called DS-2325a in 9 adults with Netherton syndrome, a rare genetic condition causing severe skin redness, scaling, and allergies. The study aimed to check safety and whether the drug could help control the disease. However, the trial was term…
Phase 1/2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New prostate cancer combo trial ends early
Disease control Stopped earlyThis study tested a new drug called exicorilant (CORT125281) combined with enzalutamide in men with metastatic castration-resistant prostate cancer. The goal was to find a safe dose and check for side effects. The trial was terminated early, so results are limited. It involved 39…
Phase 1/2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New pill shows promise for severe baldness, but trial cut short
Disease control Stopped earlyThis study tested a drug called KL130008 in 114 adults with severe alopecia areata, a condition causing major hair loss. The goal was to see if the drug could safely regrow hair, measured by how many people achieved 80% or more scalp coverage. However, the trial was terminated ea…
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New device zaps away acid reflux – but is it safe Long-Term?
Disease control Stopped earlyThis study tracked 350 people with GERD who received a device that electrically stimulates the muscle that keeps stomach acid from rising. The goal was to see how safe the device is over 5 years and whether it improves symptoms and quality of life. The registry included both new …
Sponsor: EndoStim Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Continued EryDex treatment studied in rare neurological disorder
Disease control Stopped earlyThis study offered continued treatment with EryDex to 101 people with ataxia telangiectasia (A-T) who had finished a previous trial. The main goal was to monitor safety, including side effects and serious events. The study was terminated early, and it did not aim to cure the dise…
Phase 3 • Sponsor: Quince Therapeutics S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New daily pill aims to stop HAE attacks, but trial cut short
Disease control Stopped earlyThis phase 2 trial tested KVD824, an oral pill, to prevent swelling attacks in people with hereditary angioedema types I and II. The study planned to compare three doses against a placebo over several months. However, the trial was terminated early with only 33 participants, so t…
Phase 2 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a repurposed drug tame seizures in adult dravet patients?
Disease control Stopped earlyThis study tested the drug fenfluramine (FINTEPLA) in adults with Dravet syndrome whose seizures were not controlled by other medications. The trial was open-label and added fenfluramine to existing treatments. It aimed to see if the drug could reduce monthly seizures by at least…
Phase 3 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a simple saline enema save tiny preemies from deadly gut disease?
Disease control Stopped earlyThis study tested whether giving extremely preterm babies (born before 27 weeks) a gentle saline enema twice a day could help them reach full feeding sooner and prevent necrotizing enterocolitis (NEC), a severe gut infection. The trial planned to include 200 infants but was termi…
Sponsor: Uppsala County Council, Sweden • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Abandoned study: can a common painkiller help close a tiny heart vessel in preemies?
Disease control Stopped earlyThis study tested whether adding acetaminophen to standard ibuprofen treatment could better close a blood vessel (ductus arteriosus) that stays open too long in very premature infants. The trial was planned for preterm babies born at or before 27 weeks and 6 days who needed breat…
Phase 2 • Sponsor: University of South Alabama • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Experimental triple therapy for advanced cancers shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested the drug plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combination was safe and could shrink…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New pill aims to tame ulcerative colitis Flare-Ups
Disease control Stopped earlyThis study tested an experimental daily tablet called VTX002 in people with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. About 213 participants were randomly assigned to receive one of two doses of VTX002 or a placebo for 13 weeks, with the option …
Phase 2 • Sponsor: Oppilan Pharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Experimental pill aims to stop extra bone growth in rare disease
Disease control Stopped earlyThis phase 2 trial tested two doses of an oral drug called fidrisertib (IPN60130) in children and adults with fibrodysplasia ossificans progressiva (FOP), a rare condition where soft tissues turn into bone. The goal was to see if the drug could reduce new abnormal bone growth com…
Phase 2 • Sponsor: Clementia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental Parkinson's drug talineuren put to early safety test
Disease control Stopped earlyThis early-stage trial tested the safety of an intravenous drug called talineuren (liposomal GM1) in 22 people with Parkinson's disease. The study was open-label and designed to find a safe dose, but it was terminated before completion. No conclusions about effectiveness can be d…
Phase 1 • Sponsor: InnoMedica Schweiz AG • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental KRRO-110 trial for rare lung condition halted early
Disease control Stopped earlyThis study tested an experimental drug called KRRO-110 in healthy volunteers and people with Alpha-1 Antitrypsin Deficiency (AATD), a genetic condition that can cause lung and liver damage. The goal was to check safety and how the drug moves through the body. However, the trial w…
Phase 1/2 • Sponsor: Korro Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Cystic fibrosis drug repurposed: can a liver medication fix lung function?
Disease control Stopped earlyThis early-phase trial tested whether glycerol phenylbutyrate (Ravicti), a drug already used for urea cycle disorders, could help restore chloride transport in the nasal cells of adults with cystic fibrosis. The study enrolled 16 participants and compared low-dose Ravicti to a pl…
Phase 1/2 • Sponsor: National Jewish Health • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill for tough blood cancers tested in early trial
Disease control Stopped earlyThis early-stage study tested an oral drug called AUR104 in 9 adults with certain blood cancers (lymphomas and leukemia) that had come back or stopped responding to treatment. The main goal was to check the drug's safety and how the body processes it. The trial was terminated ear…
Phase 1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stem cells tested for tough Crohn's fistulas – but trial stopped early
Disease control Stopped earlyThis study tested whether stem cells from donated bone marrow could heal fistulas (abnormal tunnels) in people with Crohn's disease who had a pouch after colon removal. The trial planned to enroll 24 adults but was terminated early, so we don't have clear results on safety or hea…
Phase 1/2 • Sponsor: Anthony Lembo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stem cells tested for a tough Crohn's complication – but trial stopped early
Disease control Stopped earlyThis study tested whether stem cells from donated bone marrow could safely heal rectovaginal fistulas in women with Crohn's disease. These fistulas are abnormal connections between the rectum and vagina that cause pain, infections, and poor quality of life. The trial planned to e…
Phase 1/2 • Sponsor: Anthony Lembo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could stem cells heal painful fistulas in kids with Crohn's?
Disease control Stopped earlyThis early-phase study tested whether injecting stem cells from donated bone marrow could help heal perianal fistulas in teenagers with Crohn's disease. Six patients aged 13-17 received injections of 75 million stem cells directly into the fistula tract, with a possible second do…
Phase 1 • Sponsor: Anthony Lembo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stem cells injected into gut to fight Crohn's – but trial stops early
Disease control Stopped earlyThis early-phase study tested whether injecting donor stem cells directly into the colon could help people with severe Crohn's colitis that didn't respond to standard treatments. Only 7 people took part before the study was stopped early. The main goal was to check safety, but be…
Phase 1/2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stem cells tested for tough bowel disease – but trial stopped early
Disease control Stopped earlyThis early-stage study tested whether injecting donor stem cells (remestemcel-L) into the colon could help people with severe ulcerative colitis that hadn't responded to other treatments. Only 7 adults took part before the trial was stopped early. The main goal was to check safet…
Phase 1/2 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Stem cell shot aims to heal painful Crohn's fistulas
Disease control Stopped earlyThis early-stage study tested whether injecting donor stem cells directly into fistulas (abnormal tunnels) could help people with Crohn's disease. The trial planned to enroll 25 adults but was terminated early. The goal was to check safety and see if the treatment could lead to c…
Phase 1/2 • Sponsor: Anthony Lembo • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Crohn's surgery showdown: which technique wins?
Disease control Stopped earlyThis study compared two surgical methods for removing diseased intestine in people with Crohn's disease: one that cuts the main artery high up, and one that spares the mesentery (the tissue holding the intestine). The goal was to see which technique better prevents the disease fr…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a common cholesterol drug protect bones and hearts after spinal injury?
Disease control Stopped earlyThis study tested whether the statin drug rosuvastatin, taken daily with supplements, could improve bone density and reduce heart disease risk in adults with long-term spinal cord injury. Only 8 people enrolled before the trial was stopped early. Participants received either rosu…
Phase 2 • Sponsor: Dr. B. Catharine. Craven • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Experimental drug tested for rare cancer, trial stopped early
Disease control Stopped earlyThis study tested a drug called XmAb23104 in people with advanced sarcoma, a rare cancer. The goal was to see if the drug could shrink tumors and if it was safe. Only 6 people took part before the study was ended early.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Hope dashed: drug trial for Post-COVID racing heart stopped early
Disease control Stopped earlyThis study tested a drug called IgPro20 (HIZENTRA) to see if it could help people with post-COVID POTS, a condition that causes a rapid heart rate and dizziness when standing. The trial was stopped early after enrolling only 16 adults. The goal was to see if the drug could reduce…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental drug for cholesterol and fatty liver fails to advance
Disease control Stopped earlyThis early-stage trial tested a new drug called LY3885125 in people with high cholesterol (dyslipidemia) and non-alcoholic fatty liver disease (NAFLD). The main goal was to check safety and how the body processes the drug. The study was terminated, meaning it stopped early, so it…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental gene therapy aims to fix immune system in rare childhood disease
Disease control Stopped earlyThis early-phase trial tested a gene therapy for X-linked chronic granulomatous disease (X-CGD), a rare genetic disorder that leaves boys unable to fight off bacteria and fungi. The treatment involved taking the patient's own blood stem cells, adding a corrected gene, and infusin…
Phase 1/2 • Sponsor: Genethon • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental gene therapy targets rare immune disorder
Disease control Stopped earlyThis trial tested a gene therapy for X-linked chronic granulomatous disease (X-CGD), a rare genetic disorder that leaves boys unable to fight off infections. The treatment involved taking the patient's own blood stem cells, adding a working copy of the faulty gene, and returning …
Phase 1/2 • Sponsor: Genethon • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Ankle cartilage repair therapy trial halted early
Disease control Stopped earlyThis study tested a treatment called Chondron, made from a patient's own cartilage cells, for repairing ankle cartilage defects. The trial aimed to see if the treatment could improve cartilage quality and ankle function over 18 months. However, the study was terminated early and …
Phase 3 • Sponsor: Cellontech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental drug TPN-101 tested in rare childhood brain disease
Disease control Stopped earlyThis study tested a drug called TPN-101 (censavudine) in people with Aicardi-Goutières syndrome, a rare genetic disorder that causes severe brain inflammation. The trial enrolled only 4 participants and aimed to see if the drug could reduce immune system overactivity and check fo…
Phase 2 • Sponsor: Transposon Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising liver drug trial halted early: what it means for patients
Disease control Stopped earlyThis study tested a new drug called belcesiran in people with a genetic condition called alpha-1 antitrypsin deficiency that causes liver damage. The goal was to see if the drug is safe and can lower harmful protein levels in the liver. The trial was stopped early, so results are…
Phase 2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
HIV pill combo fails to slim belly fat in early trial
Disease control Stopped earlyThis study tested whether switching to a two-drug HIV treatment (raltegravir plus maraviroc) could reduce belly fat (lipohypertrophy) in people whose HIV was already well-controlled. It included 48 adults on stable HIV therapy for at least 5 years. The study was stopped early, so…
Phase 2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Growth hormone study for short kids halted early
Disease control Stopped earlyThis study looked at two ways of giving growth hormone to short children who were born small for their age. The goal was to see which dosing method works better for growth and has fewer side effects on metabolism. Only 10 children took part before the study was stopped early.
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Lupus flare prevention drug trial halted early
Disease control Stopped earlyThis study tested a drug called PRV-3279 to see if it could prevent lupus flares in people with active systemic lupus erythematosus (SLE). The trial included 28 adults with moderate to severe lupus who had improved after steroid treatment. The study was terminated early, so resul…
Phase 2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Parkinson's drug trial halted: what we learned from UCB0599
Disease control Stopped earlyThis study looked at whether taking UCB0599 early or later could slow brain changes in people with Parkinson's disease. It involved 428 adults who had already completed an earlier study. The trial was stopped early, but researchers measured brain scans and medication use over 18 …
Phase 2 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Stem cell transplant study halted early: which prep works best?
Disease control Stopped earlyThis study tested two different drug combinations given before a stem cell transplant for people with myeloid blood cancers like leukemia. One group got fludarabine and busulfan, the other got those drugs plus low-dose total body irradiation. The goal was to see which regimen led…
Phase 3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
DMD drug tested in wheelchair users – but trial stops early
Disease control Stopped earlyThis study tested the safety of golodirsen (Vyondys 53) in boys and men with Duchenne muscular dystrophy who can no longer walk. Only 2 people took part before the trial was stopped early. Participants received weekly IV infusions for up to 96 weeks, with extra follow-up. The goa…
Phase 4 • Sponsor: Rare Disease Research, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New stem cell method aims to protect kids with rare immune disease
Disease control Stopped earlyThis study tested a way to improve stem cell transplants for children with combined immunodeficiency (CID), a condition where the immune system doesn't work properly. The approach removed certain naive cells from the donor stem cells to try to prevent graft-versus-host disease (a…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Crohn's drug trial halted early: what happened?
Disease control Stopped earlyThis study was designed to see if brazikumab is safe and tolerable over the long term for people with moderate to severe Crohn's disease. It enrolled 18 participants who had previously been in a related study. The trial was terminated early, meaning it did not reach its planned e…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug OMS721 tested for rare kidney conditions
Disease control Stopped earlyThis study tested a drug called OMS721 in 31 people with certain kidney diseases, including IgA nephropathy and lupus nephritis. The main goal was to check if the drug is safe and if it reduces protein in the urine, a sign of kidney damage. The study was stopped early, so results…
Phase 2 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Experimental drug shows promise for rare immune disorder, but study cut short
Disease control Stopped earlyThis study tested the long-term safety and effectiveness of a drug called CDZ173 in people with APDS/PASLI, a rare genetic condition that causes a weak immune system and swollen lymph nodes. The 37 participants had already taken CDZ173 or a similar drug in a previous study. The t…
Phase 2/3 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Promising psoriasis drug trial halted early – what now?
Disease control Stopped earlyThis study tested a drug called imsidolimab for adults with generalized pustular psoriasis (GPP), a rare and painful skin condition. The trial aimed to see if the drug is safe and works over the long term. However, the study was terminated early, so we have less information than …
Phase 3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Epilepsy drug study halted early: BHV-7000 shows limited promise
Disease control Stopped earlyThis study tested whether BHV-7000, taken alongside other medications, could reduce generalized tonic-clonic seizures in people with idiopathic generalized epilepsy. The trial was terminated early and enrolled only 27 adults aged 18-75. The main goal was to see how long it took f…
Phase 2/3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Experimental drug shows promise for rare genetic disorder
Disease control Stopped earlyThis Phase II trial tested a drug called N-Acetyl-L-Leucine (IB1001) in 17 people with Ataxia-Telangiectasia, a rare genetic disease that affects movement and immunity. The study aimed to see if the drug could improve symptoms and slow the disease over time. The trial was termina…
Phase 2 • Sponsor: IntraBio Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Sickle cell drug safety trial ends early
Disease control Stopped earlyThis study looked at the long-term safety of the drug osivelotor in people with sickle cell disease who had already taken it in an earlier trial. The goal was to track side effects and blood changes over time. However, the study was terminated early, so the full safety picture is…
Phase 2/3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New approach aims to protect new Moms' brains after preeclampsia
Disease control Stopped earlyThis study tested a new way to manage blood pressure in new mothers with severe postpartum preeclampsia. Participants received standard blood pressure medications, but one group had personalized blood pressure targets based on real-time brain monitoring. The goal was to keep bloo…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Plant-Based diet shows promise for diabetes remission in new study
Disease control Stopped earlyThis study looked at whether a plant-based diet and lifestyle changes could help people with type 2 diabetes, prediabetes, or obesity improve their health. Researchers aimed for diabetes remission (normal blood sugar without medication for at least 3 months) or significant weight…
Sponsor: National Council of Scientific and Technical Research, Argentina • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Obesity drug cocktail tested for heart benefits – study halted early
Disease control Stopped earlyThis study looked at whether using a combination of weight-loss medications could help people with obesity lose weight and improve the health of their blood vessels. It involved 128 adults aged 40-75 who were obese and had at least one heart risk factor. The study was stopped ear…
Phase 2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug hope for painful hand and foot pustules
Disease control Stopped earlyThis trial tested the drug deucravacitinib in people with moderate-to-severe palmoplantar pustulosis, a skin condition causing painful pustules on the palms and soles. The study planned to enroll 25 participants who would take the drug daily for 16 weeks, but it was terminated ea…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Computer-tailored drug dosing aims to tame Crohn's in kids
Disease control Stopped earlyThis trial tested whether a computer program that customizes infliximab doses based on blood tests can help children and young adults with Crohn's disease reach better drug levels than standard dosing. Only 6 participants were enrolled before the study was stopped early. The goal…
Phase 2/3 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New PKU formula shows promise in managing blood levels
Disease control Stopped earlyThis study tested a new amino acid formula called PKU GOLIKE in people aged 16 and older with phenylketonuria (PKU). The goal was to see if it could better control daily swings in blood phenylalanine levels compared to standard treatment. The study was stopped early, so results a…
Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Bile acid hope for pouchitis patients fizzles in early study
Disease control Stopped earlyThis study tested whether a bile acid supplement called UDCA could reduce inflammation and improve quality of life in people with pouchitis, a complication after ulcerative colitis surgery. Only 2 participants were enrolled before the study was terminated. The goal was to see if …
Phase 2/3 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug aims to tame gluten reaction in celiac disease
Disease control Stopped earlyThis study tested an experimental drug called KAN-101 in people with celiac disease. The goal was to see if it could safely reduce the immune response to gluten. The trial included 128 participants and was split into phases to check safety and how the body processes the drug. How…
Phase 1/2 • Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Sickle cell drug trial in kids halted early – but data may still help
Disease control Stopped earlyThis study tested a daily pill called voxelotor in children aged 2 to 14 with sickle cell disease who had slightly abnormal blood flow in the brain. The goal was to see if the drug could improve that blood flow and reduce stroke risk. The trial was stopped early, but the results …
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental CAR T-Cell therapy targets rare B-Cell cancers
Disease control Stopped earlyThis phase 2 study tested a treatment called brexucabtagene autoleucel, a CAR T-cell therapy made from a patient's own immune cells, for four rare B-cell cancers: Waldenstrom macroglobulinemia, Richter transformation, Burkitt lymphoma, and hairy cell leukemia. The trial enrolled …
Phase 2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo aims to wipe out hidden leukemia cells
Disease control Stopped earlyThis phase II trial tested adding asciminib (ABL001) to standard tyrosine kinase inhibitor therapy in 7 people with chronic myeloid leukemia who still had traces of cancer. The goal was to see if the combination could eliminate remaining cancer cells. The study was terminated ear…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Experimental kidney cancer drug trial halted early
Disease control Stopped earlyThis early-stage trial tested a new drug called DFF332, which targets a protein (HIF2α) that helps some cancers grow. The study included 40 adults with advanced clear cell renal cell carcinoma or other cancers with specific gene changes. DFF332 was tested alone and in combination…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Antifungal drug targets gut fungus in Crohn's patients with genetic risk
Disease control Stopped earlyThis study tested the antifungal drug posaconazole in people with active Crohn's disease who carry a specific gene variant (CARD9 S12N). The goal was to see if reducing a type of fungus in the gut could lower inflammation and improve symptoms. The trial was stopped early and incl…
Phase 4 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
OCD drug trial halted early: what happened with troriluzole?
Disease control Stopped earlyThis study looked at the long-term safety of a drug called troriluzole for people with obsessive-compulsive disorder (OCD) who hadn't improved enough with standard treatments. The trial planned to enroll 772 participants but was terminated early. The main goal was to check for si…
Phase 3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for ulcerative colitis? drug trial shows promise
Disease control Stopped earlyThis study tested a drug called vixarelimab in 79 people with moderate to severe ulcerative colitis (UC) who had not responded well to other treatments. The goal was to see if the drug could help control the disease and reduce symptoms like diarrhea and bleeding. The study was st…
Phase 2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Experimental cancer drug tested in rare tumors, but trial stopped early
Disease control Stopped earlyThis phase 2 trial tested the drug guadecitabine (SGI-110) in people aged 12 and older with rare cancers like wild-type GIST, pheochromocytoma, paraganglioma, and HLRCC-related kidney cancer that had not responded to other treatments. Participants received daily injections for 5 …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Promising leukemia drug falls short in kids trial
Disease control Stopped earlyThis phase 2 trial tested inotuzumab ozogamicin (Besponsa) in children with B-cell acute lymphoblastic leukemia who had low levels of remaining cancer cells (MRD) despite treatment. The drug targets CD22, a protein on leukemia cells, and delivers a potent toxin. Only 5 children w…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Ulcerative colitis drug study halted early
Disease control Stopped earlyThis study looked at the safety and effectiveness of the drug ozanimod for people with moderate to severe ulcerative colitis. It aimed to see if the drug could improve symptoms like diarrhea and rectal bleeding, and how it affected quality of life. The study was terminated early,…
Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Virus therapy fails to advance in colorectal cancer trial
Disease control Stopped earlyThis study tested a new approach using a virus that attacks cancer cells (oncolytic immunotherapy) along with two standard drugs (atezolizumab and bevacizumab) in people with advanced colorectal cancer that had stopped responding to other treatments. The trial was stopped early a…
Phase 2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Experimental combo for tough leukemias shows early promise
Disease control Stopped earlyThis early-phase study tested two drugs, AZD1775 and belinostat, together in 20 adults with blood cancers like acute myeloid leukemia that had come back or not responded to treatment. The main goal was to find the safest dose and understand side effects. The study was stopped ear…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental vaccine combo for rare adrenal cancers shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested a new therapeutic vaccine (EO2401) combined with the immunotherapy drug nivolumab in 70 people with advanced adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma. The goal was to see if the combination is safe and can shrink tumors or…
Phase 1/2 • Sponsor: Enterome • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Gene therapy shot for dry AMD shows promise in early trial
Disease control Stopped earlyThis study tested a single injection of a gene therapy called GT005 in 98 people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes vision loss. The goal was to see if the treatment could slow the growth of damaged areas in the eye and c…
Phase 2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Hope fades: trial of Tay-Sachs drug venglustat terminated early
Disease control Stopped earlyThis Phase 3 trial tested an oral drug called venglustat in 75 adults and children with late-onset Tay-Sachs or Sandhoff disease, rare genetic disorders that cause progressive nerve damage. The drug aimed to lower toxic fat buildup in the brain and slow disease worsening. However…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Gene therapy shot for dry AMD shows promise but trial halted early
Disease control Stopped earlyThis study tested a single injection of GT005, a gene therapy, in 255 people with geographic atrophy from dry age-related macular degeneration. The goal was to see if it could slow the growth of blind spots in the eye. The trial was terminated early, so we have less data than hop…
Phase 2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental CAR t therapy targets lupus and related diseases – but trial ends early
Disease control Stopped earlyThis early-phase trial tested a single infusion of IMPT-514, a personalized CAR T cell therapy, in 3 adults with severe lupus, vasculitis, or inflammatory myopathy that did not respond to standard treatments. The goal was to check safety and see if the therapy could reset the imm…
Early phase 1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Cancer drug may tame sickle cell pain, early study hints
Disease control Stopped earlyThis small pilot study tested whether imatinib, a drug used for certain cancers, could reduce painful blockages in blood vessels (vaso-occlusive crises) in people with sickle cell anemia. Seven participants aged 18–25 took the drug for 6 months while researchers measured changes …
Phase 1/2 • Sponsor: Indiana University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental gene injection targets dry AMD
Disease control Stopped earlyThis early-stage trial tested a gene therapy called GT005 for dry age-related macular degeneration (AMD), a leading cause of vision loss. The therapy delivers a working gene to the retina via a single injection. The study enrolled 56 people and focused on safety and dosing, but w…
Phase 1/2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Old arthritis drug tested against rare tumor syndrome – but trial stalls
Disease control Stopped earlyThis study tested leflunomide, a drug used for rheumatoid arthritis, in 3 adults with MEN1 syndrome—a genetic condition that raises the risk of multiple tumors. The goal was to see if 6 months of daily leflunomide could shrink or stabilize tumors. However, the trial was terminate…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Gene therapy zolgensma tested in kids with SMA who can sit but not stand
Disease control Stopped earlyThis phase 1 trial tested a gene therapy called AVXS-101 (Zolgensma) in 32 children with spinal muscular atrophy (SMA) who could sit but not stand or walk. The therapy delivers a working SMN gene via a spinal injection to help improve muscle function. The study focused on safety …
Phase 1 • Sponsor: Novartis Gene Therapies • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Cancer drug combo trial for kids halted early
Disease control Stopped earlyThis early-stage study tested a combination of two drugs, niraparib and dostarlimab, in children and teens (ages 6 months to 17 years) with solid tumors that had come back or were not responding to treatment. The goal was to find a safe dose and see if the drugs could shrink tumo…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental drug ravulizumab tested for kidney inflammation
Disease control Stopped earlyThis Phase 2 study tested the drug ravulizumab (Ultomiris) in 123 adults with lupus nephritis or IgA nephropathy, two conditions that cause kidney inflammation. Participants received either ravulizumab or a placebo alongside standard care. The study aimed to see if the drug could…
Phase 2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Sickle cell drug candidate tested in first human trial – but study halted early
Disease control Stopped earlyThis was a first-in-human study testing a single dose of an experimental drug called GSK4172239D in 11 people with sickle cell disease. The main goals were to check safety and how the drug moves through the body. The study was terminated early, so results are limited.
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Stem cell therapy for Crohn's fistulas: safety check ends early
Disease control Stopped earlyThis study tested the long-term safety and effectiveness of a stem cell treatment called darvadstrocel (Alofisel) for people with Crohn's disease and complex anal fistulas. Researchers planned to give one injection of the stem cells and follow 53 participants over several visits,…
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental virus gets a second shot at brain tumors
Disease control Stopped earlyThis study tested the safety of giving a second dose of an experimental virus (C134) directly into the brain tumor of patients whose malignant glioma had returned. Only one patient was enrolled before the study was stopped. The goal was to see if repeat dosing was safe and tolera…
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental cancer drug TAK-500 tested in 61 patients – study halted early
Disease control Stopped earlyThis early-phase trial tested an experimental drug called TAK-500, alone or with the immunotherapy pembrolizumab, in 61 adults with advanced solid tumors like pancreatic, liver, and lung cancer. The main goals were to check safety and see if the drug could shrink tumors. The stud…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Neurodegenerative drug study ends early after only 17 participants
Disease control Stopped earlyThis study was designed to let people who had already taken latozinemab in an earlier study continue receiving the drug. Only 17 people took part, and the study was stopped early. The goal was to track safety and how long people stayed on treatment, not to test if the drug could …
Phase 3 • Sponsor: Alector Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Hemophilia drug study falls short: only 3 patients enrolled before termination
Disease control Stopped earlyThis study aimed to see if a new medicine (efanesoctocog alfa) helps people with moderate or severe hemophilia A reach their personal goals and be more physically active. It planned to enroll 35 people aged 12 to 50, but was stopped early after only 3 joined. The medicine is used…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Bronchiectasis drug trial halted early – what we know
Disease control Stopped earlyThis trial tested the drug Cayston (aztreonam lysine) in adults with bronchiectasis, a chronic lung disease causing cough and infections. The goal was to see if it could safely delay or reduce lung flare-ups. However, the study was stopped early and only enrolled 34 people, so we…
Phase 4 • Sponsor: University of Dundee • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental UC drug trial halted midway
Disease control Stopped earlyThis study tested a new drug called efavaleukin alfa in 221 adults with moderate to severe ulcerative colitis. The goal was to see if it could help patients achieve remission after 12 weeks of treatment. The trial was terminated early, so final results are limited, but the data m…
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental drug for rare lung disease shows early promise but trial halted
Disease control Stopped earlyThis early-phase study tested a drug called ARC-AAT in healthy volunteers and people with Alpha-1 Antitrypsin Deficiency (AATD), a genetic condition that can lead to lung and liver damage. The main goal was to check safety and how the drug affects levels of a key protein in the b…
Phase 1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Lupus drug trial halted early: what we know
Disease control Stopped earlyThis study tested a weekly injection called telitacicept against a placebo in 91 people with moderate-to-severe lupus. The goal was to see if the drug could reduce disease activity and allow lower steroid doses. However, the trial was terminated early, so we have less information…
Phase 3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Sickle cell gene therapy trial halted after just 4 patients
Disease control Stopped earlyThis early-phase trial tested a gene-edited stem cell product called OTQ923 in 4 people with severe sickle cell disease. The goal was to boost fetal hemoglobin to reduce painful crises and other complications. The study was terminated early, so we have limited data on safety and …
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Sickle cell drug oxbryta tracked in real life: what happened?
Disease control Stopped earlyThis study followed 265 people with sickle cell disease who were taking Oxbryta (voxelotor) as part of their normal care. Researchers wanted to see how the drug affected hemoglobin levels, sickle cell complications, and overall health over up to 5 years. The study was observation…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New breathing device could help COPD patients who reject standard machines
Disease control Stopped earlyThis study tested a high-flow nasal cannula device (Airvo) in COPD patients with high carbon dioxide levels who could not or would not use standard non-invasive ventilation. The goal was to see if the device improved blood gas levels and reduced flare-ups over one year. Only 3 pa…
Sponsor: Turku University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Neck disc device study halted after just 2 patients
Disease control Stopped earlyThis study looked at a disc replacement device called CerPass for people with a damaged disc in their neck. It aimed to see if the device could reduce pain and improve movement without needing further surgery. Only 2 people joined before the study was stopped early, so results ar…
Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control Stopped earlyThis study tested an experimental drug called tildacerfont in 67 children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The goal was to see if adding this once-daily pill to standard steroid treatment could improve d…
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Experimental gene therapy aims to halt vision loss in rare blindness
Disease control Stopped earlyThis study tested a gene therapy for retinitis pigmentosa, an inherited eye disease that causes gradual vision loss. The treatment involved injecting a corrected gene under the retina in one eye. The trial included 19 people aged 13 and older with a specific genetic defect. The m…
Phase 1/2 • Sponsor: eyeDNA Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Real-World tofacitinib study in ulcerative colitis ends early
Disease control Stopped earlyThis study looked at how well the drug tofacitinib (Xeljanz) works for people with moderate to severe ulcerative colitis in everyday medical practice in Switzerland. It measured symptom improvement and gut inflammation using stool samples. The study was small with 18 participants…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Diet study for Crohn's disease halted early – what we know
Disease control Stopped earlyThis study looked at whether an anti-inflammatory whole-food diet (rich in vegetables, fruits, and omega-3s, low in processed foods) could improve symptoms in people with mild to moderate Crohn's disease. It enrolled 28 adults and compared the diet to regular eating habits. The t…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug hope for fatty liver in PCOS women?
Disease control Stopped earlyThis study tested a drug called saroglitazar in women with polycystic ovary syndrome (PCOS) who also have nonalcoholic fatty liver disease (NAFLD). The goal was to see if the drug could safely reduce liver fat over 24 weeks compared to a placebo. The trial was planned for 60 wome…
Phase 2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Huntington's drug safety study halted early
Disease control Stopped earlyThis study aimed to see if the drug SAGE-718 is safe for people with Huntington's disease when taken over a long period. It was an open-label study, meaning everyone knew they were getting the drug. The study was terminated early, so results are limited.
Phase 3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Sickle cell drug inclacumab safety checked in long-term study
Disease control Stopped earlyThis study looks at the long-term safety of inclacumab in people with sickle cell disease who have already taken the drug in a previous study. It tracks side effects and how often pain crises occur. The goal is to see if long-term use is safe and helps control the disease.
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Sickle cell drug voxelotor tested for brain benefits in kids – study cut short
Disease control Stopped earlyThis study looked at whether voxelotor, a daily pill for sickle cell anemia, can improve blood flow and oxygen supply to the brain in children. The trial planned to enroll 22 participants aged 4 to 30 years with a severe form of sickle cell disease. However, the study was termina…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental drug roscovitine tested in cystic fibrosis patients
Disease control Stopped earlyThis phase II trial tested an experimental drug called roscovitine in 36 adults with cystic fibrosis who have a common genetic mutation and a chronic lung infection. The goal was to check the safety of different doses given in short cycles. The study was terminated early, so its …
Phase 2 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Eye injections tested to save sight in rare coats disease
Disease control Stopped earlyThis study tested whether anti-VEGF injections into the eye could help treat Coats disease, a rare condition that causes abnormal blood vessels and fluid buildup in the retina, potentially leading to blindness. The trial included 18 people with early-stage Coats disease who had n…
Phase 3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Promising aHUS drug trial stalls after only 6 patients enrolled
Disease control Stopped earlyThis study tested a drug called narsoplimab (OMS721) for atypical hemolytic uremic syndrome (aHUS), a rare condition that causes blood clots and organ damage. The trial aimed to see if the drug could improve platelet counts and was safe for adults and adolescents. However, the st…
Phase 3 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Kidney disease drug trial halted midway
Disease control Stopped earlyThis study tested a drug called OMS721 for people with IgA nephropathy, a kidney disease that can lead to kidney failure. The goal was to see if the drug could reduce protein in the urine, a sign of kidney damage. The trial was stopped early, so results are limited.
Phase 3 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New dialysis device for Wilson's disease tested but trial stopped early
Disease control Stopped earlyThis trial tested a special dialysis device (MEX-CD1) designed to remove extra copper from the blood of people with Wilson's disease, a genetic condition that causes copper buildup. The study planned to give 5 to 10 treatments over consecutive days and check if the device worked …
Sponsor: Mexbrain • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Growth hormone trial for CF wasting halted early
Disease control Stopped earlyThis small Phase 1 trial tested growth hormone in 5 adults with cystic fibrosis who were underweight. The goal was to see if the hormone could help them gain weight and muscle, improve their quality of life, and monitor effects on lung function and diabetes. The study was termina…
Phase 1 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Experimental drug losmapimod tested in rare muscle disease – early hopes, but trial cut short
Disease control Stopped earlyThis study tested an experimental drug called losmapimod in 14 adults with FSHD1, a rare genetic condition that causes progressive muscle weakness. The main goal was to check safety and tolerability, and to see if the drug affects certain biological markers. The trial was termina…
Phase 2 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug trial for duchenne MD halted early – what we know
Disease control Stopped earlyThis phase 2 study tested a drug called PGN-EDO51 in 7 people with Duchenne muscular dystrophy whose genetic mutation can be corrected by skipping exon 51. The drug was given by IV infusion to see if it is safe and tolerable. The trial was terminated, so results are limited.
Phase 2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a common cholesterol drug tame inflammatory bowel disease?
Disease control Stopped earlyThis study tested whether statins, a common cholesterol drug, could change the gut bacteria in people with ulcerative colitis or Crohn's disease to a healthier type. The goal was to see if this change could reduce disease activity. The study was terminated early, so results are l…
Phase 2/3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Psoriasis combo therapy trial ends early: what happened?
Disease control Stopped earlyThis study tested whether adding low-dose methotrexate to standard anti-TNF therapy could improve and extend the response in adults with moderate to severe psoriasis. The trial planned to enroll 78 participants but was terminated early. The main goal was to see how long patients …
Phase 4 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New surgical trick may fix stubborn eye holes
Disease control Stopped earlyThis study tested a new surgical technique for macular holes that remained open after standard treatment. The procedure involves moving a thin membrane from the eye to cover the hole. Only 16 people were enrolled, and the study was stopped early, so we don't yet know if this appr…
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Sickle cell drug voxelotor tested for Long-Term safety
Disease control Stopped earlyThis study looked at the long-term safety of voxelotor (a daily pill) in 179 people with sickle cell disease who had already taken it in a previous trial. Participants continued taking the drug and were monitored for side effects and complications like pain crises. The trial was …
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Promising c. diff drug trial halted after just 3 patients
Disease control Stopped earlyThis study tested a new drug called REC-3964 to see if it could prevent repeat Clostridioides difficile (C. diff) infections in adults. Only 3 people were enrolled before the trial was stopped early. The goal was to check safety and whether the drug helped people stay infection-f…
Phase 2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Sickle cell drug voxelotor tested for Long-Term safety – but trial ends early
Disease control Stopped earlyThis study looked at the long-term safety of the drug voxelotor in 162 people with sickle cell disease who had already taken it in earlier trials. Everyone received voxelotor once daily. The main goal was to track side effects. The trial was terminated early, so the full safety p…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New inhaled drug aimed at stubborn lung infection shows promise, but trial halted early
Disease control Stopped earlyThis phase 3 study tested an inhaled form of the antibiotic clofazimine added to standard therapy for people with MAC lung disease that did not respond to previous treatment. The goal was to see if the drug could clear the infection from sputum cultures and improve quality of lif…
Phase 3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
HIV drug extension study halted early: what happened?
Disease control Stopped earlyThis study looked at whether weekly injections of PRO 140, taken with standard HIV medications, could keep the virus under control over the long term. It enrolled 43 people who had already completed an earlier PRO 140 study and had undetectable virus levels. The study was termina…
Phase 2/3 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Promising combo for tough blood cancers halted early — only 4 patients enrolled
Disease control Stopped earlyThis study tested whether adding rapamycin to high-dose chemotherapy could help people with aggressive blood cancers (like certain leukemias and lymphomas) that had returned or not responded to prior treatment. Only 4 adults aged 18–65 took part before the study was stopped early…
Phase 1/2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental cell therapy targets deadly childhood brain cancer
Disease control Stopped earlyThis early-phase trial tested a new immunotherapy approach for children with DIPG, a rare and aggressive brain stem tumor. After standard radiation and chemotherapy, patients received special vaccines and immune cells designed to attack the tumor. The study was small (11 particip…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental drug for Post-COVID POTS study halted early
Disease control Stopped earlyThis study looked at the long-term safety of efgartigimod in adults with post-COVID postural orthostatic tachycardia syndrome (POTS), a condition causing rapid heart rate and dizziness upon standing. The trial was an open-label extension for people who completed a previous study.…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New program aims to boost HIV medication adherence for medicaid patients
Disease control Stopped earlyThis study tested a program to help Virginia Medicaid enrollees with HIV fill their antiretroviral prescriptions on time. The program offered support from providers, pharmacies, and community groups, with extra help for those who were very late refilling. Only 4 people enrolled b…
Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Gene therapy for duchenne muscular dystrophy under Long-Term watch
Disease control Stopped earlyThis study follows 7 people with Duchenne muscular dystrophy who previously received an experimental gene therapy called fordadistrogene movaparvovec. Researchers will monitor them for 10 years to check for side effects and see if the treatment continues to help with movement. Th…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Spesolimab shows promise for Long-Term control of painful hand and foot pustules
Disease control Stopped earlyThis study looks at the long-term safety of spesolimab for people with palmoplantar pustulosis, a chronic skin condition causing painful pustules on hands and feet. Participants who benefited from spesolimab in earlier trials can continue treatment for up to 5 years, with monthly…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental drug targets rare fat Disorder's metabolic woes
Disease control Stopped earlyThis phase 2 trial tested a drug called REGN4461 (mibavademab) in 20 people with familial partial lipodystrophy, a rare condition causing abnormal fat distribution and metabolic problems. The study aimed to see if the drug could lower high triglycerides and improve blood sugar co…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug shows promise for Long-Term ulcerative colitis control
Disease control Stopped earlyThis study tested a drug called efavaleukin alfa in people with moderate to severe ulcerative colitis who had already completed a previous study. The goal was to see if the drug is safe and works over a longer period, up to 104 weeks. The study was terminated early and enrolled o…
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Dravet syndrome drug trial halted early: did lorcaserin help?
Disease control Stopped earlyThis study tested whether lorcaserin, when added to current medications, could reduce convulsive seizures in people with Dravet syndrome, a severe form of epilepsy. The trial planned to enroll about 22 participants aged 2 and older, but it was terminated early. The main goal was …
Phase 3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
HIV Antibody-Only therapy falls short in Long-Term trial
Disease control Stopped earlyThis study tested whether a single antibody called PRO 140 could keep HIV under control in 20 adults who had been stable on standard combination therapy. Participants stopped their usual HIV pills and received only PRO 140 infusions. The trial was stopped early, and the main goal…
Phase 2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New combo surgery for obesity and reflux tested – but study stopped early
Disease control Stopped earlyThis study aimed to compare a standard sleeve gastrectomy (removing part of the stomach) with a modified version called N-Sleeve, which adds a wrap around the top of the stomach to prevent acid reflux. The trial was designed for people with severe obesity and GERD, but only 2 pat…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Experimental drug losmapimod tested for rare muscle disease
Disease control Stopped earlyThis phase 2 trial tested the drug losmapimod in 76 adults with FSHD, a genetic condition that causes progressive muscle weakness. Participants took either losmapimod or a placebo for 48 weeks to see if the drug was safe and could help control the disease. The study was terminate…
Phase 2 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Heart drug for diabetics shows promise but trial ends early
Disease control Stopped earlyThis study tested whether pemafibrate, a drug that lowers triglycerides, could reduce heart attacks, strokes, and heart-related deaths in over 10,000 people with type 2 diabetes and high triglycerides. Participants took either pemafibrate or a placebo twice daily. The trial was t…
Phase 3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Kidney drug trial halted: venglustat fails to slow disease
Disease control Stopped earlyThis study looked at whether taking venglustat earlier versus later could help people with a fast-progressing form of polycystic kidney disease. The trial was stopped early because the main study found the drug did not work well enough. Only 24 people took part, so no clear concl…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 18:08 UTC
-
Experimental drug zavesca tested for rare fatal brain diseases in infants
Disease control Stopped earlyThis phase 3 trial tested the drug miglustat (Zavesca) in 30 infants with Sandhoff or Tay-Sachs diseases, rare genetic disorders that destroy nerve cells. The goal was to see if the drug could reduce hospitalizations, seizures, and feeding problems while improving motor function.…
Phase 3 • Sponsor: Tehran University of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
Crohn's drug trial halted early: what we know about ozanimod
Disease control Stopped earlyThis study was an extension of earlier trials, testing the drug ozanimod in people with moderately to severely active Crohn's disease. The goal was to see if the drug could help patients achieve remission and to track any side effects. The trial was terminated early, meaning it s…
Phase 3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 26, 2026 17:48 UTC
-
Experimental kidney drug for alport syndrome falls short in early trial
Disease control Stopped earlyThis phase 2 trial tested a weekly injection of lademirsen in 43 adults with Alport syndrome, a genetic condition that damages kidneys. The goal was to see if the drug could slow the decline in kidney function. The study was terminated early, so the results are limited and it's u…
Phase 2 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
Lupus drug combo tested in tiny trial – but study halted early
Disease control Stopped earlyThis phase 2 trial tested the drugs mycophenolate mofetil (CellCept) alone or with voclosporin in 12 people with lupus. The goal was to see if these treatments work better in certain patient groups. However, the study was terminated early, so the results are very limited.
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 26, 2026 15:22 UTC
-
Can plasma exchange clear the way for gene therapy in duchenne?
Disease control Stopped earlyThis early study tested whether a blood-cleaning procedure called plasmapheresis could allow boys with Duchenne muscular dystrophy who have antibodies against the gene therapy carrier to still receive the treatment. Only 3 boys were enrolled before the study was stopped early. Th…
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC
-
Experimental gene therapy tested for rare muscular dystrophy
Disease control Stopped earlyThis early-stage trial tested a gene therapy called SRP-9004 in just 4 people with limb girdle muscular dystrophy type 2D/R3, a rare muscle-weakening disease. The main goal was to check safety, not effectiveness. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:47 UTC
-
Brain cancer drug trial halted after just two patients
Disease control Stopped earlyThis study tested a new drug called VAL-083 in people with glioblastoma, an aggressive brain cancer that had returned after standard treatments. The trial aimed to see if VAL-083 could help patients live longer. However, the study was stopped early after only 2 people enrolled, s…
Phase 3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:46 UTC
-
Can your phone spot eye cancer? app tested for retinoblastoma
Diagnosis Stopped earlyThis study tested a smartphone app called CRADLE that uses a photo to detect leukocoria (a white glow in the pupil), which can be a sign of retinoblastoma, cataracts, or glaucoma. Researchers planned to compare the app's accuracy to a standard eye exam in children with these cond…
Sponsor: St. Jude Children's Research Hospital • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Blood test may tame the tightrope walk of transplant drugs
Diagnosis Stopped earlyThis study tests whether a blood test called TruGraf can help doctors fine-tune immunosuppression medications in liver transplant recipients with autoimmune liver diseases like autoimmune hepatitis, primary sclerosing cholangitis, or primary biliary cirrhosis. The test measures g…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New PET tracer aims to spot Parkinson's protein in living brains
Diagnosis Stopped earlyThis early-phase study tests a new imaging drug called [18F]MK-0947 that works with PET scans to show where a protein called α-synuclein builds up in the brain—a hallmark of Parkinson's disease. Researchers will check safety and how well the tracer works in 22 adults (some with P…
Early phase 1 • Sponsor: Invicro • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC
-
New Light-Based test aims to catch deadly newborn gut disease early
Diagnosis Stopped earlyThis study looked at whether measuring oxygen levels in the brain and gut using a light-based device (NIRS) could help doctors diagnose necrotizing enterocolitis (NEC) earlier in newborns with symptoms like bloody stool or a swollen belly. The study planned to include 45 newborns…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New blood test could replace risky amniocentesis for genetic disorders
Diagnosis Stopped earlyThis study tested a new blood test that looks for fetal cells in the mother's blood to diagnose genetic diseases in the baby. It aimed to replace invasive tests like amniocentesis, which carry a small risk of miscarriage. The trial enrolled 18 pregnant women but was terminated ea…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New Light-Based scanner aims to spot inflammation without needles
Diagnosis Stopped earlyThis study tested a new imaging tool called multispectral optoacoustic tomography (MSOT) to see if it could safely detect inflammation in people with graft-versus-host disease, Crohn's disease, or colitis. The device uses light and sound to create images of inflamed areas. The tr…
Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New blood pressure gadget put to the test in pregnancy
Diagnosis Stopped earlyThis study aimed to see if the CONNEQT Pulse blood pressure monitor gives accurate readings in pregnant women, including those with high blood pressure or pre-eclampsia. Researchers compared it to a standard blood pressure cuff in 41 pregnant volunteers. The study was stopped ear…
Sponsor: Mount Carmel Health System • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
New MRI could replace invasive scans for brain AVM Follow-Up
Diagnosis Stopped earlyThis study tested whether special MRI sequences can spot leftover brain arteriovenous malformations (AVMs) after embolization treatment. Researchers compared the MRI results to standard angiography in 53 adults. The study was terminated early, so its findings are limited.
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Ultrasound vs. MRI: spotting fetal gut twist risk before birth
Diagnosis Stopped earlyThis study looked at whether a third-trimester ultrasound can accurately find bowel rotation issues in fetuses that raise the risk of a life-threatening twist (volvulus). Researchers compared ultrasound results with fetal MRI, the current best method. The study included 77 pregna…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
AI mole checker tested at home – but trial stops early
Diagnosis Stopped earlyThis study tested whether a device called the Sklip System, which uses artificial intelligence, could help people at home decide if a mole might be skin cancer. Only one person took part before the study was stopped early. The goal was to see if the AI could match or beat standar…
Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Neck-Worn swallow detector fails key test
Diagnosis Stopped earlyThis study tested a wearable device that sits on the neck to detect swallowing problems in people with conditions like stroke, Parkinson's, multiple sclerosis, Alzheimer's, or dementia. The device was compared to a standard X-ray test. Unfortunately, the device did not meet the a…
Sponsor: Société des Produits Nestlé (SPN) • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
New embryo test could boost IVF success without poking the embryo
Diagnosis Stopped earlyThis study tested a new, non-invasive way to check embryos for chromosome problems before IVF. Instead of taking a cell from the embryo, doctors analyzed the fluid the embryo grew in. The goal was to see if this method could help choose the embryo most likely to lead to a healthy…
Sponsor: Igenomix • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
Corn could be key to saving your eyesight
Prevention Stopped earlyThis study looked at whether eating corn rich in zeaxanthin (a natural pigment) could increase the density of the macular pigment in the eye, which may help prevent age-related macular degeneration (AMD), a leading cause of blindness. Nine healthy volunteers aged 20-35 ate a dail…
Sponsor: University Hospital, Bordeaux • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Blood pressure drug tested to prevent transplant complication
Prevention Stopped earlyThis pilot study tested the blood pressure drug telmisartan (Micardis) to prevent acute graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers. The trial aimed to enroll 60 participants but was terminated early with 32. Researchers tracked s…
Sponsor: Hackensack Meridian Health • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Promising FNAIT prevention study halted early after just one participant
Prevention Stopped earlyThis study tested a drug called RLYB212 in pregnant women at high risk for a condition where the mother's immune system attacks the baby's platelets, causing dangerous bleeding. The goal was to see if the drug was safe and how it moved through the body. Only one woman enrolled be…
Phase 2 • Sponsor: Rallybio • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
Mesh may stop hernias after stoma closure, but study halted early
Prevention Stopped earlyThis pilot study tested whether placing a special mesh during ileostomy closure surgery could prevent hernias in people with inflammatory bowel disease. Only 8 patients were enrolled before the study was stopped. The main goal was to check safety, like infections or wound problem…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Breathing machine may ease lung risk for kids with sickle cell
Prevention Stopped earlyThis study tested whether a non-invasive breathing machine (ventilation) could prevent acute chest syndrome, a serious lung complication, in children with sickle cell disease who were hospitalized for severe pain. The standard prevention is spirometry, which requires active deep …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Monthly HIV prevention pill tested in women – study halted early
Prevention Stopped earlyThis study tested a new monthly pill (islatravir) to see if it could prevent HIV infection better than a daily pill in 730 women at high risk. The trial was stopped early, so results are limited. The goal was to offer a more convenient prevention option.
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Porphyria prevention study halted early – little data to go on
Prevention Stopped earlyThis small phase 2 trial tested whether the drug Panhematin could prevent acute attacks in people with certain types of porphyria. Only 13 participants were enrolled before the study was terminated early. Researchers tracked attacks and serious side effects, but the limited data …
Phase 2 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Cholesterol drug tested to stop dangerous pregnancy complication
Prevention Stopped earlyThis study tested whether the cholesterol-lowering drug pravastatin could prevent preeclampsia in women who had a previous early preterm delivery due to the condition. The trial planned to enroll 1,550 women but was terminated early with only 102 participants. Because it stopped …
Phase 3 • Sponsor: The George Washington University Biostatistics Center • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Can an eczema drug calm a rare genetic skin disease?
Symptom relief Stopped earlyNetherton syndrome is a rare genetic disorder that causes red, scaly, inflamed skin and intense itching. No targeted treatments exist, so researchers are testing dupilumab, an injectable drug already used for eczema, against a placebo in 10 adults with moderate to severe Netherto…
Phase 2/3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Sep 21, 2026 21:00 UTC
-
Does mixing numbing agent into steroid shots ease hand pain?
Symptom relief Stopped earlyDoctors often treat trigger finger, de Quervain's tenosynovitis, and carpal tunnel syndrome with steroid injections. Some mix in a local anaesthetic to reduce pain after the shot, while others do not. This trial compares pain levels in adults who receive a steroid injection with …
Phase 3 • Sponsor: University Hospital Plymouth NHS Trust • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a High-Fat diet boost brain health in early Alzheimer's?
Symptom relief Stopped earlyThis study looks at whether a ketogenic diet (high-fat, low-carb) is practical and safe for people with early-stage Alzheimer's disease over one year. The diet may provide an alternative energy source for the brain and reduce inflammation. Researchers will track diet adherence, b…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a Quit-Smoking program built for transgender adults help them stop?
Symptom relief Stopped earlyTransgender and gender diverse adults smoke at higher rates than the general population, and stigma, discrimination, anxiety, and depression may make quitting harder. Researchers at Massachusetts General Hospital are adapting an existing smoking cessation program called QUIT, whi…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a breathing gadget calm anxious teens?
Symptom relief Stopped earlyThis study tests whether a biofeedback breathing system called Freespira can reduce anxiety and panic symptoms in young people aged 9 to 17. Over 8 weeks, one group uses the device while a control group waits. The goal is to see if the device helps lower anxiety scores on a stand…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Dementia agitation drug trial halted after just 5 patients
Symptom relief Stopped earlyThis study tested a fast-dissolving film (BXCL501) placed under the tongue to quickly reduce severe agitation in older adults with dementia. The trial aimed to enroll many participants but was stopped early after only 5 people joined. Because it ended so soon, we cannot draw reli…
Phase 2 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a Once-Daily eye drop ease pain and swelling after cataract surgery?
Symptom relief Stopped earlyThis trial tests whether OCS-01, a dexamethasone eye drop, can reduce inflammation and pain after cataract surgery. About 117 adults scheduled for cataract removal will receive either the active drop or a placebo once daily. The study measures how well the drop clears eye inflamm…
Phase 3 • Sponsor: Oculis • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Can a synthetic cannabinoid calm agitation in frontotemporal dementia?
Symptom relief Stopped earlyThis phase 2 trial tests whether nabilone, a synthetic cannabinoid, can reduce agitation in people with frontotemporal dementia (FTD). Participants receive both nabilone and a placebo in random order to compare effects. The study includes adults with behavioral variant FTD or pri…
Phase 2 • Sponsor: Simon Ducharme, MD • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Tiny incision, big relief? ultrasound procedure challenges carpal tunnel surgery
Symptom relief Stopped earlyThis study compared a new, minimally invasive ultrasound-guided procedure to standard surgery for carpal tunnel syndrome. The goal was to see if the new technique could provide similar relief with a smaller incision and faster recovery. Only 7 people were enrolled before the stud…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Hands-On therapy may offer Drug-Free relief for chronic heartburn
Symptom relief Stopped earlyThis study investigates whether osteopathic manipulative treatment (OMT) — a form of hands-on manual therapy — can reduce symptoms like heartburn and regurgitation in people with gastro-oesophageal reflux disease (GERD). The trial includes 26 adults who have had symptoms for at l…
Phase 2 • Sponsor: Studio Osteopatico Busto Arsizio • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Hope for rare hunger disorder: new drug enters final testing phase
Symptom relief Stopped earlyThis phase 3 trial tests whether ARD-101 can reduce the intense, constant hunger (hyperphagia) seen in Prader-Willi syndrome. About 90 participants will take either ARD-101 or a placebo daily for 12 weeks. Caregivers will track changes in hunger-related behaviors using a standard…
Phase 3 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a scented fan ease breathlessness at the end of life?
Symptom relief Stopped earlyThis study looked at whether blowing a fan with aromatherapy on the face can help reduce breathlessness in people with terminal illness. The trial planned to enroll 26 adults who were near the end of life and had trouble breathing. Participants were randomly assigned to receive a…
Sponsor: Tsai-Wei Huang • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Nerve block or antidepressant? study tests two migraine treatments Head-to-Head
Symptom relief Stopped earlyThis study compares two treatments for transformed migraine (chronic daily headache): a sphenopalatine ganglion nerve block using lidocaine gel applied inside the nose, versus daily oral amitriptyline (Elavil), an antidepressant often used for migraine prevention. Ten adults aged…
Phase 4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Simple needle puncture may replace scalpel for pilonidal abscesses
Symptom relief Stopped earlyThis study compared two ways to drain a pilonidal abscess: a simple needle puncture (aspiration) versus the standard incision. The goal was to see if puncture leads to faster healing, lower cost, and less time off work. Only 5 adults took part before the trial was stopped early, …
Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a common heart drug tame nosebleeds in rare disease?
Symptom relief Stopped earlyThis study tested whether propranolol, a beta-blocker usually used for heart conditions, can reduce nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT), a genetic disorder that causes abnormal blood vessels. Fifteen adults with HHT took either propranolol or a p…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Nasal spray could replace needles for sickle cell pain emergencies
Symptom relief Stopped earlyThis study tested a nasal spray containing a strong painkiller (sufentanil) for adults with sickle cell disease experiencing a painful crisis. The goal was to see if it could provide faster relief than the standard gas mixture (EMONO) before giving morphine through an IV. The tri…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could a nerve pain drug and exercise ease long COVID fatigue?
Symptom relief Stopped earlyThis study tests whether the drug pregabalin, alone or with a rehabilitation program, can reduce chronic fatigue in people with post-COVID syndrome. Participants are adults aged 18 to 65 who had COVID-19 at least six months ago and still feel very tired. The trial compares four g…
Phase 2 • Sponsor: National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Parkinson's drug side effect targeted by antioxidant NAC – but trial stalls
Symptom relief Stopped earlyThis study tested whether N-acetylcysteine (NAC), an antioxidant, could help reduce impulse control disorders caused by Parkinson's medications. Only 14 people with mild-to-moderate symptoms were enrolled before the trial was stopped early. The goal was to see if 10 weeks of NAC …
Phase 3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Acupressure tested to ease Post-Surgery nausea in chest deformity repair
Symptom relief Stopped earlyThis study looked at whether acupressure, a non-invasive technique, can reduce nausea and vomiting after the NUSS procedure for pectus excavatum. The trial planned to enroll 40 people aged 8 to 40 but was terminated early. The goal was to see if this simple method could improve r…
Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Lavender scent tested to ease Women's pain and anxiety during procedure
Symptom relief Stopped earlyThis study tested whether smelling lavender essential oil before and during an office hysteroscopy (a procedure to look inside the uterus) could lower women's anxiety and pain. Twenty-two women were randomly assigned to inhale either lavender oil or distilled water (placebo). The…
Phase 2 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Heart hole closure for migraines? tiny study halted early
Symptom relief Stopped earlyThis study tested whether closing a small hole in the heart (called a PFO) with a device could reduce migraine headaches. It planned to compare the real procedure to a sham (fake) procedure in adults aged 18-55 with frequent migraines. However, the study was stopped early after e…
Sponsor: W.L.Gore & Associates • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Steroid combo fails to show benefit for UC flares
Symptom relief Stopped earlyThis study looked at whether adding high-dose steroid pulses to the usual oral steroid course could help people with moderate ulcerative colitis flares achieve remission without needing other treatments. The trial was terminated early and enrolled 75 adults with left-sided or ext…
Phase 4 • Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Laser zaps acne? small trial fizzles out
Symptom relief Stopped earlyThis study tested whether a fractional carbon dioxide laser can improve moderate to severe acne in adults aged 18 to 40. Participants received up to 3 laser treatments and were followed for changes in blemish count and skin severity. The trial was terminated early and only enroll…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Ear device aims to cut opioid use after liver transplant
Symptom relief Stopped earlyThis study tested a small device worn on the ear that uses mild electrical pulses to help control pain after a liver transplant. The goal was to see if it could reduce the need for strong painkillers like opioids. The study was stopped early and included 27 adults waiting for a l…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New radiation technique aims to calm tremors without surgery
Symptom relief Stopped earlyThis study tested a new way to treat hand tremors caused by essential tremor or Parkinson's disease using a linear accelerator, a common radiation machine. Instead of one large dose, the radiation was given in three smaller sessions to protect healthy brain tissue. The goal was t…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New therapy targets memory doubts to curb OCD checking
Symptom relief Stopped earlyThis study tested a new, short therapy module for people with obsessive-compulsive disorder (OCD) who struggle with compulsive checking. The therapy focuses on fixing unhelpful beliefs about memory that drive the urge to check. Researchers aimed to see if this approach reduces ch…
Sponsor: University of Manitoba • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Mindfulness app for anxiety in underserved groups fizzles out early
Symptom relief Stopped earlyThis study tested a smartphone app that teaches mindfulness meditation to help Black and Latino adults with anxiety during the COVID-19 pandemic. About 400 participants were assigned to one of two mindfulness programs or a waitlist. The trial was terminated early, so we don't hav…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Experimental drug aims to curb disinhibition in dementia patients
Symptom relief Stopped earlyThis study tested a drug called AVP-786 to see if it could safely reduce disinhibition—impulsive or inappropriate behavior—in people with neurodegenerative disorders like Alzheimer's or frontotemporal dementia. The trial planned to include many participants but was terminated ear…
Phase 2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Touchscreen device aims to give voice to dementia patients
Symptom relief Stopped earlyThis study tested a personalized touchscreen device (My PATI) to help people with Alzheimer's or related dementias communicate their care preferences. The goal was to improve quality of life for both patients and their caregivers. The study was terminated early, so results are li…
Sponsor: Florida International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Personalized exercise trial for chronic fatigue ends early
Symptom relief Stopped earlyThis study tested whether a personalized exercise program could reduce fatigue in people with chronic fatigue syndrome. About 101 participants were planned, but the trial was terminated early. The approach involved tailoring aerobic and resistance exercises based on weekly fatigu…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Brain zaps for pain and fatigue: a quick fix?
Symptom relief Stopped earlyThis study looked at whether a brief, noninvasive brain stimulation technique called tDCS could immediately reduce pain and improve function in people with fibromyalgia or chronic fatigue syndrome. About 20 participants received one session, and researchers measured changes in pa…
Sponsor: Hospital Donostia • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
CBDV study for Prader-Willi syndrome halted early
Symptom relief Stopped earlyThis study tested whether a cannabis-derived compound called CBDV could safely reduce irritability in children and young adults with Prader-Willi syndrome. Only 6 people enrolled before the study was stopped early. The goal was to see if CBDV helped with mood and behavior problem…
Phase 2 • Sponsor: Eric Hollander • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Robot trainer aims to help Parkinson's patients walk better
Symptom relief Stopped earlyThis study tested a robotic device called the G-EO Gait Trainer to help people with Parkinson's disease improve their walking. The device supports the body and guides leg movements to make walking practice safer and more effective. The trial was terminated early, so only limited …
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Exercise for IBD fatigue: tiny trial ends early
Symptom relief Stopped earlyThis study looked at whether moderate physical activity three times a week could reduce chronic fatigue in people with inflammatory bowel disease (IBD). Fatigue affects about 40% of IBD patients and can lower quality of life. The trial planned to compare a group that added extra …
Sponsor: University Hospital, Rouen • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Pill vs. IV: which works faster for postpartum hypertension?
Symptom relief Stopped earlyThis study aimed to compare two blood pressure medications—oral nifedipine (a pill) and intravenous labetalol (given through a vein)—for treating dangerously high blood pressure in women who have just given birth. The goal was to see which drug lowers blood pressure faster. Howev…
Phase 4 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can an antioxidant supplement ease bladder troubles in older women?
Symptom relief Stopped earlyThis pilot study tested whether MitoQ, an antioxidant supplement, could improve bladder symptoms like urgency and frequency in women aged 50 and older with metabolic syndrome. Twenty participants took either MitoQ or a placebo for 4 months, tracking their symptoms through questio…
Phase 2 • Sponsor: Iman Al-Naggar, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can less pressure mean better fibroid surgery?
Symptom relief Stopped earlyThis study looked at whether using a lower fluid pressure (60 mmHg) during hysteroscopy, a procedure to remove fibroids, works as well as the standard pressure (80 mmHg). The goal was to see if it improves surgery time, fluid use, and surgeon's view. The study was stopped early a…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Can a blood injection boost carpal tunnel surgery results?
Symptom relief Stopped earlyThis study looked at whether adding platelet-rich plasma (PRP) to standard carpal tunnel release surgery helps people with severe carpal tunnel syndrome. The trial planned to enroll 15 adults with severe nerve damage. It compared surgery with PRP to surgery alone. The study was t…
Sponsor: Michael Fredericson, MD • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
HIV-Positive Men's mental health study shuts down after just one participant
Symptom relief Stopped earlyThis study aimed to see if acceptance and commitment therapy (ACT), a type of talk therapy, could help HIV-positive men with mental health issues like stress and anxiety. Only one person enrolled before the study was stopped early. Because of this, no meaningful results were obta…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Psoriasis drug trial for sensitive areas halted early
Symptom relief Stopped earlyThis study tested the drug deucravacitinib (SOTYKTU) in 130 people with psoriasis on the palms, soles, and genitals. The goal was to see if it improves skin clearance and reduces symptoms. The trial was terminated early, so final results are limited.
Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Down syndrome hyperactivity drug trial stalls after just 3 kids enrolled
Symptom relief Stopped earlyThis study tested the drug guanfacine to see if it could reduce hyperactivity and impulsivity in children aged 6 to 12 with Down syndrome. The plan was to give the drug or a placebo for 8 weeks and measure behavior changes. However, the trial was stopped early after only 3 childr…
Phase 2 • Sponsor: Rachel G. Greenberg, MD, MB, MHS • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Mindfulness may ease anxiety for heart device patients
Symptom relief Stopped earlyThis study tested whether a mindfulness program (including meditation, body scans, and gentle yoga) could help people with implanted heart devices like ICDs or pacemakers feel less anxious, stressed, and depressed. The study planned to enroll 34 adults who had recently received s…
Sponsor: Chien Chih-Yin • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Breathing machine showdown: which mode helps obese patients best?
Symptom relief Stopped earlyThis study compared two types of non-invasive breathing support for people with sudden breathing failure who are obese or have sleep apnea. One machine automatically adjusts pressure and volume, while the other uses a fixed pressure setting. The goal was to see which method clear…
Sponsor: University Hospital, Rouen • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Walking poles tested for Parkinson's: a simple step forward?
Symptom relief Stopped earlyThis study looked at whether using walking poles during an 8-week independent walking program could improve walking and activity levels in people with Parkinson's disease. Eleven participants were assigned to walk with or without poles at least three times a week. The trial was t…
Sponsor: Pacific Northwest University of Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New drug aimed at treating apathy in dementia patients tested
Symptom relief Stopped earlyThis study tested a drug called CVL-871 to see if it is safe and can help reduce apathy (lack of motivation or interest) in people with dementia. The trial included 41 participants with mild to moderate dementia and clinically significant apathy. The main goal was to check for si…
Phase 2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Parkinson's sleep study halted early – what we know
Symptom relief Stopped earlyThis study looked at whether the drug safinamide (Xadago) could improve sleep quality in people with Parkinson's disease. Eleven participants took safinamide for 12 weeks while their sleep was measured. The trial was terminated early, so the results are not conclusive.
Phase 4 • Sponsor: Alain Kaelin • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Opioid trial for COPD breathlessness halted early
Symptom relief Stopped earlyThis study tested whether a low dose of fentanyl, a strong painkiller, placed under the tongue could help people with severe COPD feel less breathless during exercise. The trial planned to include 40 participants but was stopped early. Because it was terminated, we cannot draw cl…
Phase 2/3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Could a Head-Zap at home boost your brain?
Symptom relief Stopped earlyThis study tested whether a gentle, non-invasive brain stimulation technique (tDCS) done at home, along with computer-based brain games, could improve thinking and language skills in people with primary progressive aphasia, mild cognitive impairment, or dementia. Participants use…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New stent aims to dry up tears after eye surgery
Symptom relief Stopped earlyThis study tested a redesigned lacrimal stent, called the Slit Stent II, for people with severe tearing (epiphora) caused by a blocked tear duct. The stent has slits to allow tears to drain while it is still in place after DCR surgery. The trial planned to enroll 5 people to chec…
Sponsor: Thomas Gardner • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New COPD inhaler shows promise in tiny pilot study
Symptom relief Stopped earlyThis phase 2 pilot study tested a new dual bronchodilator inhaler called PT003 in 4 people with stable moderate-to-severe COPD. Researchers measured breathing patterns and lung function right after the first dose and again after 4 weeks of treatment. The goal was to see if PT003 …
Phase 2 • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Parkinson's apathy drug trial stalls after just 8 patients
Symptom relief Stopped earlyThis study tested whether istradefylline, a drug already approved for motor symptoms in Parkinson's, could also improve apathy and motivation. Only 8 people enrolled before the trial was terminated early. The results are too limited to draw any conclusions.
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Cooling the brain through the nose: new device tested for ICU fever
Symptom relief Stopped earlyThis study tested a device called CoolStat that is placed in the nose to cool down brain-injured patients with fever in the ICU. The goal was to see if it could safely and quickly bring their temperature to normal. Only 9 patients were enrolled before the study was stopped early,…
Sponsor: CoolTech LLC • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Glasses give kids a brighter future: study tests impact on learning and mental health
Symptom relief Stopped earlyThis study gave free eyeglasses to over 1,800 students aged 9-20 in Sierra Leone who had trouble seeing. Researchers wanted to find out if wearing glasses would improve their math and reading skills, and also help with anxiety and social well-being. The study was planned to last …
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Shock therapy for lungs? tiny TENS trial fizzles out
Symptom relief Stopped earlyThis study looked at whether a gentle electrical stimulation device (TENS) placed on the skin could help people with COPD exercise longer after a serious flare-up. The plan was to compare exercise time with and without TENS in a small group of patients. However, the study was sto…
Sponsor: Groupe Hospitalier du Havre • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Online therapy steps up against OCD in new study
Symptom relief Stopped earlyThis study tested whether a stepped-care approach using internet-based cognitive behavioral therapy (ICBT) works as well as group therapy or standard medical care for adults with obsessive-compulsive disorder (OCD). 46 adults in China received one of the three treatments for 6 we…
Sponsor: Shanghai Mental Health Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Buddy system for IBD teens: does a mentor make a difference?
Symptom relief Stopped earlyThis study looked at whether having a peer mentor—an older teen or young adult who also has IBD—can help youth ages 10-17 better manage their disease and improve their quality of life. Participants were randomly assigned to either a year-long mentoring program or educational acti…
Sponsor: Kelly Boone • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Storytime before surgery: could a toy ease Kids' fears?
Symptom relief Stopped earlyThis pilot study looked at whether an interactive storyteller called LUNII could lower anxiety in children aged 4 to 6 with cleft lip and palate before their bone graft surgery. The goal was to see if using the device before the operation would also reduce pain and shorten hospit…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Is RSV a hidden driver of severe COPD attacks?
Knowledge-focused Stopped earlyResearchers are studying adults with COPD who go to the emergency room or day hospital for sudden worsening of their breathing. The study checks how many of these patients test positive for respiratory syncytial virus (RSV) during the RSV season, from October to April. They compa…
Sponsor: Fundacio Privada Mon Clinic Barcelona • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Home infusions may help patients stick to treatment
Knowledge-focused Stopped earlyThis study looks at whether people with Fabry, Gaucher, or Hunter disease are more likely to continue their IV treatment when it's given at home versus at a hospital. Researchers will review existing data from 222 patients in Mexico. No new treatments are given; the goal is to un…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
20-Year review of lymphoma care reveals Real-World treatment success
Knowledge-focused Stopped earlyThis study examines the medical records of 400 people diagnosed with various types of lymphoma at a French hospital between 1999 and 2018. Researchers want to see how long patients survived and whether the care they received matched what medical guidelines recommend. The goal is …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can personalized recall timing boost word learning in kids with DLD?
Knowledge-focused Stopped earlyThis study explores whether tailoring when children with developmental language disorder (DLD) practice recalling new words can improve their learning. Researchers compare a standard fixed schedule to an adaptive one that adjusts to each child's progress. Four- and five-year-olds…
Sponsor: Purdue University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can new home monitors keep tabs on breathing support without a clinic visit?
Knowledge-focused Stopped earlyThis trial tests two new devices, NivolisMonitor and NivolisAnton, designed for people who use breathing support at home, such as non-invasive ventilation or high-flow nasal oxygen. NivolisMonitor measures breathing parameters like pressure, flow, and oxygen levels, while Nivolis…
Sponsor: VIVARDIS • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can genetics predict the worsening of geographic atrophy?
Knowledge-focused Stopped earlyThis study follows people with geographic atrophy, a severe form of age-related macular degeneration that causes blind spots, to see how their vision changes over time. Researchers will measure visual function, such as reading speed and sensitivity to light, and track the growth …
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
A 12-minute video could save new mothers' lives – can it teach them to spot danger?
Knowledge-focused Stopped earlyThis trial tests whether a 12-minute educational video, shown at hospital discharge, improves new mothers' knowledge of warning signs for severe postpartum complications like hemorrhage, infection, and high blood pressure. Participants – who are Black, Latinx, multiracial, Medica…
Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Ultrasound could uncover hidden vascular risks in turner syndrome
Knowledge-focused Stopped earlyThis study is looking at whether yearly ultrasound scans can detect blood vessel abnormalities throughout the body in women with Turner syndrome, not just in the heart area. Turner syndrome is a genetic condition that increases the risk of serious vascular problems, which can sho…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Study aims to predict drug failure in rare blood cancer
Knowledge-focused Stopped earlyThis study looked at whether two simple blood test results—hemoglobin and red blood cell distribution width—could predict if a person with polycythemia vera would stop responding to the drug hydroxyurea. Researchers planned to follow 76 adults starting hydroxyurea for the first t…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Which catheter wins? new study seeks patient preferences
Knowledge-focused Stopped earlyThis study looks at how adults with bladder problems decide which Coloplast catheter (SpeediCath or Luja) works best for them when they start self-catheterization. Researchers will track satisfaction and challenges over six months. The goal is to help healthcare providers recomme…
Sponsor: Coloplast NV/SA • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Gene Editing's lasting impact: a 10-Year safety watch
Knowledge-focused Stopped earlyThis study checks on people who previously received gene editing for hemophilia B or mucopolysaccharidosis (MPS) I or II. No new treatment is given; instead, participants are monitored for up to 10 years to see if any new health problems or worsening of existing conditions appear…
Sponsor: Sangamo Therapeutics • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Can a coordinated care team ease the aftermath of intensive care?
Knowledge-focused Stopped earlyThis pilot study tests a new approach to supporting people after a stay in the intensive care unit (ICU). Many ICU survivors face ongoing psychological and physical challenges, such as depression, anxiety, and disability. The intervention involves a case manager who coordinates a…
Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
MRI might reveal hidden pancreatic risks in obesity
Knowledge-focused Stopped earlyThis study investigates whether MRI can detect early signs of pancreatic damage linked to obesity and metabolic syndrome, which are risk factors for pancreatic cancer. Researchers will compare MRI images with tissue samples from patients undergoing pancreatic surgery, as well as …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
Knowledge-focused Stopped earlyThis study measures levels of a protein called NT-3 in the blood of people with peripheral neuropathy or Charcot-Marie-Tooth disease. Researchers will compare these levels with measures of muscle strength, mobility, and daily function. The goal is to see whether NT-3 levels corre…
Sponsor: Zarife Sahenk • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could a genetic marker guide future cancer therapies in taiwan?
Knowledge-focused Stopped earlyThis study is measuring how often a specific genetic marker (HLA-A*02:01) and a cancer-related protein (NY-ESO-1) appear in Taiwanese patients with solid tumors like head and neck, liver, lung, breast, and esophageal cancers. By understanding these frequencies, researchers hope t…
Sponsor: PharmaEssentia • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can 3D image fusion make angioplasty safer by cutting radiation?
Knowledge-focused Stopped earlyThis trial investigates whether using 3D image fusion during iliac angioplasty reduces the amount of radiation patients receive compared to standard practice. The study involves 37 adults with iliac artery narrowing who need angioplasty. Researchers will measure radiation exposur…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Dopamine may unclog lymphatic system in rare heart complication
Knowledge-focused Stopped earlyThis study looks at whether dopamine can improve lymph flow in people who developed protein-losing enteropathy (PLE) after Fontan surgery for single-ventricle heart disease. PLE is a serious complication where proteins leak into the gut, possibly due to poor lymphatic function. R…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Brain scans reveal why dementia changes personality
Knowledge-focused Stopped earlyThis study investigates how Alzheimer's disease and frontotemporal dementia alter a person's sense of self and ability to understand others. Researchers will compare patients with healthy older adults using questionnaires and brain imaging. The goal is to link changes in self-awa…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Psychedelics rewire Brain's learning? yale study investigates
Knowledge-focused Stopped earlyThis observational study at Yale University is recruiting 200 people who are already taking part in another trial where they may receive a serotonergic psychedelic (like psilocybin or LSD) or a placebo. Researchers want to understand how these substances change the brain's inform…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Russian study seeks hidden cases of rare liver disease in kids
Knowledge-focused Stopped earlyThis study looks at children and teens in Russia who may have a rare genetic condition called lysosomal acid lipase deficiency (LAL-D). Researchers will check for the disease in up to 1,200 participants using blood tests and genetic testing. The goal is to understand how often LA…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
How does a blood disorder drug perform in everyday practice?
Knowledge-focused Stopped earlyThis study looks at how the drug luspatercept is used in real-world clinics for patients with lower-risk myelodysplastic syndromes (MDS) or beta-thalassemia. Researchers will track patient characteristics, treatments, and outcomes like reduced need for blood transfusions. The goa…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Tafamidis tablet vs capsule: which works better?
Knowledge-focused Stopped earlyThis early-stage study aimed to compare how a tablet form of tafamidis is absorbed in the body compared to the existing capsule form. It involved 24 healthy adults who took a single dose of each form under fed conditions. The study was terminated early, so results may be limited.
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Newborn death prediction tool for early membrane rupture falls short
Knowledge-focused Stopped earlyThis study tried to create a score that doctors could use before birth to predict whether a newborn would die after the mother's water broke very early (between 22 and 28 weeks of pregnancy). The researchers looked back at medical records of 34 women to find factors that might pr…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could home blood tests transform hemophilia care? study seeks patient views
Knowledge-focused Stopped earlyThis study looked at how patients with hemophilia A or those on blood thinners feel about monitoring their blood clotting at home. Researchers interviewed 19 people to understand their needs and hopes for a new device that could measure clotting factors. The goal was to gather in…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study explores simple tests to replace colonoscopies for colitis patients
Knowledge-focused Stopped earlyThis study aimed to see if certain substances in stool and blood can predict whether the gut lining has healed in people with moderate to severe ulcerative colitis. Researchers planned to measure these markers in 62 adults before and after treatment. The study was terminated earl…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New sickle cell drug pociredir enters early human testing
Knowledge-focused Stopped earlyThis early-stage study is testing a new drug called pociredir in 24 adults with sickle cell disease. Researchers want to see how the drug moves through the body and whether taking it with food changes its effects. The goal is to gather safety and dosing information, not to treat …
Phase 1 • Sponsor: Fulcrum Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Fabry disease sperm study halted early
Knowledge-focused Stopped earlyThis study aimed to find out how common sperm problems are in men with Fabry disease. Researchers planned to check sperm samples from 22 men aged 18 to 65. The study was stopped early, so results are limited.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain and eye clues to emotion recognition in autism and psychosis
Knowledge-focused Stopped earlyThis study aimed to understand why people with autism or schizophrenia sometimes struggle to recognize emotions on faces. Researchers used brain wave recordings (EEG) and eye-tracking to see how participants processed facial expressions. The study included people with autism, sch…
Sponsor: Hôpital le Vinatier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Tiny hairs in fallopian tubes may hold key to ectopic pregnancy
Knowledge-focused Stopped earlyThis study looks at the tiny hair-like structures (cilia) inside the fallopian tubes of women who have had surgery to remove a tube or uterus. Researchers want to see if differences in these cilia help explain why some women have ectopic pregnancies (when a fertilized egg grows o…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Study checks if stopping a drug made polyps grow faster
Knowledge-focused Stopped earlyThis study reviewed medical records of 42 people with familial adenomatous polyposis (FAP) who had previously taken the drug erlotinib. Researchers wanted to see how quickly the disease progressed after the drug was stopped. The goal was to better understand what happens when tre…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Scientists probe Brain's consciousness switch during anesthesia
Knowledge-focused Stopped earlyThis study looked at how anesthesia changes brain activity in people with Parkinson's disease or essential tremor who were already scheduled for deep brain stimulation (DBS) surgery. Researchers recorded brain signals during a short period of anesthesia to understand which circui…
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Scientists dive into cells to unravel costello Syndrome's secrets
Knowledge-focused Stopped earlyThis study collects small skin samples from children aged 2 to 17 with Costello syndrome or a related condition. Researchers will analyze the cells to understand how a mutation in the HRAS gene affects energy use and mitochondria. The goal is to learn more about the disease's und…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Tiny study on eye pressure fluctuation in glaucoma patients ends early
Knowledge-focused Stopped earlyThis study aimed to measure how eye volume changes (a sign of pressure fluctuation) before and after cataract surgery in patients with exfoliative glaucoma, a type of glaucoma common in Brittany. Only 6 adults were enrolled before the study was terminated. The goal was to see if …
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
MRI vs. CT: a safer way to track cystic fibrosis lung health?
Knowledge-focused Stopped earlyThis study looked at whether MRI scans can detect changes in the lungs of people with cystic fibrosis as well as CT scans do. CT scans use radiation, so finding a reliable alternative like MRI could mean safer monitoring over time. The study included 212 patients aged 8 and older…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Yeast study in rare autoimmune disease terminated early
Knowledge-focused Stopped earlyThis study aimed to compare the types of Candida yeast found in patients with two forms of autoimmune polyendocrinopathy, a rare condition where the immune system attacks multiple glands. Researchers planned to collect samples from the mouth and urine of 7 participants to see how…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
PKU diet in childhood may shape adult IQ, study finds
Knowledge-focused Stopped earlyThis study looks at adults with phenylketonuria (PKU) who were diagnosed as newborns and treated with a special diet. Researchers want to see if how long and how strictly they followed the diet as children affects their intelligence (IQ) as adults. The goal is to use this informa…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny genetic clues may unlock eye disease mysteries
Knowledge-focused Stopped earlyThis study looked at people with cone disorders, a type of inherited eye disease that affects color vision and sharp sight. Researchers analyzed genetic changes of unknown significance to see if they cause disease. The goal was to improve genetic diagnosis, not to test a treatmen…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
COPD study investigates why patients struggle to fight lung infections
Knowledge-focused Stopped earlyThis study looked at whether a weak immune response to bacteria in COPD patients leads to more lung infections and flare-ups. Researchers collected sputum, blood, and nasal swabs from 23 hospitalized COPD patients during a flare-up and again 8 to 16 weeks later. The goal was to m…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Cleft jaw surgery study cut short: did it help patients?
Knowledge-focused Stopped earlyThis study aimed to see if orthognathic (jaw) surgery improves quality of life for people born with cleft lip and palate. Researchers planned to compare questionnaire scores before and 6 months after surgery in about 10 participants. The study was terminated early, so results are…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Spine device study ends early with only 4 patients
Knowledge-focused Stopped earlyThis study looked at the VERTICALE Cervical System, a device used to stabilize the spine during surgery. Researchers planned to track neck disability in patients with conditions like degenerative disc disease or trauma. Only 4 patients were enrolled before the study was terminate…
Sponsor: Silony Medical GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Scientists investigate mpox in severely weakened immune systems
Knowledge-focused Stopped earlyThis study looked at how the mpox virus spreads and how the immune system responds in people with advanced HIV. Researchers tracked the virus in different body samples and measured immune markers to better understand severe illness. The goal is to use these findings to improve tr…
Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists hunt for blood clues to tame unpredictable swelling attacks
Knowledge-focused Stopped earlyThis study aimed to find biomarkers (measurable substances in the blood) that could help doctors diagnose bradykinin angioedema and predict how severe attacks might be. The condition causes sudden, unpredictable swelling, and current tests don't work well for all types. Researche…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Why are people with this rare bone disorder prone to diabetes?
Knowledge-focused Stopped earlyThis pilot study aims to understand why people with pseudohypoparathyroidism type 1A (PHP1A) have a higher risk of type 2 diabetes. Researchers will measure insulin sensitivity and beta-cell function in 14 participants with PHP1A or related conditions, comparing them to matched h…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Web tool aims to boost HIV testing among black women in the south
Knowledge-focused Stopped earlyThis study tested a web-based program to help Black women in Texas use HIV and STI home tests and connect to treatment or PrEP. The program included five sessions with goal-setting and action plans. Only 31 women enrolled before the study was stopped early, so the findings are li…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Superhero training for food allergy safety falls short
Knowledge-focused Stopped earlyThis study aimed to help children aged 6-8 from low-income families learn how to avoid foods they are allergic to. The program used fun, hands-on activities to teach safety skills. The study was stopped early, so we don't have clear results on whether it worked.
Sponsor: Kent State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Brain scans reveal how skull surgery affects young Children's neural pathways
Knowledge-focused Stopped earlyThis study looked at how craniosynostosis—a condition where a baby's skull bones fuse too early—affects brain development. Researchers used special MRI scans and developmental tests to compare children with the condition before and after skull surgery to healthy children of the s…
Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Spinal tap could replace brain surgery for young tumor patients
Knowledge-focused Stopped earlyThis study looked at whether a liquid biopsy—testing the fluid around the brain and spinal cord—can find tumor DNA in children and young adults with brain tumors. The goal was to see if this safer, non-surgical test could replace risky tissue biopsies for diagnosis and monitoring…
Sponsor: Pediatric Brain Tumor Consortium • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Peeling eye membrane during retinal surgery: help or hype?
Knowledge-focused Stopped earlyThis study looked at whether peeling a thin membrane inside the eye (the internal limiting membrane) during surgery for a detached retina helps patients see better and prevents scar tissue. The trial was stopped early after enrolling only 21 people, so the results are not strong …
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New eye camera could spot hidden signs of blindness
Knowledge-focused Stopped earlyThis study tested a new, non-invasive eye imaging method called hyperspectral imaging. It takes pictures of the back of the eye using many different colors of light to find details not visible with standard cameras. About 679 adults with healthy eyes or eye diseases like diabetic…
Sponsor: Center for Eye Research Australia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Scientists hunt for clues in rare genetic brain disorder
Knowledge-focused Stopped earlyThis study aimed to observe how MECP2 duplication syndrome progresses over time by measuring biological markers in spinal fluid and blood, and by tracking changes in development, behavior, and seizures. It enrolled 29 males aged 1 month to 65 years with a confirmed genetic diagno…
Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Gut microbiome study in kids with autoimmune diseases ends early
Knowledge-focused Stopped earlyThis study aimed to compare the gut bacteria of children newly diagnosed with juvenile idiopathic arthritis, type 1 diabetes, or inflammatory bowel disease with those of their healthy siblings. Researchers wanted to see if differences in gut microbes and diet could explain why so…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Cystic fibrosis infection study halted early
Knowledge-focused Stopped earlyThis study aimed to find out how common non-tuberculous mycobacteria (NTM) infections are in people with cystic fibrosis in France. Researchers collected sputum and blood samples from 848 participants to test for NTM using culture and a new blood test. The study was terminated ea…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Sleep apnea machine tested for IPF lung health – but study stopped early
Knowledge-focused Stopped earlyThis study looked at whether using a CPAP machine at night could reduce abnormal acid reflux and lung inflammation in people with idiopathic pulmonary fibrosis (IPF) who also have sleep apnea. Only 7 people enrolled before the study was terminated early. The goal was to measure c…
Sponsor: University of Arizona • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Ibrutinib heart risks under the microscope: can we predict them?
Knowledge-focused Stopped earlyThis study aimed to understand why some people taking the cancer drug ibrutinib develop heart issues like atrial fibrillation (irregular heartbeat) and high blood pressure. Researchers planned to follow 8 patients with blood cancers, using heart tests and blood markers to try to …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New test may expand olaparib benefits to more ovarian cancer patients
Knowledge-focused Stopped earlyThis study tested a new lab method (RAD51 assay) to see if it could identify ovarian cancer patients whose tumors are vulnerable to the drug olaparib, even if they don't have BRCA gene mutations. The goal was to find a larger group of patients who might benefit from this treatmen…
Phase 2 • Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Heart study explores Yoga's effect on genes
Knowledge-focused Stopped earlyThis study tested whether a 16-week program of yoga and lifestyle changes could affect gene activity (micro RNA) and heart disease risk factors in 16 adults with coronary artery disease. Participants had either undergone a heart procedure or had non-obstructive heart disease with…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Brain wave test could spot stubborn depression
Knowledge-focused Stopped earlyThis study aimed to find brain and movement markers in people with a type of depression that doesn't respond to standard antidepressants, called anhedonic depression. Researchers measured brain waves (P300), walking speed, and hand movements in 36 participants. The goal was to id…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Which surgery keeps hiatal hernias away longer? study aims to find out
Knowledge-focused Stopped earlyThis registry tracked 336 adults who had surgery for a large hiatal hernia (over 3 cm) at least two years earlier. Some received a LINX magnetic implant to strengthen the valve between the stomach and esophagus, while others had a fundoplication (wrapping the stomach around the e…
Sponsor: Foregut Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New score could help eye surgeons predict who sees best after surgery
Knowledge-focused Stopped earlyThis study aimed to validate a scoring system that predicts whether patients will have good vision one year after combined cataract and epiretinal membrane surgery. The score uses factors like age, symptom duration, and initial vision. Researchers planned to enroll 164 adults age…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Tiny study on nerve stimulation for pain halted early
Knowledge-focused Stopped earlyThis study looked at a type of spinal cord stimulation (SCS) that doesn't cause tingling, called paresthesia-free SCS, in 10 adults with chronic pain. Researchers wanted to see how well it works and how it affects pain perception. The study was terminated early, so the findings a…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Hunt for hidden thyroid cancer genes ends early
Knowledge-focused Stopped earlyThis study looked for new genes that might increase the risk of developing differentiated thyroid cancer. Researchers planned to analyze the complete DNA of people with thyroid cancer and their family members. The study was stopped early and involved 34 participants.
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Rare disease study aims to map MLIV's natural course
Knowledge-focused Stopped earlyThis study followed 7 people with Mucolipidosis Type IV (MLIV) to learn how the disease naturally progresses. Researchers used tests like neuropsychological exams, blood and urine tests, and brain MRIs to find better ways to measure the disease. The goal was to improve future cli…
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Could a common antifungal pill fight brain tumors?
Knowledge-focused Stopped earlyThis early-phase trial tested whether posaconazole, a drug used for fungal infections, can reach brain tumors in high enough amounts to stop cancer cells from dividing. Seven adults with glioblastoma took the drug before surgery, and researchers measured drug levels in their spin…
Early phase 1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Liver study for cancer drug stopped early – only 2 people joined
Knowledge-focused Stopped earlyThis study looked at how moderate or severe liver problems change the amount of the cancer drug oral azacitidine in the blood. It was designed for adults with certain blood cancers. The study was stopped early after only 2 people enrolled, so the results are very limited.
Phase 1 • Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Lupus and COVID vaccines: immune response under the microscope
Knowledge-focused Stopped earlyThis study aimed to understand how the COVID-19 vaccine impacts the immune system in people with lupus, a chronic autoimmune disease. Researchers planned to enroll lupus patients to measure their immune response to the vaccine and see if lupus disease activity or treatments affec…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
PCOS hormone study halted early – what it means for IVF
Knowledge-focused Stopped earlyThis study looked at whether high levels of male hormones (hyperandrogenism) lower the chance of IVF success in women with PCOS. Researchers planned to track 32 women aged 18–39, but the study was terminated early. The goal was to see if these hormones affect pregnancy rates afte…
Sponsor: Clinique Ovo • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Scientists dig into DNA to unravel rare eye disorders
Knowledge-focused Stopped earlyThis study looked at over 100 people with inherited retinal dystrophies, a group of rare eye diseases that can cause vision loss. Researchers collected genetic and eye exam data to find links between specific gene mutations and symptoms. The goal was to better understand these di…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Laser vs. alcohol: which eye surgery method causes less haze?
Knowledge-focused Stopped earlyThis study compared two methods of removing the clear outer layer of the eye (the epithelium) during laser vision correction for nearsightedness and astigmatism. One method uses a laser, the other uses alcohol and manual scraping. The goal was to see which approach leads to less …
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New survey aims to better measure life quality in pituitary tumor patients
Knowledge-focused Stopped earlyThis study tested a new questionnaire called Prolac-10 to see if it can accurately measure quality of life in people with prolactinoma (a type of pituitary tumor) who are starting medical treatment. Only 8 people took part before the study was stopped early. The goal was to check…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Drug interaction study for radiprodil halted early
Knowledge-focused Stopped earlyThis early-stage study looked at how two common drugs (carbamazepine and itraconazole) change the levels of radiprodil in the blood of 30 healthy adults. The goal was to understand safety and dosing for future use in neurological conditions like tuberous sclerosis. However, the s…
Phase 1 • Sponsor: GRIN Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Elderly arthritis study reveals hidden health risks
Knowledge-focused Stopped earlyThis study aimed to understand how age influences serious health issues like infections, cancer, heart disease, and bone fractures in people with rheumatoid arthritis. Researchers compared patients over 65 with younger adults (18-50) who had the same disease. The study was stoppe…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
AI stethoscope could spot lung disease patterns
Knowledge-focused Stopped earlyThis study tested whether artificial intelligence can detect and classify abnormal lung sounds in people with cystic fibrosis, COPD, or pulmonary fibrosis. Researchers recorded lung sounds with an electronic stethoscope during routine checkups and analyzed them using AI. The goal…
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Rare disease mystery: scientists watch AMN progress in hopes of finding a cure
Knowledge-focused Stopped earlyThis study followed 65 adult men with a rare inherited nerve disease called AMN (a form of spastic paraplegia) to understand how their symptoms change over time. Researchers collected data on walking ability and quality of life. The goal was to fill gaps in knowledge about the di…
Sponsor: SwanBio Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Spine surgery registry aims to improve patient outcomes
Knowledge-focused Stopped earlyThis study was a registry that planned to follow 234 adults undergoing spine fusion surgery for conditions like spinal stenosis and degenerative disc disease. Researchers aimed to compare different surgical techniques and track long-term outcomes, including pain, function, and wh…
Sponsor: Spine and Scoliosis Research Associates • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Ear zaps may reveal nerve secrets
Knowledge-focused Stopped earlyThis study looked at how stimulating the ear with mild electrical pulses affects the body's automatic functions, like blood flow and temperature. Ten healthy volunteers had their skin temperature measured after ear stimulation. The goal was to understand if precise ear points mat…
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Cystic fibrosis gene fix tested in nasal cells
Knowledge-focused Stopped earlyThis study aimed to see if a new type of genetic therapy could fix a specific problem in the CFTR gene that causes cystic fibrosis. Researchers took nasal and rectal cell samples from 16 patients and tested the therapy in the lab. The study was terminated early, so we don't have …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:40 UTC
-
Hidden heart condition: study seeks to uncover missed diagnosis in heart failure patients
Knowledge-focused Stopped earlyThis study aims to find out how common transthyretin amyloidosis cardiomyopathy (ATTR-CM) is in Russian patients with a certain type of heart failure. Researchers will review medical records and then invite some patients for extra heart tests to confirm or rule out ATTR-CM. The g…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC
-
COVID-19 vaccine response under scrutiny in autoimmune patients
Knowledge-focused Stopped earlyThis study looked at how well the COVID-19 vaccine triggers an immune response in people with autoimmune or inflammatory diseases who take immunosuppressants or biologics. Researchers took blood samples before vaccination and at several points after to measure antibodies and T-ce…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:24 UTC
-
Gene therapy for krabbe disease: did it last?
Knowledge-focused Stopped earlyThis study follows up on children with Krabbe disease who received a one-time gene therapy infusion (FBX-101) in earlier trials. Researchers will monitor safety and measure motor skills over time. Only 2 participants are enrolled, so results are very limited.
Sponsor: Forge Biologics, Inc • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:47 UTC
-
Can a simple ultrasound replace MRI for Crohn's? small study investigates
Knowledge-focused Stopped earlyThis study looked at using point-of-care ultrasound (POCUS) to assess small bowel Crohn's disease. Researchers interviewed doctors, nurses, and patients to understand if POCUS could be useful in the NHS. They also compared how POCUS and MRI scans affected doctors' treatment decis…
Sponsor: Nottingham University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:32 UTC